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ABSTRACT  OF  THE  DISSERTATION  
  
Using  Machine-­Learning  to  Diagnose  Perception,  Feeling,  and  Action:    




Donald  Albert  Vaughn  Jr.  
Doctor  of  Philosophy  in  Neuroscience  
University  of  California,  Los  Angeles,  2017  
Professor  Mark  S.  Cohen,  Chair  
  
  
I  explored  the  capability  of  multivariate  machine  learning  on  low-­signal  and  bioinformatic  
data  to  distinguish  between  different  perceptual,  emotional,  and  behavioral  outcomes.  In  
Chapter  II,  I  designed  and  executed  an  experiment  to  evoke  differences  in  empathy  on  
the  basis  of  religious  identities  as  well  as  on  general  notions  of  ingroup  and  outgroup.  I  
discovered  that  the  act  of  simply  learning  about  another’s  religious  identity  correlated  
with  a  detectable  modulation  in  one’s  brain  activity—most  notably  in  regions  related  to  
empathy  and  sympathy—which  identified  subjects’  religious  ingroups  from  outgroups  
with  70%  accuracy.  In  Chapter  III,  I  used  multimodal  data  to  distinguish  between  control  
participants  and  patients  with  one  of  two  body-­image  disorders:  anorexia  nervosa  and  
body  dysmorphic  disorder.  These  data  included  psychometric  scales  of  obsessive-­
compulsive  behaviors,  depression,  anxiety,  and  insight;;  white  matter  connectivity  
patterns;;  and  neural  haemodynamic  activity.  My  models  achieved  72%  accuracy  in  
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distinguishing  healthy  controls  from  patients  with  anorexia  nervosa  or  body  dysmorphic  
disorder,  and  76%  accuracy  in  distinguishing  patients  with  anorexia  nervosa  from  those  
with  body  dysmorphic  disorder.  In  Chapter  IV,  I  extended  these  techniques  to  insurance  
claims  data  to  predict  the  actions  of  patients  and  doctors.  I  discovered  that  the  pattern  
of  care  delivered  by  doctors  predicted  the  hospitalizations  and  use  of  biologic  drugs  in  
patients  with  inflammatory  bowel  disease.  My  diagnostic  model  may  be  used  by  
healthcare  alongside  various  interventions  to  reduce  hospitalizations,  decrease  
expenditures  of  insurance  companies,  and  improve  patient  quality  of  life.  
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Chapter  I  -­  Introduction  
  
I  conducted  my  research  at  UCLA  under  the  mentorship  of  Dr.  Mark  Cohen.  During  this  
time,  I  worked  on  a  number  of  projects  related  to  the  functional  interpretation  of  
haemodynamics,  including  functional  near-­infrared  spectroscopy,  bias  introduced  into  
functional  magnetic  resonance  imaging  (MRI)  by  compressive  sensing  reconstruction,  
and  classification  of  attention  states  using  functional  MRI  (fMRI).  While  working  on  
classifying  attention,  I  began  to  comprehend  the  major  role  that  machine  learning  will  
play  in  the  future  of  neuroscience  and  medicine.  I  avoid  saying  that  you  are  your  brain  
because  so  far,  we  have  made  correlative  observations  with  regard  to  consciousness  
only.  It  is  eminently  clear,  however,  that  you  need  your  brain  (at  least  for  now).  If  you  
lose  the  pinky-­finger-­sized  piece  of  cortex  called  the  hippocampus,  the  brain  cannot  
form  episodic  memories.  If  you  drink  a  lot  of  alcohol,  your  saccades  will  be  jerky;;  your  
volition  does  not  seem  to  be  able  to  influence  the  binding  of  ethanol  to  neurotransmitter  
receptors.  A  change  in  the  brain  is  reflected  by  a  change  in  function.  As  far  as  
neuroscientists  can  tell,  the  converse  is  also  true:  a  change  in  function  is  reflected  by  a  
change  in  the  brain.  This  observation  is  the  fundamental  motivation  behind  my  thesis:  
namely,  we  can  employ  machine  learning  on  differences  in  brain  function  and  structure  
to  diagnose  various  human  conditions  in  novel  and  useful  ways.  
  
Here,  I  present  my  work  using  linear  classifiers  to  diagnose  how  we  perceive,  feel,  and  
act.  I  used  the  term  diagnosis  in  its  more  general  definition:  “to  analyze  the  cause  or  
nature  of”  human  conditions  (Merriam-­Webster  and  Inc  1997).  In  this  vein,  I  explored  
the  capability  of  multivariate  machine  learning  on  low-­signal,  bioinformatic  data  to  
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distinguish  between  different  perceptual,  emotional,  and  behavioral  outcomes.  I  made  
contributions  in  three  categories:  sensory  input,  emotional  computation,  and  motor  
output.  In  the  first  two  categories,  I  used  neuroimaging  and  psychometric  data;;  in  the  
last  case,  I  stretched  diagnostic  capabilities  further  by  using  non-­biological  data  to  
predict  both  the  medical  outcomes  of  patients  and  the  behavior  of  doctors.  
  
In  Chapter  II,  I  designed  and  executed  an  experiment  to  evoke  differences  in  empathy  
on  the  basis  of  religious  identities.  I  extended  this  investigation  and  model  beyond  
religion  to  the  general  notions  of  ingroup  and  outgroup.  I  discovered  that  the  act  of  
simply  learning  of  another’s  religious  identity,  without  ever  meeting  the  person  or  
gathering  additional  information,  correlated  with  a  detectable  modulation  in  one’s  brain  
activity,  most  notably  in  regions  related  to  empathy  and  sympathy.  Although  my  
manipulation  of  religious  labeling  was  a  small  perturbation  in  information,  it  produced  
neural  changes  sufficiently  robust  to  distinguish  between  each  participant’s  perceptions  
from  ingroup  members  versus  outgroup  members.  My  model  also  generalized  to  newly  
formed  arbitrary  affiliations  as  well  as  modulation  to  the  status  of  existing  religious  
outgroups.  This  experiment  showed  that  neuroimaging  can  distinguish  the  status  of  
social  affiliations  within  a  participant.  This  classification  was  motivated  by  DARPA’s  
funding  for  this  study  to  support  the  development  of  a  model  to  diagnose  large  biases  in  
empathy.  
  
In  Chapter  III,  I  used  multimodal  data  to  distinguish  between  control  (CTL)  participants  
and  patient  participants  with  one  of  the  two  body-­image  disorders:  anorexia  nervosa  
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(AN)  and  body  dysmorphic  disorder  (BDD).  These  data  included  psychometric  scales  of  
obsessive-­compulsive  behaviors,  depression,  anxiety,  and  insight;;  white  matter  
connectivity  patterns;;  and  neural  haemodynamic  activity.  The  results  supported  the  
hypothesis  that  differences  in  visual  processing  accounted  at  least  partially  for  the  
differences  between  patients  with  AN  /  BDD  and  neurotypical  CTL  participants.  In  the  
clinical  setting,  participants  with  AN  and  BDD  often  present  with  many  similarities,  
making  it  difficult  to  diagnose  AN  versus  BDD  with  certainty  (Hollander  et  al.  1992;;  
Ruffolo  et  al.  2006).  Given  their  symptomatic  overlap,  they  are  almost  certainly  not  
mutually  exclusive  diseases.  In  the  context  of  this  diagnostic  challenge,  I  created  a  two-­
part  classification  model  to  assess  the  degree  of  overlap.  My  models  achieve  72%  
accuracy  distinguishing  CTL  participants  from  patients  with  76%  accuracy  distinguishing  
patients  with  AN  from  those  with  BDD.  With  clinical  validation,  this  tool  may  be  useful  in  
the  clinical  management  of  participants  with  AN  and  BDD.  
  
In  Chapter  IV,  I  used  the  aforementioned  techniques  to  predict  the  actions  of  patients  
and  doctors.  My  classification  challenge  here  differed  fundamentally  from  the  previous  
chapters  because  my  data  were  not  related  to  neuroimaging  but  to  insurance  claims.  
These  insurance  claims  had  little  biological  information.  In  the  data  analysis,  I  used  
many  variables  (e.g.  that  the  occurrence  of  a  test  or  use  of  a  medication  did  not  convey  
the  patient’s  outcomes  from  the  test  or  use  of  medication).  For  example,  the  data  
indicated  that  an  x-­ray  was  performed,  but  not  how  it  was  interpreted  by  the  radiologist.  
Similarly,  the  number  of  Inflammatory  Bowel  Disease  (IBD)-­related  claims  submitted  by  
a  member  in  a  given  year  was  known,  but  it  was  unclear  if  these  claims  were  warranted  
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by  the  severity  of  medical  conditions.  Despite  this  ostensible  lack  of  biological  
information,  the  data  in  aggregate  correlated  with  an  important  latent  variable—the  
diagnostic  ability  and  methodology  of  clinicians.  To  some  degree,  the  tests  and  
treatment  provided  to  a  patient  reflected  the  diagnostic  ability  of  the  doctors.  I  
discovered  that  the  pattern  of  care  delivered  by  doctors,  in  concert  with  insurance  
company  protocols,  predicted  the  hospitalizations  of  and  use  of  biologic  drugs  in  
patients  with  IBD.  My  diagnostic  model  may  be  used  by  healthcare  to  couple  with  
various  interventions  to  reduce  hospitalizations,  reduce  expenditures  of  insurance  
companies,  and  improve  quality  of  life  among  patients.  
  
Next,  I  will  introduce  a  few  terms  and  methodologies  that  are  fundamental  to  this  study.  
1.1  Neuroimaging  
  
To  make  inferences  about  brain  structure  and  function,  it  is  helpful  to  measure  brain  
activity.  Many  well-­established  methods  use  blood  flow,  such  as  functional  near-­infrared  
spectroscopy  (Irani  et  al.  2007),  MRI  (Turner  2003),  metabolic  activity  via  PET  scan  
(Turner  2003),  and  electrical  activity  using  electroencephalography  (EEG),  
electrocorticography,  local  field  potential,  and  voltage  clamp  (Bunce  et  al.  2006;;  
Villringer  1997;;  Mulert  et  al.  2004).  In  this  thesis,  I  used  an  fMRI  metric  based  on  blood  
oxygenation  level-­dependent  (BOLD)  signals,  which  measures  the  ratio  of  
oxyhemoglobin  to  deoxyhemoglobin  by  exploiting  their  differences  in  magnetic  
susceptibility  (Kwong  et  al.  1992;;  Ogawa  et  al.  1990).  
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We  used  neuroimaging  software,  such  as  Statistical  Parametric  Mapping  (SPM)  and  
Oxford  Centre  for  Functional  MRI  of  the  Brain  Software  Library  (FMRIB  Software  
Library,  or  FSL),  to  convolve  the  timing  of  events  in  the  experiment  with  the  empirically  
observed  time  course  of  the  BOLD  signals  to  generate  a  model  of  blood  flow.  We  then  
used  the  magnitude,  timing,  and  noise  of  these  fits,  called  parameter  estimates  (PEs),  
to  estimate  the  strength  of  response  to  each  event  or  effect.  We  iterated  this  method  
across  all  brain-­volume  elements  (voxels)  that  were  collected  in  the  neuroimaging.  The  
method  was  both  univariate  (i.e.  the  response  in  each  voxel  is  assumed  independent  
from  its  neighbors)  and  linear  (i.e.  the  haemodynamic  response  is  from  the  overlap  of  
two  stimuli).  We  assumed  that  they  summed  together  rather  than  interacting.  This  
framework  for  processing  data  is  known  as  the  general  linear  model  (GLM).  
1.2  Classification  
  
Classifiers  are  mathematical  models  that  discriminate  between  different  groups.  In  my  
work,  this  involved  discriminating  between  either  different  groups  of  participants  (e.g.  
participants  diagnosed  with  AN  versus  BDD)  or  different  outcomes  within  a  participant  
(e.g.  being  stabbed  with  a  needle  versus  touched  with  a  cotton-­swab).  All  classification  
methods  were  applied  on  a  set  of  instances  (examples),  each  with  one  or  more  features  
(variables).  For  example,  when  classifying  participants  diagnosed  with  AN  from  those  
with  BDD,  each  participant  was  an  instance;;  their  age,  gender,  and  white  matter  density  
were  all  features.  Although  classifiers  can  be  applied  to  discriminate  between  multiple  
groups,  my  work  utilized  binary  classification  as  two  classes.  To  define  the  notion  of  
“group”  mathematically,  I  assigned  one  group  the  label  of  0  and  another  group  the  label  
of  1.    
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Scholars  used  multiple  methods  to  accomplish  classification,  including  logistic  
regression,  support  vector  machine  (SVM),  neural  network,  and  decision  tree  
(Westreich,  Lessler,  and  Funk  2010;;  Dreiseitl  and  Ohno-­Machado  2002).  This  study  
used  the  first  two  methods  (Dreiseitl  and  Ohno-­Machado  2002).  A  logistic  regression  is  
a  process  utilizing  all  available  data  points  and  assuming  that  the  data  will  conform  to  a  
particular  distribution  and  corresponding  probabilistic  interpretation  (Iyer,  Hosmer,  and  
Lemeshow  1991),  whereas  an  SVM  is  a  process  using  only  a  few  important  points  as  
the  support  vectors  and  making  no  assumptions  about  the  distribution  of  the  data  
beyond  these  points  (Suykens,  Vandewalle,  and  De  Moor  2001).  In  other  words,  an  
SVM  (Shawe-­Taylor  and  Sun  2011)  indicates  the  hyperplane  that  best  divides  the  data.  
I  clarify  “best”  in  the  Measuring  distance  section  below.  A  logistic  regression  is  better  
suited  for  a  probabilistic  interpretation,  while  an  SVM  is  more  appropriate  when  the  data  
distribution  is  unknown  (Boyd,  Parikh,  and  Chu  2011).  
  
I  chose  to  use  linear  classification  schemes  rather  than  artificial  neural  networks  
(ANNs),  which  are,  as  suggested  by  the  name,  mathematical  imitations  of  neurons  .  
Each  “neuron”  receives  input  from  multiple  other  neurons  in  the  network  and  then  
computes  the  sum  of  inputs  to  send  a  signal  with  some  probability  to  all  of  its  
downstream  neurons  (Yegnanarayana  2009).  ANNs  are  applied  successfully  in  
computer  vision  (Ciresan,  Meier,  and  Schmidhuber  2012),  Google  deep  learning  
(Schmidhuber  2015),  particle  detection  in  high-­energy  physics  (Baldi,  Sadowski,  and  
Whiteson  2014),  handwriting  recognition  (Voigtlaender,  Doetsch,  and  Ney  2016),  and  
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prostheses  (Li  et  al.  2010).  Unfortunately,  sufficient  training  of  ANNs  requires  a  large  
amount  of  input  data  (Hippert,  Pedreira,  and  Souza  2001).  Additionally,  as  a  result  of  
their  interconnected  design,  ANNs  are  highly  nonlinear,  so  it  is  difficult  to  interpret  the  
influence  of  a  single  feature  in  the  dataset  (Dreiseitl  and  Ohno-­Machado  2002).  Since  
my  three  projects  did  not  have  sufficient  examples  to  train  ANNs,  and  because  I  was  
interested  in  interpreting  the  relative  importance  of  each  feature,  I  chose  linear  
classification  schemes  instead.  
1.2.1  Signal  detection  theory  curves  
We  needed  a  concrete  method  to  assess  and  compare  the  performances  of  
classification  models.  One  model  may  be  sufficient  to  perform  more  accurately  than  
multiple  models,  but  if  we  place  unequal  value  on  the  performance  of  each  model  with  
one  particular  outcome,  multiple  models  will  be  ideal.  For  example,  in  Chapter  IV  I  
created  a  model  to  predict  whether  a  patient  will  be  admitted  to  the  hospital.  
Considering  the  cost  of  inaccurate  predictions,  the  cost  of  predicting  incorrectly  that  
someone  will  go  to  the  hospital  involves  follow-­up  tests  and  office  visits  only.  The  cost  of  
predicting  incorrectly  that  someone  will  not  go  the  hospital  is  far  greater  due  to  
thousands  of  dollars  in  medical  bills,  surgeries,  and  quality-­of-­life  disruption.  Therefore,  
the  large  financial  and  medical  impact  of  a  hospitalization  necessitates  that  diagnostic  
tests  are  biased  in  favor  of  predicting  a  hospitalization.  
  
For  the  cases  in  which  we  valued  each  outcome  equally,  we  measured  performance  by  
the  receiver  operator  characteristic  (ROC)  that  true-­positives  as  a  fraction  of  instances  
of  class  1  meant  identified  correctly  and  false-­positives  as  a  fraction  of  instances  of  
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class  0  meant  identified  incorrectly  (Swets  2014).  In  other  words,  ROC  measures  
sensitivity  vs  specificity.  We  used  the  area  under  curve  (AUC)  of  the  ROC  (AUC-­ROC)  
as  a  comparison  metric.  Despite  concerns  about  its  noisiness  and  application  to  small  
sample  sizes  (Hanczar  et  al.  2010;;  Lobo  and  Jiménez-­‐ Valverde  2008;;  Hand  2009),  the  
machine-­learning  community  often  uses  AUC-­ROC  for  model  comparison  (Hanley  and  
McNeil  1983).  Perfect  classifiers  have  100%  sensitivity  and  specificity  corresponding  to  
an  AUC  of  100%,  while  chance  classifiers  have  a  mean  AUC  of  50%.    
  
For  the  cases  in  which  we  valued  the  outcomes  of  class  1  more  than  outcomes  of  class  
0,  we  measured  the  performance  by  the  precision-­recall  (PR)  curve  (Fawcett  2006)  as  
precision  versus  recall,  another  name  for  sensitivity.  Precision,  also  known  as  positive  
predictive  value  (PPV),  was  calculated  as  the  instances  of  class  1  that  were  identified  
correctly  divided  by  the  number  of  times  that  the  model  predicted  class  1.  Perfect  
classifiers  had  an  area  under  the  PR  curve  (AUC-­PR)  of  100%,  whereas  chance  
classifiers  had  a  mean  AUC-­PR  at  the  frequency  of  class  1  in  the  dataset.  We  used  
AUC-­ROC  in  two  cases  and  AUC-­PR  in  a  third  case  because  optimizing  in  ROC  space  
does  not  guarantee  optimal  model  performance  in  PR  space  (Davis  and  Goadrich  
2006).  
1.3  Odds  ratios  
  
In  Chapter  IV,  I  worked  with  the  odds  ratio  (OR),  also  known  as  likelihood,  as  the  
probability  of  one  outcome  divided  by  the  probability  of  the  other  (Bland  2000).  If  the  
participant  had  AN  with  probability  ⅔  and  BDD  with  probability  ⅓,  the  OR  is  2  due  to  the  
probability  of  AN  divided  by  probability  of  BDD  (⅔  divided  by  ⅓).  In  other  words,  it  is  
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twice  as  likely  that  the  participant  has  AN  than  BDD.  An  OR  greater  than  1  signified  that  
the  outcome  was  more  likely  than  the  alternative,  while  an  OR  less  than  1  signified  that  
the  outcome  was  less  likely  than  the  alternative.  A  variant  of  the  OR  is  the  log  odds  ratio  
(LOR,  also  termed  log  odds  or  log  likelihood)  or  simply  the  log  of  OR.  The  LOR  was  
relevant  because  the  coefficients’  output  from  a  logistic  regression  were  log  odds.  For  
the  LOR,  a  negative  coefficient  indicated  that  the  parameter  was  predictive  of  the  label  
0,  while  a  positive  coefficient  was  predictive  of  the  label  1.  
1.4  Measuring  distance  
  
One  important  factor  in  quantifying  the  “best”  hyperplane  is  the  method  of  distance  
calculation.  Let  us  say  that  you  are  in  downtown  San  Diego,  which,  like  Manhattan,  has  
a  street  grid.  If  you  are  standing  on  4th  Ave  and  A  St,  and  you  assume  the  blocks  are  
square,  which  is  closer:  (1)  10th  Ave  and  A  St  or  (2)  8th  St  and  D  St?  Option  (1)  is  6  
blocks  up  and  0  blocks  over,  while  option  (2)  is  4  blocks  up  and  3  blocks  over.  If  you  
walk,  (1)  is  closer  since  6  blocks  are  fewer  than  7.  If  you  fly,  (2)  is  closer  since  sqrt(32  +  
42)  =  5  blocks.  Mathematicians  quantify  this  concept  as  L1  vs  L2  distance  (Bellot  and  
Krause  1988).  The  “best”  hyperplane  or  regression  fit  may  depend  on  the  type  of  
distance  used  because  L1  distance  is  always  greater  than  or  equal  to  L2  distance.  L1  
classifiers,  therefore,  incur  a  greater  distance  penalty  for  each  feature  included;;  
subsequently,  more  features  have  coefficients  driven  to  0  because  their  explanatory  
power  does  not  outweigh  those  of  other  features  significantly  (Aggarwal,  Hinneburg,  
and  Keim  2001).  I  invoked  this  sparsifying  effect  of  an  L1  penalty  regularly  in  my  
models.  
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1.5  Graph  theory  metrics  
  
In  a  highly  linear  system,  such  as  firing  a  gun,  the  finger  pulls  the  trigger  to  enable  the  
firing  pin  to  contact  with  a  round  in  the  chamber,  which  ignites  the  gunpowder  and  
expels  the  bullet.  It  is  trivial  to  trace  causality.  The  human  brain,  on  the  other  hand,  is  a  
highly  nonlinear  interconnected  network  where  causality  is  difficult  to  define,  much  less  
trace.  To  understand  the  nonlinear  behavior  of  the  brain,  neuroscientists  employ  a  
graph  theory,  which  is  a  branch  of  mathematics  designed  for  dealing  with  networks  
(West  2001).  In  the  analysis  of  white  matter  data  of  patients  with  AN  or  BDD,  I  used  a  
single  graph  theory  metric,  the  characteristic  path  length.    
  
Path  length  represents  the  shortest  distance  between  two  nodes  /  vertices  in  a  graph  
(Newman  2006).  The  mean  shortest  path  length  is  defined  as  the  shortest  number  of  
steps  required  to  connect  two  nodes  averaged  across  all  unique  node  pairs.  This  is  also  
known  as  the  characteristic  path  length  (CPL)  (Sporns  et  al.  2004).  In  this  analysis,  CPL  
gives  a  numerical  metric  for  the  ease  of  parallel  information  transfer.  One  concern  with  
CPL  is  that  a  population  (e.g.  participants  with  AN)  may  have  a  larger  CPL  simply  
because  the  population  had  a  larger  network  size  (van  Wijk,  Stam,  and  Daffertshofer  
2010).  We  therefore  used  the  normalized  path  length,  defined  as  observed  CPL  divided  
by  the  CPL  of  an  identically  sized  but  randomly  connected  network  (calculated  by  
simulation)  to  measure  information  transfer  while  controlling  the  network  scale.  
1.6  Technical  methods  
The  methods  described  in  this  section  are  common  in  all  chapters.    
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I  calculated  confidence  intervals  for  all  summary  statistics  using  a  percentile  bootstraps  
with  10,000  resamples  (Dixon  2002).  I  performed  all  significance  testing  for  a  difference  
in  the  means  of  multiple  groups  using  a  permutation  test  (also  known  as  an  exact  test  or  
randomization  test)  with  10,000  resamples  (Oden  and  Wedel  1975).  
1.6.1  Feature  extraction  from  functional  data  
This  section  details  how  I  translated  the  whole-­brain  GLM  results  from  fMRI  data  into  
the  features  of  classification.  For  each  subject  and  each  condition,  I  averaged  the  
whole-­brain  PEs  in  a  region  of  interest  (ROI)  to  obtain  the  average  activation  in  the  
region  (Figure  1).  I  repeated  this  method  for  all  ROIs,  resulting  in  a  collection  of  
features  for  the  instance  and  condition,  and  then  for  each  condition  and  instance,  





Figure  1  -­  creating  features  from  whole-­brain  activity.  For  any  given  conditions  and  subjects,  the  
whole-­brain  PEs  (A)  averaged  in  an  ROI  (B)  averaged  activation  in  the  region.  This  was  completed  for  all  
ROI  resulting  in  a  collection  of  features  for  the  instance  and  condition  (C).  This  method  was  repeated  for  
each  condition  and  instance,  resulting  in  a  dataset  of  instances  by  the  features  and  conditions.  Image  (B)  
was  used  under  license  for  non-­commercial  use  with  modification.  
  
  
Since  PEs  have  arbitrary  units,  it  may  be  difficult  to  compare  activation  across  subjects.  
For  example,  a  participant  may  respond  with  magnitude  5  in  the  visual  cortex  when  
observing  one  of  the  hands  being  stabbed  painfully  and  4  when  observing  a  hand  being  
touched  with  a  cotton  swab.  Another  participant  may  respond  with  magnitude  8  for  
being  stabbed  and  6  for  being  touched.  The  second  subject  responds  more  to  both  
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conditions,  which  indicates  that  using  the  raw  values  would  not  confer  any  
discriminatory  power  between  stabbing  and  touching.  Instead,  if  we  look  at  a  subject’s  
response  to  each  condition  with  reference  to  their  mean  response,  a  detectable  signal  
will  emerge.  Consequently,  the  first  subject’s  stab  response  is  0.5  units  higher  than  their  
average  response,  and  the  second  subject’s  stab  response  is  1  unit  higher  than  their  
average  (Figure  2).  This  technique  is  reminiscent  of  a  paired  t-­test  but  is  more  general.  
The  main  difference  is  that  I  demeaned  multiple  instances  per  subject  and  used  the  
resulting  values  together  to  train  my  classification  model.  I  am  specific  about  the  exact  
methodology  here  because  a  counterfactual  methodological  choice  could  have  been  to  
take  the  ratio  of  each  PEs  with  respect  to  the  mean  rather  than  the  arithmetic  difference.  
  
  
Figure  2  -­  creating  features  from  whole-­brain  activity.  For  classification,  ROI-­averaged  PEs  from  the  
GLM  were  demeaned,  per  subject,  to  bring  all  values  into  a  comparable  space.  
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1.6.2  Significance  testing  
To  assess  model  performance,  I  performed  cyclical  leave-­one-­out  cross-­validation  of  
the  data.  In  this  validation  process,  the  models  are  trained  using  all-­but-­one  exemplar  
and  tested  on  the  one  excluded  exemplar.  The  identity  of  the  test  exemplar  was  cycled  
such  that  every  datapoint  was  used  for  testing  only  once.    
  
To  assess  the  significance  of  my  predictions,  I  used  permutation  testing  to  estimate  the  
empirical  probability  distributions  of  a  classifier  with  no  relationship  between  the  
potentially  predictive  features  and  the  label.  To  disrupt  any  potential  relationship  
between  features  and  outcomes,  I  permuted  diagnosis  labels  randomly  without  
replacement  while  keeping  input  data  the  same.  I  conducted  the  same  process  of  
training  and  validation  on  these  permuted  datasets  and  repeated  this  for  10,000  
permuted  datasets  to  estimate  the  probability  distribution  of  all  reported  summary  
statistics  empirically.  I  determined  the  empirical  p-­value  as  the  fraction  of  permuted  
datasets  that  achieved  a  summary  statistic  as,  or  more,  extreme  than  that  observed  in  
the  original  data.  Finally,  I  used  the  results  of  these  permutations  to  determine  the  
significance  of  feature  weights.  
  
In  Chapters  II  and  III,  I  used  AUC-­ROC  as  the  summary  statistic  for  assessing  model  
performance.  In  Chapter  IV,  I  used  AUC-­PR  as  the  summary  statistic  for  assessing  
model  performance.  AUC  has  been  shown  to  provide  a  better  assessment  of  model  
performance  than  accuracy  (Bradley  1997).  I  performed  all  classifications  in  MATLAB  
using  the  LibLinear  toolbox  (Fan  et  al.  2008).  
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I  was  careful  to  avoid  non-­independence  errors  -­  “  a  violation  of  independence  between  
selection  and  the  subsequent  statistical  measure“  (Vul  and  Kanwisher  2010)  -­  as  they  
guarantee  a  statistical  result  and  thus  yield  no  information  (Culham  2006).  This  type  of  
error  plagued  the  formative  years  of  social  neuroscience  research  and  must  be  avoided  
carefully  (Vul  et  al.  2009).  As  an  example,  if  I  generated  two  sets  of  random  data,  
subtracted  one  from  the  other  to  identify  distinguishing  features,  and  then  used  those  
features  to  see  if  I  could  classify  one  set  versus  the  other,  my  classifier  would  perform  
better  than  chance,  but  only  because  I  am  relying  on  areas  that  I  pre-­selected  to  show  
the  effect.  As  an  example,  in  Chapter  II  I  do  not  use  the  network  found  by  subtracting  
the  ingroup  and  outgroup  conditions  to  classify  those  conditions  subsequently,  even  
though  there  is  a  priori  reason  to  suspect  those  same  regions  may  be  involved.  
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When  observers  witness  someone  in  pain,  they  display  neural  activation  patterns  similar  
to  if  they  have  experienced  the  pain  themselves.  I  located  the  brain  regions  activated  in  
this  so-­called  empathy  network  and  analyzed  activation  in  observers  who  watched  
videos  of  hands  subjected  to  pain.  I  found  that  the  empathy  network  and  other  
mentalizing  regions  displayed  more  activation  when  observers  watched  hands  labeled  
with  the  observer’s  own  religion  rather  than  hands  labeled  with  other  religions.  
Multivariate  activation  patterns  in  empathy  and  mentalizing  networks  discriminated  
religious  ingroups  from  religious  outgroups  with  70%  accuracy.  In  two  validation  
experiments,  this  model  also  discriminated  successfully  between  newly  formed  teams.  
The  interaction  of  empathy  and  mentalizing  regions  may  prove  to  be  a  useful  diagnostic  
tool  in  assessing  bias  in  relationships  and  affiliations.  
2.2  Introduction  
  
To  diagnose  differences  in  empathy,  I  first  need  to  define  the  term.  Unlike  quantum  
mechanics,  diffusor  tensor  imaging,  or  special  relativity,  empathy  is  a  word  and  concept  
coined  by  society  and  culture  long  before  it  appeared  in  a  rigorous  academic  context.  
Without  constraints  and  specifications,  it  is  ambiguous.  Over  a  hundred  years  ago,  
Edward  Titchener  introduced  “empathy”  from  German  to  English  as  “the  attempt  by  one  
self-­aware  self  to  comprehend  unjudgmentally  the  positive  and  negative  experiences  of  
another  self”  (Cuff  et  al.  2016).  Since  then,  the  field  of  psychology  developed  a  gradual  
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appreciation  for  the  complexity  of  human  emotional  exchange  and  subsequently  
differentiated  empathy  from  other  related  phenomena  such  as  mimicry  (automatic  
synchronization  of  expressions  and  physicality),  emotional  contagion  (automatic  
“infection”  by  other  people’s  emotions),  and  sympathy  (intentional  feeling  for  another  
person),  among  many  others  (Becker  1931;;  Hatfield,  Cacioppo,  and  Rapson  1994;;  
Batson  2009;;  Hatfield,  Rapson,  and  Le  2009;;  Batson,  Fultz,  and  Schoenrade  1987).    
  
Here,  I  focused  on  empathy  and  sympathy.  These  concepts  are  often  conflated  (Barnett  
and  Mann  2013;;  Pavey,  Greitemeyer,  and  Sparks  2012;;  Wispé  1986;;  Eisenberg  and  
Miller  1987)  but  disambiguated  succinctly  by  Tania  Singer  and  Claus  Lamm  as  (1)  
empathy:  feeling  with  someone  and  (2)  sympathy:  feeling  for  someone  (Singer  and  
Lamm  2009).  In  this  phrasing,  empathy  and  the  often-­mentioned  experience  sharing  
(“vicariously  sharing  targets’  internal  states”)  (Gallese,  Keysers,  and  Rizzolatti  2004)  are  
two  words  for  approximately  the  same  concept.  
  
The  most  plausible  causal  explanation  for  this  automatic,  empathic  experience  sharing  
is  the  mirror  neuron  system.  First  discovered  in  macaques  (di  Pellegrino  et  al.  1992;;  
Gallese  et  al.  1996;;  Rizzolatti  et  al.  1996),  mirror  neurons  fire  when  an  animal  is  
performing  an  action  or  watching  another  animal  perform  the  same  action.  Since  social  
cognition  and  mimicry  are  fundamental  to  prosocial  human  behavior,  it  is  logical  that  
brain  activation  in  regions  associated  with  mimicry  may  also  be  related  to  social  and  
empathetic  behavior  (Eisenberg  and  Miller  1987;;  Miller  and  Eisenberg  1988;;  Perry  and  
Szalavitz  2010).  Activity  in  the  pars  opercularis,  a  key  player  in  the  mirror  neuron  
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system  (Iacoboni  et  al.  2005),  correlates  with  children's  empathic  behaviors  and  
interpersonal  skills  (Pfeifer  et  al.  2008).  Scholars  also  found  that  functional  and  
structural  abnormalities  in  this  network  are  correlated  with  psychopathy  (Decety  et  al.  
2013),  a  diseased  characterized  by  deficits  in  affective  and  interpersonal  abilities  (Ellis  
1982;;  Hare  2003).  Although  it  was  thought  originally  that  psychopathy  was  associated  
with  a  nonspecific  decrease  in  empathy-­related  neural  activity,  more  recent  evidence  
suggests  that  there  is  a  marked  but  multivariate  difference  (Decety,  Skelly,  and  Kiehl  
2013).  One  of  the  most  robust  diagnostic  measures  of  differences  in  empathy—from  
psychopaths  to  children  to  normally  functioning  adults—involves  the  response  to  
watching  another  person  in  pain.  
  
Neuroimaging  reveals  that  when  we  watch  another  person  getting  hurt,  we  experience  
activation  in  affective  regions  involved  in  the  perception  of  our  own  pain  (Botvinick  et  al.  
2005;;  Hein  and  Singer  2008;;  Bruneau,  Jacoby,  and  Saxe  2015;;  Singer  2004;;  Valeriani  
et  al.  2008).  Importantly,  this  empathy-­related  response  is  not  constant;;  rather,  it  is  
modulated  by  one’s  beliefs  about  the  person  being  hurt.  For  example,  if  the  observer  
believes  that  the  pain  recipient  has  acted  unfairly  in  a  simple  economic  exchange,  the  
observer  displays  a  diminished  empathy  response  (Singer  et  al.  2006).  Similarly,  if  the  
observer  learns  that  the  victim  is  receiving  a  large  monetary  compensation  for  
undergoing  the  pain,  empathy  diminishes  (Guo  et  al.  2011).
  
  
Modulation  of  empathy-­associated  regions  occurs  along  the  lines  of  group  distinctions  
as  well.  In  general,  people  are  more  empathic  toward  members  of  their  ingroup  than  
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toward  members  of  an  outgroup.  Prior  research  demonstrates  a  neural  ingroup  bias  for  
one’s  preferred  sports  team  (Cikara,  Botvinick,  and  Fiske  2011;;  Hein  et  al.  2010),  for  
one’s  cognitive  equivalents  (Montalan  et  al.  2012),  and  for  members  of  the  same  racial  
group  (Contreras-­Huerta  et  al.  2013;;  Xu  et  al.  2009;;  Azevedo  et  al.  2012).  
    
Ingroup  bias  affects  more  than  our  neurons;;  it  motivates  our  actions  (and  inaction)  
subconsciously  with  tangible  consequences.  At  the  simplest  level,  members  of  an  
ingroup  are  more  likely  to  help  a  fellow  ingroup  member  (Nadler,  Harpaz-­Gorodeisky,  
and  Ben-­David  2009).  Judicial  outcomes  favor  ingroup  members  (Shayo  and  Zussman  
2011)  and  ingroup  biases  modulate  how  bystanders  respond  in  emergency  situations  
(Levine  et  al.  2005).    
  
More  often,  however,  the  signs  of  ingroup  memberships  are  less  obvious.  We  are  
already  beginning  to  appreciate  how  these  biases  exert  influence  in  situations  such  as  
the  court,  where  the  jury  has  significant  information  about  the  people  whom  they  
subconsciously  assign  to  their  "ingroup"  or  "outgroup."  But  what  if  this  bias  can  be  
evoked  with  much  less  information,  such  as  a  simple  text  label  denoting  a  faceless  
stranger's  religion?  Then,  perhaps,  the  ingroup/outgroup  bias  may  be  affecting  everyday  
situations  in  more  subtle  ways  that  we  have  yet  to  appreciate.  To  what  degree  does  the  
constant  barrage  of  information  suggesting  micro-­allegiances  –  perhaps  appearing  as  
symbols,  text  labels,  clothing  choices,  or  conversational  intonation  –  influence  neural  
activity  and  subsequent  behavior?  Can  a  text  label  denoting  someone’s  religion,  for  
instance,  elicit  a  biased  response?  Understanding  the  influence  of  this  allegiance  
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information  may  aid  in  detecting  the  biasing  effect  of  narratives  and  eventually  help  
prevent  harmful  action  by  people  with  strong  biases.  
  
Despite  being  one  of  the  most  strongly  polarizing  allegiances,  the  effect  of  religious  
labels  on  neural  activity  has  not  been  widely  studied;;  in  fact,  to  my  knowledge  there  is  
only  one  case.  In  2014,  a  single  EEG  study  found  a  bias  in  P2  (a  positive  deflection  in  
the  event-­related  potential  around  200ms)  and  N2  (a  negative  deflection  in  the  event-­
related  potential  after  200ms)  amplitudes  on  the  basis  of  religious  identity  congruency.  
However,  it  is  unclear  which  regions  drive  this  effect  and  to  what  degree  they  might  be  
able  to  diagnose  larger  biases  in  empathy  (Huang  and  Han  2014).  As  detailed  in  this  




I  recruited  135  participants  (29.2  +/-­  8.9  years,  63  males,  108  right-­handed)  with  normal  
or  corrected-­to-­normal  vision  from  the  Houston,  TX  metropolitan  area  and  compensated  
the  participants  for  their  time.  I  excluded  8  participants’  data  due  to  errors  in  MRI  
acquisition  or  reconstruction  and  an  additional  22  participants  due  to  excessive  head  
motion  as  indicated  by  an  absolute  mean  displacement  greater  than  3.0  mm,  leaving  
105  participants  for  analysis.    
    
To  obscure  the  true  motivation  for  the  study,  I  informed  participants  that  I  was  
investigating  the  relationship  between  pain  and  memory  for  religions.  Since  I  did  not  
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disclose  our  true  interest—understanding  the  neural  empathetic  response—this  study  
qualifies  as  deceptive  research.  The  Baylor  College  of  Medicine  IRB  approved  the  study  
before  its  conduction.  During  an  informal  exit  interview,  none  of  the  subjects  reported  
skepticism  towards  its  purported  nature.  
2.3.2  Behavioral  Questionnaires  
First,  participants  declared  their  religious  identity  (including  agnostic  or  atheist)  as  
specifically  as  possible.  Next,  participants  completed  five  additional  surveys,  which  
collectively  quantified  their  degree  of  religiosity,  alignment  with  right  wing  
authoritarianism,  and  strength  of  overall  empathy:  (1)  Balanced  Emotional  Empathy  
Scale  (BEES)  (Mehrabian  and  Epstein  1972;;  Mehrabian  1997);;  (2)  Davis  Emotional  
Empathy  Interpersonal  Reactivity  Index  (Davis  1983)  (3)  Right  Wing  Authoritarianism  
Scale  (Altemeyer  1981);;  (4)  Religious  Conviction  Scale  (Dawkins  2016);;  and  (5)  
Religious  Orientation  Scale  (Allport  and  Ross  1967).  None  of  the  surveys  asked  
participants  about  the  extent  of  empathy  they  feel  toward  members  of  their  own  or  other  
religions,  since  this  would  have  revealed  the  true  purpose  of  the  study.    
2.3.3  Stimuli  
I  programmed  all  stimuli  in  MATLAB  with  PsychToolbox  (Kleiner  et  al.  2007;;  Brainard  
1997;;  Pelli  1997).  Participants  viewed  the  stimuli  on  a  back-­projected  screen  while  lying  
supine  in  the  scanner.  Overall,  I  designed  the  experiments  with  two  primary  intentions:  
to  provide  the  minimum  amount  of  information  on  each  ingroup  and  outgroup,  and  to  
reflect  realistically  the  religious  diversity  found  in  communities  around  the  world.  
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Baseline  block  
First,  participants  viewed  the  trials  in  which  6  hands,  selected  randomly  from  12  
possible  versions,  appeared  on  the  screen.  Each  hand  was  similar  in  skin  tone  and  
apparent  age  but  was  differentiated  by  an  arbitrary  bracelet  and  text  label  that  conferred  
a  unique  identity.  The  text  label  remained  in  association  with  its  hand  for  the  duration  of  
the  trial.  After  2-­4  seconds,  the  computer  selected  a  hand  randomly,  as  indicated  by  the  
appearance  of  a  red  border  around  the  image.  After  6  seconds,  the  selected  image  
moved  into  the  middle  of  the  screen.  The  image  became  a  video,  lasting  2.3  seconds,  in  
which  the  hand  was  either  stabbed  with  a  syringe  needle  or  touched  with  a  cotton  swab  
(Figure  3A);;  the  events  were  similar  from  a  visual  perspective  (angle-­of-­approach  and  
timing)  but  different  in  emotional  impact  (Supplementary  Figure  S1).  Participants  
viewed  multiple  stabbing  and  touching  events,  separated  by  a  blank  screen  for  8-­12  
seconds  as  the  inter-­trial  interval  (ITI).  To  reduce  desensitization  over  the  course  of  
viewing  many  stabs  and  touches,  I  filmed  stabbing  and  touching  events  from  6  different  
angles,  and  I  shuffled  the  position  of  each  hand  and  its  associated  text  label  for  each  
trial.    
  
In  most  versions  of  the  experiment  (see  Experiment  1,  below),  participants  began  by  
observing  6  stab  trials  and  6  touch  trials.  I  used  the  differences  between  the  baseline  
stab  and  touch  conditions  as  a  functional  localizer  to  generate  an  operational  definition  
for  the  empathy  network.  A  few  participants  completed  alternative  experiments  instead  
(see  Experiment  2  and  Experiment  3  below).  
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Experiment  1:  religious  affiliations  
After  participants  completed  the  baseline  block,  the  hands  reappeared  with  labels  of  
religious  groups  rather  than  arbitrary  text  labels.  The  next  60  trials  were  otherwise  
identical  to  the  first  block.  For  each  participant,  the  computer  assigned  religious  labels  
to  the  hands  randomly,  but  once  assigned,  labels  remained  with  the  same  hands  for  the  
duration  of  the  trials.  Each  hand  was  subjected  to  an  equal  number  of  stabs  and  
touches,  and  each  hand  was  selected  for  the  same  number  of  trials  as  each  other  hand.  
In  these  60  trials,  each  of  the  6  religions  were  selected  for  5  stab  and  5  touch  trials.    
  
I  defined  the  religious  ingroup  condition  to  include  trials  in  which  the  participant  
observed  a  hand  labeled  with  their  religious  identity,  and  I  defined  the  religious  outgroup  
condition  to  include  trials  in  which  the  participant  observed  a  hand  labeled  with  any  
religious  identity  other  than  their  own.  I  subdivided  each  of  these  conditions  further  into  
a  touch  and  stab  condition.  This  yielded  6  conditions  in  the  GLM:  baseline  touch,  
baseline  stab,  religious  ingroup  touch,  religious  ingroup  stab,  religious  outgroup  touch,  
and  religious  outgroup  stab.  The  condition  religious  ingroup  by  itself  refers  to  the  mean  
of  religious  ingroup  stab  and  religious  ingroup  touch.  Similarly  the  condition  religious  





Figure  3  -­  experimental  design  for  the  main  empathy  experiment.  A.  I  used  the  baseline  block  as  the  
functional  localizer  to  identify  neural  regions  that  responded  more  to  stabbing  than  touching.  In  each  trial,  
hands  appeared  with  arbitrary  text  labels;;  the  computer  selected  a  hand,  and  that  hand  received  either  a  
stab  or  a  touch.  B.  The  religious  ingroup  –  religious  outgroup  block  was  identical  in  structure  and  timing  to  
the  baseline  block  with  the  exception  of  religious  labels.  
  
  
To  reflect  the  varying  degrees  of  religious  diversity  across  different  communities,  I  
utilized  three  variations  within  the  religious  ingroup  –  religious  outgroup  block:  
a.   6  hands,  6  different  religious  labels,  ITI  8-­12  s,  12  baseline  trials,  60  
religion  trials  (n  =  38  participants,  including  10  agnostic)  
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b.   6  hands,  2  different  religious  labels  (3  Christian  and  3  Atheist  to  boost  and  
balance  number  of  religious  ingroup  trials),  ITI  8-­12  s,  12  baseline  trials,  60  
religion  trials  (n  =  11  participants,  including  4  agnostic)  
c.     4  hands,  4  different  religious  labels,  ITI  14-­18  s,  8  baseline  trials,  56  
religion  trials  (n  =  23  participants,  including  5  agnostic)  
  
Next,  I  conducted  two  separate  versions  of  the  experiment  on  separate  and  smaller  sets  
of  participants  to  address  ingroup  bias  and  determined  whether  this  could  be  
manipulated  rapidly.  
Experiment  2:  flexibility  of  religious  affiliations  
I  investigated  the  effect  of  bringing  a  former  religious  outgroup  member  into  closer  
alliance  with  an  ingroup.  I  assigned  the  6  religions  arbitrarily  to  2  teams,  the  green  team  
and  the  blue  team,  with  3  hands  each.  A  text  box  explained  that  a  group  of  the  3  
religions  was  now  at  war  with  the  other  3  religions.  This  set  of  trials  used  6  hands,  ITI  
10-­14  s,  6  religions,  12  baseline  trials,  and  60  religion  trials  (n  =  19,  including  5  
agnostic).    
  
This  experiment  introduced  the  concept  of  allies.  I  defined  the  religious  ally  condition  to  
include  trials  in  which  the  participant  observed  hands  labeled  with  an  outgroup  religion  
on  the  same  blue  or  green  team  as  the  participant’s  ingroup  religion.  As  before,  I  
subdivided  each  of  these  conditions  further  into  touch  and  stab  conditions.  This  yielded  
8  conditions  in  the  GLM:  baseline  touch,  baseline  stab,  religious  ingroup  touch,  religious  
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ingroup  stab,  religious  ally  touch,  religious  ally  stab,  religious  outgroup  touch,  and  
religious  outgroup  stab.  
  
  
Figure  4  -­  experimental  design  for  the  allegiance  experiment.  The  allegiance  experiment  was  
identical  in  structure  to  the  main  experiment  except  for  the  story  presented  to  participants  after  the  




Experiment  3:  arbitrary  teams  
Before  initiating  the  fMRI  portion  of  the  experiment,  I  used  a  coin  toss  to  assign  
participants  randomly  to  one  of  two  fictional  groups:  “Augustinians”  or  “Justinians.”  
Since  participants  flipped  the  coin  themselves,  they  understood  that  the  assignment  
was  arbitrary.  I  assigned  heads  or  tails  randomly  for  each  participant.  Participants  
received  a  bracelet  for  their  “team”  with  the  instruction  to  wear  the  bracelet  during  the  
experiment.  This  both  reminded  participants  of  their  team  identity  and  encouraged  
bonding  to  the  identity.  This  set  of  trials  used  6  hands,  ITI  10-­14  s,  2  groups,  12  
baseline  trials,  and  60  group  trials  (n  =  14  participants).    
  
I  defined  the  arbitrary  ingroup  condition  to  include  trials  in  which  the  participant  
observed  hands  labeled  with  the  group  to  which  the  participant  was  assigned;;  arbitrary  
outgroup  included  trials  in  which  the  participant  observed  hands  labeled  with  the  group  
to  which  the  participant  was  not  assigned.  As  before,  I  subdivided  each  of  these  
conditions  further  into  touch  and  stab  conditions.  This  yielded  6  conditions  in  the  GLM:  
baseline  touch,  baseline  stab,  arbitrary  ingroup  touch,  arbitrary  ingroup  stab,  arbitrary  
outgroup  touch,  and  arbitrary  outgroup  stab.  
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Figure  5  -­  experimental  design  for  the  arbitrary  assignment  experiment.  The  arbitrary  assignment  
experiment  was  identical  in  structure  to  the  main  experiment,  except  that  participants  flipped  a  coin  for  
random  assignment  to  one  of  the  two  teams.  They  received  a  team  wristband  and  later  read  a  slide  
explaining  that  “the  Augustinians  and  Justinians  are  two  warring  tribes.”  
  
Behavioral  response  
Since  I  led  participants  to  believe  that  the  study  was  investigating  the  effects  of  pain  on  
memory,  participants  believed  that  they  would  receive  evaluation  frequently  to  test  their  
memory  of  which  hand  had  been  stabbed.  To  buttress  this  impression,  increase  
attention,  and  quantify  alertness,  I  asked  participants  on  a  random  20%  of  trials  to  
report  which  religion  was  associated  with  the  selected  hand  10-­14  seconds  after  the  
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trial.  All  participants  with  usable  fMRI  data  scored  successfully  with  a  response  
accuracy  greater  than  80%.  
2.3.4  MRI  data  
Acquisition  
I  acquired  data  on  a  Siemens  3T  Trio  (Erlangen,  Germany)  scanner.  First,  I  used  an  MP  
RAGE  sequence  (0.4785  x  0.4785  x  1.0  mm  voxels)  to  create  high-­resolution  T1-­
weighted  scans  (Mugler  and  Brookeman  1990).  Functional  image  acquisition  details  are  
echo-­planar  imaging,  gradient  recalled  echo;;  repetition  time  (TR)  =  2000  ms;;  echo  time  
(TE)  =  40  ms;;  flip  angle  =  90°;;  64  x  64  matrix,  twenty-­nine  4  mm  axial  slices,  yielding  
functional  3.4  mm  x  3.4  mm  x  4.0  mm  voxels,  and  one  30-­45  minute  run.  To  account  for  
the  slight  initial  instability  in  the  magnetic  field,  the  scanner  software  discarded  the  first  
two  volumes  from  every  participant’s  functional  run.  
  
To  ensure  the  accuracy  of  these  results,  my  colleague  and  I  completed  the  full  analysis  
pipeline  as  preprocessing,  GLM  modeling,  and  group  analysis  using  FSL  
(www.fmrib.ox.ac.uk/fsl),  and  SPM  (http://www.fil.ion.ucl.ac.uk/spm/),  respectively.  
Preprocessing  
FSL  
We  used  FEAT  (fMRI  Expert  Analysis  Tool)  Version  6.00,  part  of  FSL  5.0.9,  to  process  
fMRI  data.  We  performed  the  pre-­statistics  processing,  which  involved  motion  correction  
using  MCFLIRT  (Jenkinson  et  al.  2002),  slice-­timing  correction  using  Fourier-­space  
time-­series  phase-­shifting,  non-­brain  removal  using  BET  (Smith  2002),  spatial  
smoothing  using  a  Gaussian  kernel  of  FWHM  5  mm,  grand-­mean  intensity  
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normalization  of  the  entire  4D  dataset  by  a  single  multiplicative  factor,  and  highpass  
temporal  filtering  (Gaussian-­weighted  least-­squares  straight  line  fitting,  with  sigma  =  30  
s).  We  conducted  all  first-­level  analyses  and  model  fitting  in  the  functional  space.  
  
For  group-­level  analyses,  we  registered  PEs  and  contrasts  of  beta  weights  to  the  
Montreal  Neurological  Institute  (MNI)152  template  brain  (Tzourio-­Mazoyer  et  al.  2002).  
We  used  FLIRT  full-­search,  boundary  based  registration  (BBR)  for  registration  to  high-­
resolution  structural  images  (Jenkinson  and  Smith  2001;;  Jenkinson  et  al.  2002).  We  
then  used  FNIRT  (nonlinear  registration)  of  full-­search  and  12  degrees  of  freedom,  warp  
resolution  10  mm  for  registration  from  high-­resolution  structural  to  standard  space  
(Andersson,  Jenkinson,  and  Smith  2007b;;  Andersson,  Jenkinson,  and  Smith  2007a).  
  
SPM  
I  processed  the  fMRI  data  with  SPM8  (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/).  
I  performed  the  pre-­statistics  processing,  which  involved  motion  correction  realignment  
through  6  parameter  rigid-­body  spatial  transformation  (Friston  et  al.  1995;;  Thevenaz,  
Blu,  and  Unser  2000;;  Collignon  et  al.  1995;;  Wells  et  al.  1996),  segmentation  (Ashburner  
and  Friston  2005),  normalization  to  MNI  space  (Ashburner  et  al.  1997;;  Ashburner  and  
Friston  1999),  and  smoothing  with  a  8  mm  full-­width  /  half-­maximum  kernel.  
GLM  analysis  
In  both  platforms,  we  fit  a  GLM  (Worsley  et  al.  1996;;  Friston  et  al.  1994)  to  each  
participant’s  time-­series  data,  including  6  standard  motion  regressors,  individual  motion  
outlier  regressors,  and  a  temporal  high-­pass  filtering  of  signal  >  128  s.  In  FSL,  we  used  
FILM,  FMRIB’s  improved  linear  model  with  local  autocorrelation  correction  (Smith  et  al.  
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2001),  and  root  mean  square  intensity  difference  to  middle  volume  (fsl_motion_outliers).  
In  SPM,  we  employed  the  autoregressive  AR(1)  model  during  parameter  estimation  and  
motion  difference  to  the  first  volume.    
  
For  each  trial  condition  (baseline,  religious  ingroup,  religious  ally,  arbitrary  ingroup,  
etc.),  we  included  a  separate  set  of  regressors  for  stab  and  touch  trials,  which  
corresponded  to  the  onset  of  the  video  showing  the  hand  receiving  either  a  stab  or  a  
touch.  We  also  included  regressors  to  mark  the  following:  hand  selection  for  each  
condition,  corresponding  to  the  time  when  the  hand  with  a  particular  label,  religion,  and  
group  was  selected;;  time  of  trial  onset;;  time  of  questions  asked;;  and  time  of  answer  
selection.  For  each  regressor,  we  fit  a  temporal  derivative  regressor  to  allow  slight  
offsets  in  peak  timing  (Henson  et  al.  2002;;  Friston  et  al.  1998).  
Group  analysis  
First,  we  identified  the  empathy  network  by  contrasting  the  initial  6  stab  trials  with  the  
initial  6  touch  trials  (baseline  stab  –  baseline  touch).  In  the  FSL  data,  we  used  FSL  
FEAT  mixed-­effects  modeling  (FLAME  1)  with  outlier  de-­weighting  for  the  group-­level  
contrasts.  We  did  not  use  outlier  de-­weighting  for  our  SPM  pipeline.  
  
Next,  we  used  a  whole-­brain  search  to  identify  regions  outside  of  the  pre-­defined  
empathy  network  that  responded  more  to  the  stabbing  of  a  religious  ingroup  hand  than  
of  a  religious  outgroup  hand.  We  used  nonparametric  statistics  via  permutations  testing  
as  FSL  randomize  (Winkler  et  al.  2014)  to  perform  the  whole-­brain  religious  ingroup  –  
religious  outgroup  searches.  We  conducted  contrasts  between  religious  ingroup  and  
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religious  outgroup  on  all  eligible  participants  (n  =  67;;  agnostics  were  excluded  since  
they  had  no  religious  ingroup).  From  within  these  two  networks,  we  extracted  PEs  and  
converted  them  to  percent  signal  change,  using  featquery  for  FSL  data  and  MATLAB  for  
SPM  data.  
2.3.5  Classification  methods  
ROI  averaging  
I  used  the  average  values  of  the  PE  in  different  brain  ROIs  as  features  (see  
Introduction,  Figure  2).  I  selected  the  regions  of  the  empathy,  relief,  and  mentalizing  
networks  as  features  in  my  initial  mode,  which  I  label  as  the  a  priori  model.  For  the  
following  whole-­brain  analyses,  I  employed  the  ROIs  from  the  Harvard-­Oxford  atlas  
distributed  with  FSL  (Caviness  et  al.  1996;;  Makris  et  al.  2006;;  Desikan  et  al.  2006).  To  
rule  out  a  classification  based  on  the  label  text  by  visual  word  form  or  other  visual  areas  
(Petersen  et  al.  1990;;  McCandliss,  Cohen,  and  Dehaene  2003;;  Cohen  et  al.  2000),  I  did  
not  use  visual  areas  as  features  in  my  a  priori  model  in  which  I  performed  all  hypothesis  
testing.  I  generated  the  visual  exclusion  mask  from  the  Harvard-­Oxford  atlas  (Figure  6).  
Specifically,  I  excluded  the  left  fusiform  and  right  middle  temporal  gyrus  clusters  from  
the  empathy  network,  the  left  and  right  angular  gyri  and  precuneus  clusters  from  the  
relief  network,  and  the  precuneus  cluster  from  the  mentalizing  network.  After  exclusion  





Figure  6  -­  visual  exclusion  mask.  A  mask  of  areas  considered  to  be  visual.  Areas  of  the  
empathy,  relief,  and  mentalizing  network  overlapping  with  this  mask  were  not  included  in  the  
initial  a  priori  model.  
  
Modeling  
I  predicted  religious  affiliations  using  an  L2-­regularized  logistic  regression  model  with  
AUC-­ROC  as  the  statistic  of  interest  (see  Introduction  for  details).  In  all  experiments  and  
models,  I  assigned  the  outgroup  condition  the  value  of  zero;;  thus,  positive  weights  for  
features  contributed  to  a  prediction  of  ingroup  (or  ally  in  the  classification  religious  ally  
vs  religious  outgroup).  All  individual  weights  reported  are  presented  uncorrected.  For  all  
ingroup  and  outgroup  classification  tests  of  significance,  I  included  stab  and  touch  
conditions  as  separate  exemplars.  For  example,  in  the  religious  ingroup  vs  religious  
outgroup  classification,  each  participant  had  4  exemplars:  religious  ingroup  touch,  
religious  ingroup  stab,  religious  outgroup  touch,  and  religious  outgroup  stab.    
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If  a  classification  was  found  to  have  an  area  under  the  curve  significantly  different  from  
chance,  I  re-­ran  the  classification.  For  this  second  calculation,  I  averaged  together  the  
(leave-­one-­out)  test  participant’s  touch  and  stab  instances  within  their  class.  As  an  
example,  in  the  religious  ingroup  block,  for  each  cross-­validation  fold  I  trained  my  model  
on  the  66  participants  x  4  instances  =  264  instances  (as  identical  to  the  above  
hypothesis  testing).  I  tested  on  the  left-­out  participant’s  instances  of  religious  ingroup  
(mean  of  religious  ingroup  touch  and  religious  ingroup  stab)  and  religious  outgroup  
(mean  of  religious  outgroup  touch  and  religious  outgroup  stab).    
  
In  other  words,  this  maximum-­performance  classification  was  identical  to  the  original  
classification  method  except  that  it  tested  on  a  participant’s  average  ingroup  activation,  
thereby  reducing  noise  and  improving  performance.  As  I  mentioned  in  the  introduction  
and  illustrated  in  Figure  2,  each  participant’s  exemplars  were  brought  into  a  common  
space  by  subtracting  that  participant’s  original  value  from  their  average  activation;;  each  
participant’s  instances  were  demeaned  together.  When  I  averaged  the  touch  and  stab  
trials  together  for  the  ingroup  and  then  for  the  outgroup  conditions,  there  were  only  two  
exemplars  left.  Since  they  were  both  demeaned,  they  were  the  negative  of  each  other  
by  definition,  and  summed  to  0  necessarily.  Consequently,  there  was  one  unique  value  
only  per  participant  in  this  classification,  which  was  precisely  what  I  was  interested  in  
testing:  the  model’s  accuracy  (right  or  wrong)  in  predicting  each  participant’s  ingroup  





Empathy  network  functional  localizer  
I  used  the  baseline  block  without  religious  affiliation  labels  from  all  participants  in  all  
experiments  to  localize  empathy-­related  brain  regions.  Here,  each  participant  observed  
hands  receiving  either  a  stab  with  a  needle  or  a  touch  from  a  cotton  swab  (Figure  S1).  
The  whole  brain  contrast  of  stab  >  touch  trials  yielded  8  significant  clusters,  which  I  
referred  to  collectively  as  the  empathy  network  (Figure  7).  
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Figure  7  -­  the  empathy  network.  A.  The  contrast  of  stabs  >  touches  revealed  8  significant  clusters  (Z  >  
2.3  and  FWE-­corrected  cluster  significance  threshold  of  p  <  0.05).  B.  Corresponding  MNI  coordinates  
represent  the  center  of  gravity  of  the  z-­statistic  for  each  cluster.  
  
This  network  was  localized  consistently  using  ordinary  least  squares  with  SPM,  FLAME,  
or  permutations  testing  with  the  FSL  randomise  package  (Figure  8).  
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Figure  8  -­  localized  empathy  network  with  multiple  approaches.  The  empathy  network  was  localized  
similarly  with  various  methods.  Processing  and  analyzing  data  with  Ordinary  Least  Squares  with  SPM,  
FLAME,  or  permutations  testing  with  FSL  randomise  all  identified  a  similar  empathy  network  for  the  
contrast  stab  >  touch.  Red  indicates  voxels  found  significant  for  all  3  approaches,  yellow  indicates  
significance  for  2  approaches,  and  blue  indicates  significance  for  1  approach  only.  Most  blue  regions  
were  areas  found  to  be  significant  using  SPM,  which  may  be  due  to  a  slightly  larger  smoothing  kernel.  
Images  are  radiologic  convention.  
  
  
I  also  defined  the  “relief  network”  operationally  as  the  opposite  contrast,  stab  <  touch.  
The  whole-­brain  contrast  yielded  8  significant  clusters  in  this  network  (Figure  9).  It  is  of  
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note  that  in  many  of  the  relief  network  ROIs,  the  baseline  stab  condition  is  less  than  
baseline;;  there  is  deactivation.  
  
  
Figure  9  -­  the  relief  network.  The  contrast  of  touches  >  stabs  reveals  8  significant  clusters  (Z  >  2.3  and  
FWE-­corrected  cluster  significance  threshold  of  p  <  0.05).  
  
  
Experiment  1:  religious  ingroups  
After  establishing  the  baseline  empathy  network,  I  assessed  if  the  religion  of  the  
stabbed  hand  modulated  the  magnitude  of  the  neural  response  within  the  empathy  
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network.  This  analysis  utilized  data  from  the  religious  ingroup  –  religious  outgroup  block,  
in  which  I  labeled  each  hand  as  either  Christian,  Muslim,  Hindu,  Jewish,  Scientologist,  
or  Atheist  (Figure  3B).  The  average  response  magnitude  in  the  empathy  network  was  
significantly  higher  for  religious  ingroup  trials  compared  to  religious  outgroup  trials  for  




Figure  10  -­  ingroup  bias  in  the  empathy  network.  Within  the  empathy  network,  BOLD  activity  to  both  
stabs  and  touches  was  larger  for  religious  ingroup-­  than  for  religious  outgroup-­labeled  hands.  A.  Within  
the  empathy  network,  participants  showed  greater  activation  for  their  religious  ingroup  than  religious  
outgroup  for  both  stab  (p  <  0.001)  and  touch  (p  <  0.005)  trials.  Error  bars  are  standard  error  of  the  mean  
(SEM).  B.  PEs  from  each  of  the  empathy-­network  clusters  in  the  religious  ingroup  condition  for  both  stab  
(red)  and  touch  (blue)  conditions.  Asterisks  represent  a  religious  ingroup  –  religious  outgroup  bias  





A  whole-­brain  contrast  for  religious  ingroup  >  religious  outgroup  combining  stab  and  
touch  trials  yielded  three  clusters  beyond  the  empathy  network:  the  mPFC,  posterior  
cingulate/precuneus,  and  superior  temporal  gyrus  (Figure  11A).  Since  these  three  
regions  appear  in  many  paradigms  about  the  understanding  of  the  perspective  of  others  
(Saxe  2006;;  Völlm  et  al.  2006;;  Jackson  et  al.  2006),  we  defined  these  ROIs  together  as  
the  “mentalizing  network”.    
  
No  significant  voxels  appeared  in  the  contrast  religious  ingroup  >  religious  outgroup.  I  
found  a  positive  correlation  between  participants’  scores  on  the  Balanced  Empathy  
Emotional  Scale  and  activity  in  the  left  insula  (Figure  11B).  However,  the  activity  in  
regions  of  the  empathy  network  did  not  correlate  with  participants’  strength  of  religious  
belief  or  with  their  score  on  the  Right  Wing  Authoritarian  Scale.  
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Figure  11  -­  religious  ingroup  vs  religious  outgroup.  A.  The  whole-­brain  religious  ingroup  >  religious  
outgroup  contrast  yielded  three  significant  clusters:  the  ACC,  posterior  cingulate/precuneus,  and  superior  
temporal  gyrus.  No  significant  voxels  appeared  in  the  contrast  religious  outgroup  >  religious  ingroup.  B.  
Participants’  normalized  scores  on  the  Balanced  Empathy  Emotional  Scale  correlated  with  their  religious  
ingroup–religious  outgroup  contrast  PEs  in  the  left  insula  (r  =  0.36,  95%  confidence  interval  0.17  to  0.54,  




The  average  activity  in  the  empathy  network,  relief  network,  and  mentalizing  network  
had  significantly  non-­zero  correlations  with  each  other  (p  <  10-­4,  q  <  10-­3  Holm-­
Bonferroni  corrected  for  all  three  comparisons,  Figure  12).  The  empathy  network  and  
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relief  network  had  a  correlation  of  0.56  with  the  95%  confidence  interval  0.45  to  0.65;;  
the  empathy  network  and  mentalizing  network  had  a  correlation  of  0.61  with  the  95%  
confidence  interval  0.50  to  0.70;;  and  the  relief  network  and  mentalizing  network  had  a  
correlation  of  0.82  with  the  95%  confidence  interval  0.78  to  0.86.  
  
  
Figure  12  -­  empathy,  relief,  and  mentalizing  network  correlations.  A.  Correlation  matrix  of  all  three  
networks.  B.  Normalized  PEs  for  religious  ingroup  and  religious  outgroup  touch  and  stab  conditions  in  the  
empathy  network  and  relief  network.  C.  Normalized  PEs  for  the  empathy  network  and  mentalizing  
network.  D.  Significance  testing  for  the  correlation  of  empathy  network  and  relief  network.  The  observed  
correlation  is  significantly  different  from  0  (p  <  10-­4,  n  =  266  instances).  
  
2.4.2  Unbalanced  design  
This  section  details  a  sub  point  of  the  thesis.    
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Since  each  participant  identified  with  one  religious  ingroup  only,  this  study  design  
yielded  a  ratio  of  approximately  4:1  religious  outgroup  trials  to  religious  ingroup  trials.  To  
account  for  possible  frequency  effects  and  differences  in  timing  between  trials,  my  
colleague  and  I  designed  a  control  experiment,  which  my  colleague,  Ricky  Savjani,  
executed.  We  swapped  religious  ingroup  trial  labels  with  the  closest  temporally  adjacent  
religious  outgroup  trial  labels  (Figure  13).  Since  this  yielded  no  significant  ingroup  
effect,  we  concluded  that  the  main  results  cannot  be  attributed  to  either  random  timing  
effects  or  to  an  unbalanced  number  of  trials.  
  
  
Figure  13  -­  control  for  unbalanced  number  of  trials.  A.  The  stick  diagram  represents  a  schematic  of  
the  true  timing  of  religious  ingroup  and  religious  outgroup  trials.  For  simplicity,  condition  type  (stab  or  
touch)  labels  are  not  shown.  B.  Religious  ingroup  trials  were  swapped  with  temporally  adjacent  religious  
outgroup  trials  with  condition  preserved.  C.  With  the  religious  ingroup  trials  swapped,  the  group  effect  of  
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the  empathy  network  is  no  longer  observed  (stab:  p  =  0.92,  touch:  p  =  0.59,  permutations  testing).  Error  
bars  SEM.  Furthermore,  a  whole-­brain  search  for  religious  ingroup  >  religious  outgroup  effects  yielded  no  
significant  voxels  for  either  stabs  (D)  or  touches  (E).
  
  
Experiment  2:  flexibility  of  religious  ingroups  
Subsequently,  I  investigated  the  flexibility  of  the  bias  between  religious  ingroups  and  
religious  outgroups.  When  the  participant  learned  that  the  6  religions  were  divided  into  2  
teams  at  war  with  each  other,  2  outgroup  religions  became  part  of  the  participant’s  
“team.”  To  represent  their  status  as  falling  somewhere  on  the  spectrum  between  
religious  ingroup  and  religious  outgroup,  I  labeled  these  hands  religious  allies.  I  found  
that  these  allies  did  not  elicit  a  neural  response  in  the  empathy  network  that  differed  
significantly  from  the  response  to  the  religious  outgroup  members  (p  =  0.40,  Figure  14,  




Figure  14  -­  results  of  the  forward  model  on  Experiment  2.  PE  for  each  condition  of  each  ROI  within  
the  empathy  network  are  shown  for  both  stab  and  touch  trials.  Manipulating  allegiances  did  not  alter  brain  
responses  within  the  empathy  network.  Specifically,  the  mean  of  the  religious  ally  condition  did  not  differ  




Experiment  3:  arbitrary  team  membership  
Next,  I  investigated  whether  an  ingroup/outgroup  bias  existed  in  the  case  of  the  
arbitrarily  assigned  teams.  I  found  that  in  the  empathy  network,  the  mean  of  the  
arbitrary  ingroup  condition  was  not  significantly  different  from  the  mean  of  the  arbitrary  
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outgroup  condition  (p  =  0.78,  n  =  14).  Since  I  did  not  find  a  significant  difference,  I  did  
not  test  each  individual  brain  region  for  a  significant  difference;;  for  completeness,  
however,  they  are  shown  below  (Figure  15).  
  
Figure  15  -­  results  of  the  GLM    in  Experiment  3.  PEs  for  each  condition  of  each  ROI  within  the  
empathy  network  are  shown  for  both  stab  and  touch  trials.  Arbitrary  assignment  to  a  team  did  not  alter  
brain  responses  within  the  empathy  network.  Specifically,  the  mean  of  the  arbitrary  ingroup  condition  did  
not  differ  significantly  from  the  mean  of  the  arbitrary  outgroup  condition  in  the  empathy  network  (p  =  0.78).  





Touch  vs  stab  
I  first  classified  the  distinction  between  baseline  events  as  unlabeled  baseline  touch  and  
baseline  stab  conditions.  I  could  not  use  the  empathy  and  relief  network  activation  as  
features  because  we  derived  them  from  the  univariate  contrast  of  baseline  stab  and  
baseline  touch.  Using  activity  in  regions  specified  by  the  Harvard-­Oxford  parcellation,  
my  classifier  discriminated  the  baseline  touch  from  baseline  stab  conditions  with  98%  
accuracy  and  99%  AUC-­ROC,  which  is  significantly  greater  than  the  chance  AUC-­ROC  
of  50%  (p  <  10-­4,  Figure  16A,  n  =  210  instances).  This  model  distinguished  a  single  
stab  and  touch  trial  with  71%  accuracy  and  77%  AUC-­ROC  (Figure  16B,  n  =  1144  
instances).  Including  visual  areas  as  features,  the  accuracy  and  AUC-­ROC  increased  to  
72%  and  80%,  respectively  (Figure  16B).    
  
  
Figure  16  -­  discriminating  the  perception  of  stab  and  touch.  A.  Using  non-­visual  regions  of  the  
Harvard-­Oxford  parcellation  as  features,  my  classifier  distinguished  a  participant’s  baseline  stab  from  
baseline  touch  conditions  with  95%  accuracy  and  98%  AUC-­ROC,  significantly  greater  than  the  chance  
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AUC-­ROC  of  50%  (p  <  10-­4,  n=210  instances).  B.  Classification  of  baseline  stab  from  baseline  touch  at  
the  individual  trial  level.  Chance  lines  are  for  reference  only;;  I  performed  no  hypothesis  testing  since  the  
discriminatory  power  was  already  shown  in  panel  A.  
  
Ingroup  vs  outgroup  
I  assessed  the  experiment’s  central  question:  is  there  a  consistent  difference  across  all  
three  experiments  in  the  neural  representation  of  ingroup  and  outgroup?  I  attempted  to  
find  answers  using  BOLD  activation  within  the  empathy  network,  relief  network,  and  
mentalizing  network.  I  excluded  visual  ROIs  because  I  did  not  want  my  classifier  
operating  on  the  uncontrollable  visual  differences  between  conditions  (a  needle  vs  a  
cotton  swab  for  baseline  stab  vs  baseline  touch,  and  the  text  of  each  religion  for  ingroup  
vs  outgroup).  Although  it  would  indeed  be  interesting  to  examine  ingroup/outgroup  bias  
based  on  text  alone,  it  is  beyond  the  scope  of  this  paper,  and  I  will  not  discuss  it  further.    
I  referred  to  this  collection  of  non-­visual  ROIs  as  the  a  priori  model  because  our  
univariate  results  informed  the  feature  choice  for  classification.  I  trained  and  cross-­
validated  the  model  on  Experiment  1,  religious  ingroup  vs  religious  outgroup,  and  then  
applied  it  to  the  validation  data  in  Experiment  2  and  Experiment  3.  I  did  not  include  the  
mentalizing  network  in  the  classification  of  religious  ingroup  vs  religious  outgroup  
because  I  derived  the  mentalizing  network  from  the  univariate  contrast  ingroup  >  
outgroup;;  thus,  inclusion  of  the  network  would  be  a  non-­independence  error.  
  
To  provide  a  diagnosis  of  ingroup-­related  empathic  bias  across  stab  and  touch  
conditions,  I  started  with  the  four  religious  conditions  from  the  religious  ingroup  –  
religious  outgroup  block.  The  classifier  distinguished  the  conditions  of  religious  ingroup  
stab  and  religious  ingroup  touch  from  religious  outgroup  stab  and  religious  outgroup  
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touch  with  an  accuracy  of  62%  and  66%  AUC-­ROC,  which  is  significantly  greater  than  
the  chance  AUC-­ROC  of  50%  (p  <  10-­4,  Figure  17A,  n  =  268  exemplars).  I  averaged  
the  stab  condition  and  touch  conditions  within  each  class  to  calculate  a  single  unique  
instance  per  participant  and  to  reduce  noise.  The  classifier  distinguished  religious  
ingroup  from  religious  outgroup  with  67%  accuracy  and  72%  AUC-­ROC  (Figure  17B,  n  
=  67  participants).  Permutations  testing  revealed  three  regions  with  significant  
contributions  in  the  model:  the  right  insula,  left  MFG  (medial  frontal  gyrus),  and  right  
MFG  (Figure  17C).  Figure  17D  shows  the  magnitude  and  uncorrected  p-­values  of  the  
model’s  features.  To  assess  the  distributed  nature  of  this  effect,  I  re-­ran  the  model  with  
the  three  significant  features  removed.  The  reduced  model  approached  significance  (p  <  




Figure  17  -­  classification  of  religious  ingroups  and  outgroups  using  the  a  priori  model.  A.  A  ROC  
curve  for  distinguishing  the  conditions  of  religious  ingroup  stab  and  religious  ingroup  touch  from  religious  
outgroup  stab  and  religious  outgroup  touch.  The  accuracy  and  AUC-­ROC  were  67%  and  72%,  
respectively,  which  is  significantly  greater  than  the  chance  AUC-­ROC  of  50%  (q  <  10-­3).  B.  Chance  lines  
are  for  reference  only;;  I  performed  no  hypothesis  testing  since  the  discriminatory  power  was  already  
shown  in  panel  A.  C.  The  significant  weights  of  the  a  priori  model  are  shown  in  blue  and  95%  null  
confidence  intervals  in  grey.  Stars  represent  a  weight’s  empirical  p-­value  is  less  than  0.05,  uncorrected.  
D.  Table  of  exact  model  weights  and  uncorrected  empirical  p-­values;;  significant  weights  in  bold.  
  
To  test  whether  this  model  was  specific  to  religious  ingroups  and  outgroups  or  instead  
pertained  to  ingroups  and  outgroups  more  generally,  I  next  applied  my  a  priori  model  
(now  including  the  mentalization  network)  to  the  validation  data  from  Experiment  2  and  
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Experiment  3.  The  weights,  now  including  the  mentalization  network  ROIs,  are  shown  in  
Figure  18A.  
  
In  Experiment  2,  two  hands  with  religious  identities  that  were  different  from  the  
participant’s  religion  were  placed  on  a  team  with  the  ingroup  hand  (Figure  4).  My  a  
priori  model  classified  religious  ally  touch  and  religious  ally  stab  conditions  from  
religious  outgroup  touch  and  religious  outgroup  stab  with  an  accuracy  of  55%  and  an  
AUC-­ROC  of  63%,  which  was  significantly  different  from  the  chance  of  50%  (p  =  0.05,  n  
=  56  instances).  After  averaging  the  stab  and  touch  conditions  for  each  participant,  as  
before,  the  classifier  discriminated  the  religious  ally  condition  from  the  religious  
outgroup  condition  with  71%  accuracy  and  an  AUC-­ROC  of  68%  (Figure  18B,  green).  
  
In  Experiment  3,  participants  received  a  random  assignment  to  one  of  the  two  fictitious  
teams  (Figure  5).  My  a  priori  model  classified  arbitrary  ingroup  touch  and  arbitrary  
ingroup  stab  conditions  from  arbitrary  outgroup  touch  and  arbitrary  outgroup  stab  with  
an  accuracy  of  59%  and  an  AUC-­ROC  of  63%,  which  was  significantly  different  from  the  
chance  of  50%  (p  =  0.02,  n  =  56  instances).  After  averaging  the  stab  and  touch  
conditions  together  for  each  participant,  the  classifier  discriminated  the  arbitrary  ingroup  
condition  from  the  arbitrary  outgroup  condition  with  71%  accuracy  and  74%  AUC-­ROC  
(Figure  18B,  magenta).  All  three  independent  significance  tests  of  the  model  





Figure  18  -­  validation  results.  A.  Weights  of  the  11  non-­visual  regions  of  empathy,  relief,  and  
mentalizing  networks,  which  comprise  the  a  priori  model.  One  or  more  components  from  each  network  
are  significant;;  there  are  no  multiple  comparisons  corrections  on  the  weights.  B.  Classification  results  at  
the  participant-­level  for  both  validation  experiments  distinguishing  religious  allies  from  religious  outgroup  
and  arbitrary  ingroup  from  arbitrary  outgroup  (n  =  14  participants  in  both  experiments).  
  
To  investigate  whether  expanding  beyond  my  a  priori  network  improved  my  model’s  
diagnostic  ability,  I  trained  a  model  to  classify  between  the  main  religious  ingroup  
versus  religious  outgroup  activation  in  regions  of  the  Harvard-­Oxford  atlas  whole-­brain  
parcellation  as  features.  This  whole-­brain  model  had  an  accuracy  of  59%  and  an  AUC-­
ROC  of  63%,  which  was  significantly  different  from  the  chance  of  50%  (p  <  0.01,  n  =  
268  instances).  After  averaging  the  stab  and  touch  conditions  for  each  participant,  as  
before,  the  classifier  performance  increased  to  an  accuracy  of  69%  and  an  AUC-­ROC  
of  68%  (Figure  19A).  Significant  features  are  listed  in  Figure  19B  and  illustrated  in  
Figure  20.  Excluding  visual  regions,  the  accuracy  and  AUC-­ROC  for  religious  ingroup  




Figure  19  -­  whole  brain  ingroup  vs  outgroup  model.  A.  ROC  curves  for  the  whole  brain  model.  As  with  
all  previous  assessments  of  significance,  chance  curves  are  per  condition,  and  the  stab  and  touch  
conditions  are  averaged  together  for  the  per-­participant  ROC  curve.  B.  Model  weights  that  are  





Figure  20  -­  rendering  of  significant  weights  in  the  whole  brain  model.  Significant  weights  from  the  
whole-­brain  ingroup  model.  All  regions  have  an  empirical  p-­value  <  0.05,  uncorrected.  
  
2.5  Discussion  
The  empathy  network,  which  I  defined  operationally  as  baseline  stab  >  baseline  touch  in  
my  univariate  analysis,  is  highly  consistent  with  previous  findings.  It  contains  common  
affective  components  (Zaki  and  Ochsner  2012;;  Singer  2004;;  Decety  2010)  including  the  
bilateral  insula  and  anterior  /  medial  cingulate  cortex.  Sensorimotor  components  of  the  
empathy  network  for  pain  are  less  exact  because  they  depend  on  the  task  stimuli  
(Lamm,  Decety,  and  Singer  2011).  Indeed,  most  imaging  studies  on  empathy  for  pain  
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have  suggested  the  anterior  insula  (AI)  and  anterior  cingulate  cortex  (ACC)  as  the  main  
areas  involved  (Cheng  et  al.  2007;;  Lamm,  Batson,  and  Decety  2007;;  Jackson  et  al.  
2006;;  Morrison,  Peelen,  and  Downing  2007;;  Saarela  et  al.  2007;;  Morrison  and  Downing  
2007).    
  
Nevertheless,  primary  and  secondary  somatosensory  regions  have  demonstrated  
involvement  in  empathy  for  pain  (Lamm  et  al.  2007;;  Bufalari  et  al.  2007;;  Cheng  et  al.  
2008).  Avenanti  et  al.  supported  this  finding:  they  used  transcranial  magnetic  stimulation  
(TMS)  to  show  that  the  simple  observation  of  a  needle  penetrating  the  hand  muscle  
results  in  a  reduction  in  the  amplitude  of  the  motor-­evoked  potentials  (i.e.  motor  
inhibition)  (Avenanti  et  al.  2006;;  Avenanti  et  al.  2005).  Tasks  involving  visual  stimuli  of  
body  parts  in  painful  situations  tend  to  recruit  the  ventral  premotor  area  and  the  inferior  
parietal  lobule  (Chong  et  al.  2008;;  Decety  and  Grèzes  1999),  which  are  involved  in  
processing  observed  action  (Fogassi  et  al.  2005;;  Buccino  et  al.  2001;;  Grèzes  and  
Decety  2001).    
  
Picture-­based  paradigms,  which  include  the  presentation  of  photographs  displaying  
limbs  in  painful  situations,  are  likely  to  activate  the  somatosensory  cortex  (Avenanti  et  
al.  2005;;  Avenanti  et  al.  2006;;  Bufalari  et  al.  2007;;  Cheng  et  al.  2008;;  Lamm  et  al.  2007;;  
Lamm,  Decety,  and  Singer  2011;;  Van  Overwalle  and  Baetens  2009).  A  picture-­based  
paradigm  of  mere  observation  of  touch  activates  the  secondary  somatosensory  cortex  
(Keysers  et  al.  2004;;  Avenanti  et  al.  2005).  Generally,  researchers  also  observed  a  
subset  of  the  inferior  frontal  gyrus  and  lateral  occipital  gyrus  (Carr  et  al.  2003;;  Iacoboni  
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et  al.  1999).  The  empathy  network  I  localized  includes  all  of  these  areas  as  well  as  the  
left  fusiform  gyrus,  which  may  be  included  because  the  fusiform  is  often  recruited  in  
hand  representation  (Grosbras  and  Paus  2006;;  James  and  Engelhardt  2012).  This  
observation  is  also  in  line  with  previous  reports  suggesting  the  activation  of  the  fusiform  
in  intentional  empathy  (de  Greck  et  al.  2012;;  Nomi  et  al.  2008).  
  
Likewise,  my  univariate  contrast  religious  ingroup  >  religious  outgroup  yielded  areas  
implicated  in  self-­referential  thought  and  mentalizing  (Zaki  and  Ochsner  2012;;  Mitchell,  
Banaji,  and  Macrae  2005).  The  canonical  mentalizing  network  includes  the  medial  
prefrontal  cortex  (mPFC),  precuneus,  right  temporoparietal  junction,  temporal  poles,  
and  sometimes  amygdala  (Rameson,  Morelli,  and  Lieberman  2012;;  Lawrence  et  al.  
2006;;  Völlm  et  al.  2006).  Some  studies  find  the  middle  temporal  gyrus  present  in  
mentalizing  paradigms  (Shamay-­Tsoory  2011;;  Marsh  et  al.  2010),  while  others  included  
it  in  the  empathy  network  (Zaki  and  Ochsner  2012;;  de  Greck  et  al.  2012).  Similarly,  
some  studies  find  that  the  inferior  parietal  lobule  is  recruited  in  both  experience-­sharing  
(Keysers  et  al.  2004)  and  perspective-­taking  paradigms  (Decety  and  Lamm  2006).  
  
There  is  a  strong  qualitative  correspondence  between  the  three  networks  I  localized  
(Figure  21A)  and  the  two  generally  accepted  networks  underlying  affective  and  
cognitive  empathy  (Figure  21B)  (Zaki  and  Ochsner  2012).  Note  that  many  studies  find  
very  caudal  ACC  activation  (sometimes  even  middle  cingulate  cortex)  in  empathy  for  




Figure  21  -­  comparison  of  the  empathy  and  mentalizing  network  with  previous  work.  A.  The  
empathy,  relief,  and  mentalizing  networks  localized  in  our  univariate  paradigm.  B.  Affective  empathy  and  
mentalizing  networks  reproduced  from  a  2012  Nature  Neuroscience  review  article  on  empathy  (Zaki  and  
Ochsner  2012).  The  empathy  network  is  shown  in  green  and  mentalizing  in  blue.  Our  empathy  and  
mentalizing  networks  are  a  superset  of  those  listed  here,  with  the  exception  of  the  temporal  pole.Key:  
ACC  =  Anterior  Cingulate  Cortex,  AI  =  Anterior  Insular,  IPL  =  Inferior  Parietal  Lobule,  MPFC  =  Medial  
Prefrontal  Cortex  ,  PMC  =  Premotor  Cortex,  pSTS  =  posterior  Superior  Temporal  Sulcus,  TP  =  Temporal  
Pole  ,  TPJ  =  Temporal-­Parietal  Junction.
  
Our  results  expanded  upon  previous  findings  by  demonstrating  that  a  neural-­empathy  
bias  is  present  in  religions  affiliations.  The  ingroup  bias  was  elicited  by  changing  the  text  
label  written  above  a  hand  only,  without  any  other  information.  Furthermore,  the  
strength  of  the  ingroup  bias  correlated  with  an  individual’s  empathic  rating  but  not  with  
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their  religious  conviction.  This  indicated  that  the  more  a  person  can  empathize  with  
another,  the  stronger  their  ingroup  bias.  This  ostensibly  counter-­intuitive  result,  
informally  dubbed  “the  dark  side  of  empathy”  by  Dr.  Iacoboni,  has  several  
interpretations.  
  
There  are  multiple  plausible  explanations  for  the  larger  ingroup  bias  among  participants  
with  high  BEES  scores.  It  could  stem  from  reduced  activation  in  empathy  and  
mentalizing  regions  for  outgroup  members:  ergo,  more  self-­reported  empathy  
corresponds  to  larger  bias.  Alternatively,  this  ingroup  bias  may  be  present  as  a  default  
in  all  humans  at  similar  levels,  but  empathy  acts  as  an  amplitude  modulator,  and  the  
response  to  both  ingroup  and  conditions  is  multiplied.  Highly  empathic  people  would  
therefore  have  a  larger  response  to  both  conditions,  and  the  arithmetic  difference  
between  the  two  conditions  would  be  inflated.  These  two  hypotheses  may  be  
disambiguated  in  future  analyses  of  this  data,  by  regressing  the  religious  ingroup  and  
religious  outgroup  conditions,  separately,  against  BEES  scores.  A  positive  correlation  of  
BEES  with  religious  ingroup  and  a  negative  correlation  of  BEES  with  religious  outgroup  
would  support  the  first  hypothesis.  Both  correlations  being  positive  supports  the  second  
hypothesis.  
  
A  third,  non-­exclusive  consideration  is  that  self-­reported  empathy  may  be  biased.  One  
pitfall  of  empathy  questionnaires  is  the  lack  of  specificity  about  the  “other”  alluded  to  in  
the  questionnaires.  For  example,  the  Davis  Interpersonal  Reactivity  Index  asks,  “When  I  
see  someone  being  taken  advantage  of,  I  feel  kind  of  protective  towards  them.”  When  
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answering  empathy-­related  questions,  perhaps  participants,  by  default,  imagine  their  
“their  own”.  I  doubt  participants  would  respond  identically  if  the  question  were  specific  to  
their  political/social/business  opponents.  Thus,  it  would  not  be  surprising  to  find  a  
correlation  between  self-­reported  empathy  for  one’s  own  ingroup  and  a  neural  correlate  
of  that  bias.  Studies  assessing  empathy  as  it  relates  to  ingroup  and  outgroup  
differences  should  specify  to  whom  each  theoretical  question  is  directed.  The  finding  
about  more  bias  correlated  with  more  self-­reported  BEES  is  further  evidence  that  self-­
reported  empathy  is  not  a  scalar  value,  but  rather  a  vector  quantity,  with  different  
magnitude  for  different  groups.  
  
In  Experiments  2  and  3,  I  investigated  the  flexibility  of  religious  ingroups  and  the  
generalizability  of  our  model  to  arbitrarily  formed  groups.  Specifically,  can  a  simple  story  
about  team  membership  prompt  the  brain  to  generate  a  new  representation  of  allies,  
bringing  certain  outgroup  members  into  a  role  resembling  ingroup  members  more  
closely?  Does  a  similar  process  happen  with  the  formation  of  arbitrary  groups?  In  both  
cases,  no  significant  effect  appeared  in  the  forward  GLM  for  one  of  several  
explanations:  (1)  no  detectable  neural  representational  difference  appeared  between  a  
religious  ally  and  a  religious  outgroup  member  because  the  difference  was  purely  
semantic;;  (2)  a  representational  difference  may  exist  in  some  situations,  but  my  simple  
narrative  about  team  membership  was  insufficient  to  evoke  the  difference;;  (3)  a  
representational  difference  existed  even  in  my  simple  experiment,  but  I  had  insufficient  
power  to  detect  it;;  or  (4)  the  representation  of  ingroup  and  outgroups  is  a  multivariate  
interaction  fundamentally.  My  multivariate  classification  model  distinguished  religious  
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allies  from  religious  outgroup  members  and  arbitrary  ingroup  from  arbitrary  outgroup  
members  successfully.  Additionally,  using  the  average  activation  in  each  of  the  three  
networks  (combining  the  activation  in  each  of  their  respective  ROIs)  did  not  distinguish  
the  religious  allies  from  the  religious  outgroup  condition  significantly  (data  not  shown).  
These  results  are  consistent  with  explanations  (3)  and  (4):  ingroup  and  outgroup  
representation  is  a  multivariate  interaction  of  empathy,  relief,  and  mentalizing  network  
ROIs,  consistent  with  recent  functional  connectivity  findings  (Christov-­Moore  and  
Iacoboni  2016).  
  
It  is  a  vast  over-­simplification  to  represent  the  complexity  of  human  affairs  and  
allegiances  as  a  one-­dimensional  spectrum  between  100%  ingroup  and  100%  outgroup.  
Yet,  these  results  show  there  is  utility  in  this  sparse,  low  dimensional  representation.  I  
found  that  this  one-­dimensional  model  of  ingroup  and  outgroup  affiliations  correlated  
with  differential  activity  in  the  empathy,  relief,  and  mentalizing  networks.  Furthermore,  
the  multivariate  interaction  of  these  networks  was  diagnostic  of  ingroup  –  outgroup  
biases  in  religions,  newly  formed  alliances,  and  arbitrarily  formed  teams.  Bolstered  by  
recent  TMS  results  which  suggest  a  causal  link  between  these  networks,  empathic  
behavior  and  religious  beliefs  (Holbrook  et  al.  2016;;  Christov-­Moore  et  al.  2017),  we  
believe  our  paradigm  and  model  may  be  used  to  diagnose  propensities  for  (non-­
)empathic  behavior,  particularly  in  non-­compliant  subject  populations.  The  applications  
are  discussed  in  detail  in  Chapter  V.  Future  studies  may  use  the  classification  of  activity  
in  these  networks  as  elicited  by  observing  other  individuals  to  assess  the  nature  of  
participants.  
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2.6  Summary  of  work  contributions  
I  designed  all  three  versions  of  the  experiment  under  the  guidance  of  Dr.  David  
Eagleman.  I  created  and  filmed  the  video  stimuli,  drafted  the  IRB  protocols,  and  
received  their  approval.  I  administered  all  surveys  and  ran  all  participants.  My  co-­author  
Ricky  Savjani  and  I  each  processed  the  data  independently  in  FSL  and  SPM,  
respectively,  and  we  used  FSL’s  randomise  to  check  our  results  and  learn  the  process.  I  
noted  specifically  the  two  analyses  we  developed  together  that  he  executed  alone.  My  
co-­author  and  I  both  conducted  the  ROI-­averaging  of  the  functional  data.  He  used  FSL,  
and  I  used  MATLAB.  I  performed  all  of  the  classifications  analysis.  
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Chapter  III  -­  Predicting  diagnoses  of  anorexia  nervosa  and  body  dysmorphic  
disorder  with  multimodal  neuroimaging  and  psychometric  data  
3.1  Abstract  
  
Anorexia  nervosa  (AN)  and  body  dysmorphic  disorder  (BDD)  share  distorted  perception  
of  appearance,  obsessive  and  compulsive  tendencies,  and  poor  insight.  AN  and  BDD  
are  comorbid  frequently.  Despite  many  similarities,  the  recommended  treatment  
strategies  differ  between  AN  and  BDD.  Correct  diagnosis  therefore  is  critical,  
particularly  in  early  stages  of  the  illness,  to  minimize  risks  associated  with  medical  
morbidity,  mortality,  and  suicide.  Unfortunately,  distinguishing  AN  from  BDD  correctly  
can  prove  difficult  in  certain  cases.  Here,  I  used  neuroimaging  and  psychometric  data  to  
predict  the  diagnoses  for  medication-­free,  normal-­weight  participants  with  AN  or  BDD  
compared  to  healthy  controls  (CTL).  The  multimodal  dataset  included  BOLD  signal  
changes  from  task-­based  fMRI  using  face,  body,  and  house  visual  stimuli;;  path  length  
metrics  from  diffusor  tensor  imaging  (DTI);;  and  psychometric  data  from  the  Brown  
Assessment  of  Beliefs  Scale,  Hamilton  Anxiety  Rating  Scale,  and  Montgomery-­Asberg  
Depression  Rating  Scale.  My  classification  models  distinguished  CTL  from  participants  
with  AN  or  BDD  with  a  peak  accuracy  of  72%  and  an  AUC-­ROC  curve  of  88%,  using  
principally  a  combination  of  participants’  depression  and  anxiety  scale  scores.  A  second  
model  distinguished  participants  with  AN  from  participants  with  BDD  with  a  peak  
accuracy  of  76%  and  an  AUC-­ROC  curve  of  82%.  Depression  and  insight  scores  and  
white  matter  normalized  path  length  contributed  significantly.  If  these  models  survive  
independent  validation,  they  have  the  potential  to  help  clinicians  disambiguate  
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participants  with  AN  from  those  with  BDD,  thereby  clarifying  the  most  appropriate  
treatment  for  each  individual,  improving  their  outcomes.    
3.2  Introduction  
  
Anorexia  nervosa  (AN)  and  body  dysmorphic  disorder  (BDD)  are  DSM-­5-­defined  
pathologies  (American  Psychiatric  Association  2013;;  Phillips  et  al.  2010;;  Brown,  
Holland,  and  Keel  2013)  that  share  distorted  perception  of  appearance  (Grant,  Kim,  and  
Eckert  2002;;  Hartmann,  Greenberg,  and  Wilhelm  2013;;  Hrabosky  et  al.  2009),  
obsessive  and  compulsive  tendencies  (Woodside  and  Staab  2006),  and  poor  insight  
(Madsen,  Bohon,  and  Feusner  2013;;  Zhang  et  al.  2016;;  Konstantakopoulos  et  al.  2012).  
BDD  is  characterized  principally  by  a  patient’s  obsession  with  a  perceived  defect  in  their  
appearance  (Veale  2004;;  Didie,  Kuniega-­Pietrzak,  and  Phillips  2010).  Prevalence  in  the  
general  population  is  estimated  to  fall  between  0.7%  (Faravelli  et  al.  1997;;  Otto  et  al.  
2001)  and  2.4%  (Koran  et  al.  2008).  AN  is  characterized  by  restriction  of  energy  intake,  
yearning  to  be  thin,  disturbance  in  one's  perception  of  body  weight,  and  low  Body  Mass  
Index  (BMI)  (Agüera  et  al.  2015;;  Sunday  and  Halmi  2003).  In  young  females,  the  
prevalence  is  an  estimated  0.3%  (Hoek  and  van  Hoeken  2003)  with  0.6%  mortality  per  
year  (Sullivan  1995;;  Hoek  2006).  
  
Individuals  with  BDD  and  with  AN  have  elevated  rates  of  completed  suicide  (Phillips  and  
Menard  2006;;  Phillips  2007;;  Coren  and  Hewitt  1998;;  Pompili  et  al.  2004).  Medical  
morbidity  and  mortality  related  to  the  starvation  state  are  major  risks  in  individuals  with  
AN  specifically  (Keel  et  al.  2003).  Treatment  with  cognitive  behavioral  therapy  (Beck  
1979)  can  be  effective  in  BDD  (Neziroglu  et  al.  1996;;  Greenberg  et  al.  2010;;  Halmi,  
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Mitchell,  and  Crow  1999),  but  its  effectiveness  in  AN  is  minimal;;  family-­based  
psychotherapy  in  adolescents  has  more  empirical  support  (Eisler  et  al.  2000;;  Eisler  et  
al.  2007;;  Lock  et  al.  2005).  BDD  responds  to  treatment  with  selective  serotonin  reuptake  
inhibitors  (SSRIs),  but  AN  does  not  (Phillips  and  Hollander  2008;;  Holtkamp  et  al.  2005).  
Clearly,  choosing  an  effective  treatment  is  predicated  on  proper  diagnostic  classification  
of  patients.  
  
Unfortunately,  it  often  is  difficult  to  separate  the  diagnoses  of  AN  and  BDD.  Individuals  
sometimes  present  so  similarly  that  some  researchers  question  whether  one  disorder  
should  be  considered  a  subtype  of  the  other  (Grant  and  Phillips  2004;;  Grant,  Kim,  and  
Eckert  2002).  For  example,  30%  of  BDD  patients  have  significant  weight  concerns,  
even  if  they  do  not  have  a  comorbid  eating  disorder  (Kittler,  Menard,  and  Phillips  2007).  
Additionally,  AN  and  BDD  are  comorbid  with  each  other  frequently  (Grant,  Kim,  and  
Eckert  2002;;  Ruffolo  et  al.  2006;;  Rabe-­Jablonska  and  Sobow  Tomasz  2000).  
Approximately  33%  of  those  with  AN  are  diagnosed  with  lifetime  BDD,  and  
approximately  33%  of  those  with  BDD  will  have  a  lifetime  eating  disorder.  It  also  is  
important  to  distinguish  psychiatrically  ill  patients  from  non-­psychiatrically  ill  patients.  
This  may  be  particularly  challenging  and  critical  at  early  stages  in  adolescents,  as  
behaviors  consistent  with  normal  development  (e.g.  overvaluing  appearance,  thoughts  
about  dieting,  mirror-­checking)  overlap  with  pathological  symptoms  of  AN  and/or  BDD.    
  
Neuroimaging  has  elucidated  several  features  that  may  help  distinguish  AN  from  BDD.  
Recent  research  suggests  that  distorted  perceptions  of  appearance  may  be  linked  to  
66  
abnormalities  in  the  visual  system  (Madsen,  Bohon,  and  Feusner  2013;;  Pallanti  et  al.  
1998;;  Pietrini  et  al.  2011;;  Feusner  et  al.  2010;;  Grocholewski,  Kliem,  and  Heinrichs  
2012).  A  task-­based  fMRI  paradigm  showed  differences  between  patients  with  AN/BDD  
and  CTL  participants  in  the  dorsal  stream  and  early  secondary  visual  processing  
regions  (Li,  Lai,  Bohon,  et  al.  2015).  EEG  likewise  revealed  differences  in  the  latency  
and  amplitude  of  P100  and  N170  components  in  individuals  with  AN  or  BDD  (Li,  Lai,  
Loo,  et  al.  2015).  These  functional  differences  are  underscored  by  the  white  matter  
tractography  of  the  whole  brain  of  patients  with  AN/BDD,  in  contrast  with  that  of  CTL  
participants  (Hayes  et  al.  2015;;  Buchanan  et  al.  2013);;  BDD  has  a  particularly  stark  
effect  on  the  visual  system  (Arienzo  et  al.  2013;;  Zhang  et  al.  2016).  Previous  work  has  
also  found  that  specific  brain-­behavior  relationships  correlate  with  these  abnormalities:  
insight  with  ERP  amplitude  (Li,  Lai,  Loo,  et  al.  2015)  and  insight  with  DTI  path  length  
(Zhang  et  al.  2016).    
  
In  the  context  of  these  multimodal  nature  findings,  I  developed  a  classification  model  
using  the  aforementioned  neuroimaging  and  psychometric  data  to  help  clinicians  
disambiguate  AN  and  BDD  from  each  other  and  from  the  CTL  participants.  I  performed  
this  work  under  the  guidance  and  mentorship  of  Dr.  Jamie  Feusner.  
3.3  Methods  and  materials  
3.3.1.  Participants  
This  study  included  data  from  120  participants  (age  22  +/-­  4.5  years,  87.5%  female):  33  
diagnosed  with  AN,  44  diagnosed  with  BDD,  and  43  healthy  CTL.  For  semantic  ease,  I  
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defined  the  non-­control  group  (non-­CTL)  to  include  all  of  the  participants  with  either  AN  
or  BDD.  Participants  were  matched  for  age  and  educational  level.  
  
Participants  with  AN  were  administered  the  Yale-­Brown-­Cornell  Eating  Disorder  Scale  
(YBC-­EDC)  (Mazure  et  al.  1994),  and  participants  with  BDD  were  administered  the  
Yale-­Brown  Obsessive  Compulsive  Scale  (BDD-­YBOCS)  (Phillips  et  al.  1997).  
Participants  of  both  patient  populations  took  the  17-­item  Hamilton  Depression  Rating  
Scale  (HDRS)  (Hamilton  1960)  and  the  Brown  Assessment  of  Beliefs  Scale  (BABS)  
(Eisen  et  al.  1998).  All  participants  took  the  Hamilton  Anxiety  Rating  Scale  (HAM-­A)  
(Hamilton  1969)  and  the  Montgomery-­Asberg  Depression  Scale  (MADRS)  (Montgomery  
and  Asberg  1979).  We  verified  participants’  BDD  diagnosis  with  a  score  greater  than  19  
on  BDD-­YBOCS  and  with  the  BDD  diagnostic  module  (Dufresne  et  al.  2001).  
Participants  with  AN  met  all  the  DSM-­IV  criteria  except  for  BMI  less  than  18.5.  
  
Any  of  the  following  were  exclusion  criteria  for  participants:  (1)  any  medical  disorder  
affecting  cerebral  metabolism;;  (2)  a  pregnancy;;  (3)  a  neurological  disorder;;  (4)  any  
concurrent  Axis  I  disorders  other  than  dysthymia,  major  depressive  disorder,  or  
generalized  anxiety  disorder;;  (4)  a  score  higher  than  20  on  the  HDRS;;  (5)  an  
assessment  by  Dr.  Feusner  that  the  participant  was  suicidal;;  and  (6)  a  simultaneous  
diagnosis  of  both  AN  and  BDD.  
3.3.2  fMRI  data  
We  acquired  MR  images  from  a  Siemens  Trio  3T  scanner  equipped  with  a  12-­channel  
head  coil.  We  acquired  T1-­weighted  images  with  an  MP-­RAGE  sequence  and  BOLD  
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signal  changes  from  task-­based  fMRI  using  face,  body,  and  house  visual  stimuli,  
henceforth  referred  to  as  the  faces,  bodies,  and  houses  conditions,  respectively.  
Participants  engaged  in  a  simple  task  of  matching  photographs  of  others’  faces,  bodies,  
and  houses  within  separate  runs.  Each  of  these  stimulus  types  was  observed  with  low,  
normal,  or  high  spatial-­frequency  content.    
  
MRI  data  preprocessing  involved  running  all  individual  participant  data  for  three  tasks  as  
bodies,  faces,  and  houses  through  ICA-­based  Automatic  Removal  Of  Motion  Artifacts  
(ICA-­AROMA)  with  the  option  of  non-­aggressive  de-­noising  (Pruim  et  al.  2015).  Using  
FEAT  (part  of  FSL),  I  processed  participant  data  further  with  high-­pass  temporal  filtering  
and  nonlinear  BBR  registration.  
  
Two  of  Dr.  Feusner’s  lab  members,  Gigi  Cheng  and  Dr.  Teena  Moody,  executed  a  
coherence  analysis  of  the  functional  data.  To  create  group-­specific  masks,  they  used  
FSL’s  Multivariate  Exploratory  Linear  Optimized  Decomposition  into  Independent  
Components  (MELODIC)  with  multi-­session  temporal  concatenation  to  obtain  
independent  component  (ICs)  for  each  task  (Beckmann  and  Smith  2004).  Due  to  a  
software  limitation  in  processing  subjects  with  different  numbers  of  TRs,  they  had  to  
exclude  one  participant’s  data  for  the  bodies  condition  and  three  participants’  data  for  
the  faces  condition.  They  allowed  MELODIC  to  generate  an  unspecified  number  of  ICs  
automatically,  which  resulted  in  12,  9,  and  10  components  for  bodies,  faces,  and  
houses,  respectively.  They  matched  the  MELODIC-­generated  ICs  to  functional  network  
ROIs  (fROIs)  from  Shirer  et  al.  by  choosing  the  IC  that  had  the  highest  correlation  with  
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each  network  fROIs  (Shirer  et  al.  2012).  Tested  fROIs  included  the  following  networks:  
salience,  dorsal  /  ventral  default  mode,  higher  visual,  left  /  right  dorsolateral  prefrontal  
cortex  or  executive  control  network,  primary  visual,  and  visuospatial.  Then,  they  
summed  the  ICs  chosen  from  each  task  (bodies,  faces,  and  houses),  thresholded  them  
at  95%,  and  binarized  them  to  create  a  group-­level  independent  component  network  
(ICN)  mask  for  each  fROI.  The  resulting  8  ICN  masks  were  our  versions  of  the  fROIs,  
derived  from  all  participants.  
  
Through  dual  regression  (Zuo  et  al.  2010;;  Poppe  et  al.  2013),  we  used  the  group-­spatial  
maps  from  MELODIC  to  regress  into  participant-­specific  time  courses,  and  applied  
those  time  courses  to  regress  into  participant-­specific  spatial  maps  for  each  IC  
(Beckmann  et  al.  2009;;  Filippini  et  al.  2009).  For  every  network  fROI,  we  calculated  
coherence  values  for  bodies  by  averaging  the  non-­zero  voxels  within  each  participant’s  
spatial  map  for  the  IC  used  to  create  the  group-­level  ICN  mask  (Abram  et  al.  2015).  
DTI  data  
The  neuroimaging  data  also  included  DTI  in  the  form  of  a  minimally  diffusion-­weighted  
scan  (the  b0  image)  and  64  gradient  direction  diffusion-­weighted  images  with  b  =  1000  
s/mm2.  Two  colleagues  of  Dr.  Feusner  computed  the  participants’  tractography,  yielding  
CPL  (the  shortest  path  length  between  all  pairs  of  nodes,  averaged  over  all  nodes)  and  
normalized  path  length  (see  Chapter  I,  graph  theory  metrics  for  an  introduction).  I  
summarize  their  results  here;;  see  the  original  publication  for  more  details  (Zhang  et  al.  
2016;;  Leow  et  al.  2013;;  Gadelkarim  et  al.  2014).  They  derived  87  cortical  and  
subcortical  structures  from  each  participant’s  T1  imaging  and  continuous  fiber  tracking  
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from  the  diffusion-­weighted  results.  Combining  the  parcellation  and  fiber  tractography  
results  yielded  an  87  x  87  connectivity  matrix  of  tractography  relationships  between  
these  parcellations.  From  each  participants’  data,  we  calculated  CPL  of  the  actual  data  
and  of  a  random  network  of  equivalent  size  and  density.  The  ratio  of  observed  CPL  to  
that  of  a  random  network  is  the  normalized  path  length.  
Classification  
I  predicted  the  diagnoses  using  a  L2-­regularized  logistic  regression  model  and  AUC-­
ROC  as  the  statistic  of  interest  (see  introduction  for  details).  Data  are  missing  for  
participants  as  follows:  the  first  eight  patients  with  AN  did  not  receive  the  BABS,  one  
patient  with  BDD  had  no  psychometric  or  processed  fMRI  data,  and  several  participants’  
data  were  not  included  in  either  the  DTI  or  fMRI  because  of  atypical  ventricles  or  
acquisition  errors.  In  total,  119  of  the  total  participants  completed  the  HAM-­A  and  
MADRS,  65  of  the  patients  with  AN  and  BDD  completed  the  BABS,  84  of  the  total  
participants  have  acceptable  DTI  data,  and  69  of  the  total  participants  have  acceptable  
functional  coherence  data.  Specifics  on  the  presence  of  data  between  modalities  can  be  
found  in  Supplementary  Table  S1.  
3.4  Results  
  
In  box  plots  below,  the  red  bar,  pink  box,  blue  box,  and  dots  represent  the  mean,  SEM  
95%  confidence  interval,  one  standard  deviation  (SD),  and  each  participant,  
respectively.  All  tests  between  groups  unless  otherwise  specified  utilize  a  two-­tailed  
permutation  test  with  10,000  resamples  to  calculate  an  empirical  p-­value.  
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3.4.1  Psychometric  features  
Because  we  gave  participants  either  the  YBC-­EDC  or  BDD-­YBOCS  on  the  basis  of  their  
diagnosis,  we  therefore  cannot  use  these  questionnaire  scores  to  differentiate  between  
AN  and  BDD  without  creating  a  non-­independence  error.  YBC-­EDC  and  BDD-­YBOCS  
do,  however,  have  some  overlap  related  to  eating-­related  preoccupations  and  rituals  
(Hoffman  et  al.  2012),  I  reasoned  that  if  the  distributions  did  not  differ  in  central  
tendency  or  variance,  they  could  be  included  in  the  classification  to  capture  multivariate  
interactions  between  the  severity  of  eating  disorder  symptoms  and  the  other  variables.  
In  spite  of  the  similarities  between  the  questionnaires,  the  distributions  were  significantly  
different  in  their  mean  (p  <  10-­4,  n  =  24  AN  and  43  BDD,  Figure  22A).  As  such,  I  did  not  
use  YBC-­EDC  or  BDD-­YBOCS  scores  further  in  these  analyses.  BABS  scores,  
however,  were  independent  of  diagnosis  and  differed  significantly  between  participants  
with  AN  vs  BDD  (p  <  0.01,  Figure  22B).  
  
CTL  subjects  had  significantly  lower  mean  HAM-­A  and  MADRS  scores  (data  not  shown)  
than  did  subjects  with  AN  and  BDD  diagnoses  (both  p  <  10-­4,  Figure  22C,  n  =  42  CTL  
and  77  non-­CTL).  I  used  HAM-­A  and  MADRS  to  distinguish  patients  with  AN  from  those  
with  BDD,  as  well  as  CTL  from  non-­CTL,  subject  to  the  dimensionality  reduction  




Figure  22  -­  distributions  of  psychometric  data.  A.  Mean  YBC  and  BDD-­YBOCS  scores  from  
participants  with  AN  and  BDD,  respectively,  differed  significantly  and  were  not  used  for  any  classifications  
(p  <  10-­4).  B.  BABS  scores  differed  significantly  in  mean  between  participants  with  AN  and  BDD  (p  <  0.01)  




I  observed  a  high  Pearson  correlation  between  the  HAM-­A  and  MADRS  scores  of  all  
three  participant  groups  (r  =  0.85,  95%  CI  [0.79,  0.90]  percentile  bootstrap,  Figure  
23A).  To  reduce  the  number  of  redundant  features,  I  collapsed  both  scales  using  
principal  components  analysis  (PCA).  The  first  component  explained  93%  of  the  
variance  in  the  data  (Figure  23B).  I  generated  a  combined  metric,  “MH”  (MADRS  &  





Figure  23  -­  combining  HAM-­A  and  MADRS  using  PCA.  A.  Histogram  of  10,000  bootstraps  of  the  
correlation  between  HAM-­A  and  MADRS.  Red  lines  are  95%  confidence  interval.  B.  The  first  single  
principal  component  (PC1)  of  HAM-­A  and  MADRS  explained  93%  of  the  variance  among  all  participants  
with  HAM-­A  and  MADRS  scores  (n  =  119).  Each  marker  represents  1  participant.  
  
3.4.2  MR  features  
Normalized  path  length  differed  significantly  between  participants  with  AN  and  
participants  with  BDD  (p  <  0.01,  n  =  24  AN  and  29  BDD)  but  notably  not  between  CTL  
and  non-­CTL  participants  (p  =  0.35,  Figure  24A,  n  =  24  AN,  29  BDD,  and  31  CTL).  The  
AN  group  distribution  was  possibly  bimodal,  and  a  fraction  of  patients  had  a  normalized  
path  length  similar  to  CTL  and  participants  with  BDD  and  another  fraction  had  an  even  
larger  one.  Since  normalized  path  length  is  a  fraction,  I  investigated  whether  this  
distribution  was  attributable  to  a  difference  in  the  observed  CPL  or  to  large  fluctuations  
in  the  denominator  (the  CPL  of  the  randomized  network).  The  random  network  CPL  did  
not  differ  significantly  between  the  three  populations  (anova  p  =  0.92)  The  bimodal  
phenomenon  appeared  to  stem  from  a  larger  CPL  in  the  actual  observed  mean  path  




Figure  24  -­  DTI  path  length  data.  A.  Box  plots  of  normalized  path  length  for  each  participant  population.  
B.  Relationship  between  actual  and  random  CPL  for  all  participants.  Marker  size  reflects  the  normalized  
path  length  value.  Each  marker  represents  a  participant.  
  
  
Because  of  the  small  sample  size,  I  elected  to  use  the  coherence  values  in  three  
hypothesis-­driven  regions  as  the  primary  visual,  high  visual,  and  salience  networks  
since  activation  and  functional  connectivity  had  been  found  to  be  affected  in  AN  and  
BDD  populations  previously  (Moody  et  al.  2015).  The  relationship  of  these  three  




Figure  25  -­  coherence  in  the  three  networks  of  interest.  A.  Coherence  values  between  the  primary  
network  and  visual  networks.  B.  Coherence  values  between  the  salience  network  and  high  visual  
network.  Two  participants  were  more  than  3  standard  deviations  from  the  distribution.  Each  marker  
represents  a  participant.    
  
3.5  Classification  
3.5.1  CTL  vs  non-­CTL  
With  the  justifications  set  forth  above,  I  used  my  derived  MH  metric,  normalized  path  
length,  and  fROI  coherence  to  classify  CTL  from  non-­CTL  for  a  total  of  56  participants  
(17  AN,  19  BDD,  and  21  CTL).  I  assigned  non-­CTL  to  be  the  label-­positive  class;;  thus,  
sensitivity  refers  to  the  fraction  of  correctly  identified  non-­CTL,  and  false  positives  refers  
to  the  number  of  control  participants  predicted  to  be  non-­CTL.  The  model  achieved  an  
accuracy  of  72%,  a  mean  PPV  of  93%,  and  an  AUC-­ROC  of  88%,  which  differed  
significantly  from  a  chance  AUC-­ROC  of  50%  (p  <  0.01,  Figure  26).  Only  MH  
contributed  to  the  classification  significantly;;  its  removal  reduced  the  accuracy  to  63%,  
the  AUC-­ROC  to  64%,  and  rendered  the  classification  non-­significantly  different  from  




Figure  26  -­  classification  of  CTL  from  non-­CTL.  A.  My  classifier  distinguishes  CTL  from  non-­CTL  with  
an  accuracy  of  72%  and  an  AUC-­ROC  of  88%,  which  is  significantly  greater  than  the  chance  AUC-­ROC  
of  50%  (p  <  0.01).  Sensitivity  is  the  fraction  of  non-­CTL  identified  divided  by  the  total  number  of  non-­CTL.  
Only  100  null  permutations  are  shown.  B.  The  equivalent  PR  curve  is  useful  when  prioritizing  one  
outcome  over  another.  Chance  curves  are  shown  for  reference  only;;  I  performed  no  significance  testing.  
  
3.5.2  AN  vs  BDD  
Next,  I  investigated  whether  these  multimodal  data  could  distinguish  the  more  difficult  
clinical  task  of  predicting  a  diagnosis  of  AN  or  BDD.  I  assigned  participants  with  AN  to  
be  the  label-­positive  class;;  thus,  sensitivity  refers  to  the  fraction  of  correctly  identified  
participants  with  AN,  and  false  positives  refers  to  the  number  of  patients  with  BDD  
predicted  to  have  a  diagnosis  of  AN.  A  model  using  MH,  BABS,  normalized  path  length,  
and  coherence  values  had  an  accuracy  of  70%  and  an  AUC-­ROC  of  75%,  which  was  
not  different  from  the  chance  value  significantly  (p  =  0.09,  n  =  14  AN  and  19  BDD).  
Here,  there  are  3  fewer  participants  with  AN  than  the  previous  classification  of  controls  
from  non-­controls  because  those  3  participants  did  not  have  BABS  scores.  The  
coherence  features  were  highly  non-­significant,  so  I  elected  to  remove  these  features  
from  the  model,  which  also  allowed  me  include  12  additional  participants  for  whom  there  
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was  psychometric  and  DTI  data  but  no  functional  data.  A  model  incorporating  the  MH,  
BABS,  and  normalized  pathlength  distinguished  patients  with  AN  from  those  with  BDD  
with  76%  accuracy  and  an  AUC-­ROC  of  82%,  which  is  significantly  greater  than  the  
chance  AUC-­ROC  of  50%  (p  <  0.05,  Figure  27A,  n  =  16  AN  and  29  BDD).  All  three  
multimodal  features  were  significant  (Figure  27B).  All  three  features  in  this  model  also  
differed  significantly  from  0  (MH  p  <  0.05,  BABS  p  <  0.05,  normalized  path  length  <  
0.01,  uncorrected).  To  be  clear,  removing  the  coherence  features  did  not  allow  the  
model  to  reach  significance;;  rather,  removing  the  coherence  features  allowed  me  to  
include  12  additional  participants,  each  of  whom  had  data  for  MH,  BABS,  and  
normalized  path  length  data  but  not  coherence  data  and  were  thus  excluded  from  the  
first  model.  The  possibility  of  imputing  values  is  discussed  below.  
  
  
Figure  27  -­  classification  of  patients  with  AN  from  those  with  BDD.  A.  ROC  curve  for  the  model  
incorporating  the  MH,  BABS,  and  normalized  path  length,  which  distinguished  patients  with  AN  from  
those  with  BDD  with  76%  accuracy  and  an  AUC-­ROC  of  82%  (p  <  0.05,  n  =  16  AN  and  29  BDD).  B.  OR  





A  combination  of  neuroimaging  and  psychometric  data  predicted  diagnoses  of  AN,  
BDD,  or  CTL.  While  a  univariate  combination  of  anxiety  and  depression  scale  data  are  
adequate  to  distinguish  CTL  from  non-­CTL,  a  combination  of  psychometric  and  
neuroimaging  data  best  discriminate  participants  with  AN  from  those  BDD.  These  are  
not  mutually-­exclusive  classifications;;  each  group  has  overlapping,  related  features.  A  
combination  of  both  models  yields  a  more  informative  clinical  viewpoint  and  diagnostic  
flowchart:  (1)  is  this  potential  patient  neurotypical?  (2)  if  not,  how  strongly  does  the  
evidence  suggest  they  have  symptoms  of  AN  or  BDD?  By  combining  each  participant’s  
results  for  both  models,  we  can  see  the  relationship  among  these  conditions  more  
clearly  (Figure  28).    
  
This  plot  shows  fairly  strong  separability  between  groups.  If  the  threshold  were  set  at  
50%  for  both  models,  a  few  CTL  participants  would  be  misclassified  as  having  AN,  and  
a  few  participants  with  AN  would  be  misclassified  as  CTL.  It  is  interesting  to  note  that  
none  of  the  participants  with  BDD  would  have  been  misclassified  as  CTL.  Given  the  
high  PPV  in  this  context,  if  a  new  potential  patient  has  a  greater  than  50%  probability  of  
both  being  non-­neurotypical  and  having  BDD,  these  results  suggests  high  likelihood  of  a  




Figure  28  -­  joint  predictions  of  both  models.  When  synthesized,  the  CTL  vs  non-­CTL  model  and  the  
AN  vs  BDD  model  reveal  relatively  clear  delineation  between  CTL  participants  (black),  participants  with  
AN  (red),  and  participants  with  BDD  (blue).  The  predictions  of  both  models  together  reveal  the  high  
separability  of  these  3  groups.  Produced  by  Wesley  Kerr  from  our  ongoing  collaboration.  
  
  
My  discrimination  of  CTL  from  non-­CTL  participants  was  limited  by  the  criteria  that  CTL  
participants  were  required  to  meet.  The  inclusion  criteria  for  CTL  participants  required  
the  absence  of  a  concurrent  Axis  I  disorder;;  in  contrast,  I  did  allow  patients  with  
AN/BDD  to  have  anxiety  and  depression  comorbidities,  which  are  common  in  those  
populations.  Although  I  did  not  use  scores  from  the  questionnaires  to  exclude  certain  
participants,  CTL  participants  were  more  likely  to  have  lower  scores  on  HAM-­A  and  
MADRS  questionnaire  scores  (the  main  features  driving  the  CTL  versus  non-­CTL  
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discrimination).  This  did  not  in  any  way  diminish  the  power  of  this  classifier  to  
discriminate  CTL  participants  from  patients  with  AN  or  BDD.  It  did,  however,  limit  the  its  
applicability  to  the  general  population,  not  all  of  which  meet  the  screening  criteria  
satisfied  by  healthy  CTL  participants.  If  the  general  population  has,  for  instance,  higher  
HAM-­A  and  MADRS  scores  than  the  CTL  population,  the  accuracy  will  be  reduced.  
  
In  addition,  my  findings  were  limited  because  of  the  relatively  small  sample  size,  which  
prevented  me  from  dividing  the  data  into  a  training  group  and  independent  validation  
group  against  which  to  test  my  model.  An  essential  next  step  would  be  to  validate  my  
model  using  an  independent  sample  of  participants  with  AN  or  BDD.  Ideally,  this  
validation  would  have  two  parts.  First,  it  would  test  whether  my  multimodal  model  
significantly  and  usefully  distinguishes  participants  who  have  been  diagnosed  with  AN  
exclusively  from  those  diagnosed  with  BDD,  since  they  have  been  determined  not  to  
have  both.  Second,  I  would  expect  that  participants  comorbid  with  AN  and  BDD  would  
be  clearly  differentiable  from  CTL.  As  a  group,  patients  with  comorbidity  lie  closer  to  the  
AN  /  BDD  decision  plane  than  participants  with  either  AN  or  BDD.  In  other  words,  the  
variance  in  their  probability  estimates  would  be  smaller  than  an  identically  sized  group  
of  participants  with  AN  or  BDD  (but  not  comorbid).  Another  approach  to  this  step  would  
be  to  develop  and  test  a  3-­class  classification  model  on  a  group  that  includes  AN,  
AN/BDD  comorbid,  and  BDD,  which  would  perform  better  if  there  is  an  interaction  effect  
on  psychometric  or  neural  data  with  AN/BDD  comorbidity.  To  further  the  clinical  utility  of  
this  model,  the  classification  could  be  tested  on  adolescents  at  early  stages  of  illness.  If  
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these  can  be  validated,  my  multimodal  and  two-­stage  classification  model  may  aid  in  
clinical  disambiguation  between  healthy  individuals  and  patients  with  AN  or  BDD.  
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Chapter  IV  -­  Using  insurance  claims  to  predict  and  prevent  IBD  hospitalizations  
4.1  Abstract  
  
Inflammatory  Bowel  Disease  (IBD)  is  an  inflammatory  disorder  of  the  intestines  that  can  
necessitate  hospitalization  and  the  use  of  expensive  biologics.  Models  predicting  these  
interventions  may  improve  patient  quality  of  life  and  reduce  expenditures  of  insurance  
companies.  I  used  insurance  claims  from  2011  to  2013  to  predict  hospitalization  for  IBD  
and  the  use  of  biologics.  I  derived  and  optimized  our  model  from  a  2011  training  set  of  
7,771  patients  predicting  their  outcomes  the  following  year.  The  final  model  then  was  
applied  to  a  2012  validation  set  of  7,450  patients  to  predict  their  outcomes  in  2013.  The  
training  models  predicted  both  IBD  hospitalization  and  biopharmaceutical  use  in  the  
validation  set  significantly,  with  average  PPVs  of  17%  and  11%,  respectively  –  a  more  
than  300%  improvement  over  chance.  Furthermore,  I  used  topic  modeling  to  identify  
four  internally  similar  patient  subpopulations.  When  included  in  our  prediction  model,  the  
PPV  of  IBD-­related  hospitalization  increased  to  21%.  I  showed  that  using  this  
hospitalization  model,  in  concert  with  a  mildly  effective  interventional  treatment  plan  for  
the  patients  identified  as  high-­risk,  would  both  improve  patient  outcomes  and  reduce  
insurance  plan  expenditures.  These  results  indicated  a  mechanism  to  provide  
personalized  patient  care  based  on  insurance  claims  data,  which  is  demonstrated  here  
as  a  viable  alternative  to  traditional  medical  data  in  the  field  of  predictive  medicine.  
4.2  Introduction  
  
Inflammatory  Bowel  Diseases  (IBD)  are  disorders  of  the  gastrointestinal  tract  that  affect  
approximately  one  million  people  in  the  United  States  (Ford  et  al.  2011).  IBD  can  be  
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subclassified  into  Crohn’s  disease  (CD)  or  ulcerative  colitis  (UC).  While  UC  is  limited  to  
the  colon,  CD  can  affect  any  parts  of  the  gastrointestinal  tract.  These  disorders  may  
afflict  some  patients  simultaneously.  Although  the  life  expectancy  of  patients  with  IBD  is  
close  to  normal,  recurring  flares  and  serious  complications  including  toxic  megacolon  
and  fistulas  may  require  surgery  and  reduce  quality  of  life  substantially  (Podolsky  1991;;  
Sonnenberg  2007).  IBD  also  reduces  patients’  work  productivity  significantly  (Zand  et  al.  
2015).  It  can  be  treated  by  a  variety  of  immunomodulating  medications,  including  
corticosteroids,  5-­aminosalicylic  acids  (5-­ASA),  thiopurines,  and  methotrexate,  which  
decrease  the  body’s  overall  immune  response.  Alternatively,  IBD  may  be  targeted  by  
the  more  recently  developed  “biologics”:  compounds  that  target  specific  proteins  in  
inflammatory  pathways  (Talley  et  al.  2011a).  The  introduction  of  these  biological  
compounds,  such  as  anti-­TNF-­α  (adalimumab,  infliximab,  and  certolizumab  pegol)  and  
α4-­integrin  inhibitors  (natalizumab),  resulted  in  major  improvements  in  the  quality  of  life  
of  patients  with  IBD  (Vogelaar,  Spijker,  and  van  der  Woude  2009).  
  
IBD  is  associated  with  significant  costs  for  both  patients  and  insurers.  Total  annual  
expenditures  are  estimated  at  $12,000  for  a  CD  patient  and  $8,700  for  a  UC  patient,  of  
which  patients  pay  approximately  15%  out-­of-­pocket  (Gunnarsson  et  al.  2011).  
Hospitalizations  and  biological  treatment  account  for  the  highest  portion  of  these  costs  
as  13%  and  72%  respectively  for  CD  and  15%  and  39%  for  UC  (van  der  Valk  et  al.  
2016).  Biologics  are  particularly  costly,  often  exceeding  $20,000  per  person  annually  
(Gleason  et  al.  2013).  Despite  their  expense,  doctors  prescribe  biologics  because  they  
are  highly  efficacious  (Ford  et  al.  2011)  and  may  reduce  costs  in  the  long  run.  Beyond  
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inducing  remission  in  some  patients  with  IBD,  biologics  may  improve  quality  of  life  and  
work  productivity,  thereby  reducing  the  indirect  costs  associated  with  IBD  by  almost  
70%  (Zand  et  al.  2015).  The  timing  of  treatment  initiation  is  critical  because  an  early  
therapeutic  window  has  been  shown  to  improve  long-­term  outcomes  (D’Haens  et  al.  
2008;;  Schreiber  et  al.  2007;;  Kang  et  al.  2016).  In  this  case,  “patient  populations  need  to  
be  identified  that  would  benefit  from  early  use  of  these  agents“  (Panaccione  and  Ghosh  
2010).    
  
This  type  of  patient  identification  warrants  new  technological  approaches  in  predictive  
modeling.  Researchers  have  used  digitized  databases  to  predict  many  medical  
outcomes  successfully  (Bates  et  al.  2014;;  Dhar  2014;;  Parikh,  Kakad,  and  Bates  2016)  
including,  but  not  limited  to,  30-­day  hospital  readmission  (Donzé  et  al.  2013),  acute  
ischemic  stroke  (Hsieh  et  al.  2015),  and  future  autism  diagnosis  (Wall  et  al.  2012).  
Unfortunately,  patient  biomedical  data  may  not  be  readily  available  due  to  privacy  
concerns  (Weber,  Mandl,  and  Kohane  2014)  or  may  be  available  but  incomplete  or  
incompatible  across  providers  and  institutions  (Xiaoming  Wang  et  al.  2009).  Because  of  
these  limitations  related  to  biomedical  data,  recent  efforts  utilized  insurance  claims  
records  to  predict  various  outcomes.  For  example,  researchers  used  claims  data  to  
predict  the  outcomes  of  depression  treatment  (Huang  et  al.  2014)  and  falls  in  the  elderly  
(Homer  et  al.  2017).  
  
In  this  study,  I  used  insurance  claims  data  in  an  effort  to  predict  the  two  primary  cost-­
drivers  in  IBD:  hospitalizations  and  the  use  of  biologics.  By  identifying  patients  at  risk  for  
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hospitalization,  targeted  patients  could  be  advised  to  return  to  the  clinic  for  early  
intervention  and  treatment  optimization.  By  identifying  patients  who  will  need  biologics,  
treatment  could  be  expedited  to  fall  within  the  critical  therapeutic  window,  thereby  
improving  efficacy  and  quality  of  life.  Interventions  are  costly:  these  advanced  strategies  
require  a  model  to  identify  the  subpopulations  of  patients  who  would  benefit  from  them.  
To  construct  this  model,  I  analysed  36  months  of  longitudinal  insurance  claims  data  
from  patients  with  IBD  who  were  treated  at  UCLA.  These  data  contained  information  
pertaining  to  medications,  test  administrations,  psychometric  scales,  office  
appointments,  hospital  visits,  insurance  coverages,  and  demographics.  Except  for  
comorbidity  assessments,  none  of  these  data  include  biological  information  from  the  
outcomes  of  tests,  scales,  or  appointments;;  instead,  they  indicated  simply  that  a  visit  or  
test  occurred,  and  that  it  was  paid  for.  
  
To  account  for  different  IBD  subtypes  and  care  pathways,  I  selected  topic  modeling  
(Blei  2012),  a  type  of  unsupervised  learning,  to  identify  patient  subgroups.  Originally  
applied  to  the  problem  of  finding  trends  in  text  corpora,  topic  models  were  used  
effectively  to  extract  meaningful  low-­dimensional  representations  from  large  data  sets.  
Researchers  adapted  topic  modeling  techniques  in  a  variety  of  areas,  including  social  
media  (Hong  and  Davison  2010),  images  (Xiaogang  Wang  and  Grimson  2008),  ADHD  
classification  (Anderson  et  al.  2014),  and  motion  classification  (Y.  Wang,  Sabzmeydani,  
and  Mori  2007).  Although  this  subgrouping  analysis  has  been  used  in  predicting  




This  study  addressed  two  questions:  (1)  Do  insurance  claims  reveal  patterns  of  care  
that  indicate  future  hospitalizations  and  biologics  use?  (2)  Does  the  hospitalization  
model  make  predictions  sufficiently  accurate  to  justify  an  intervention  for  high-­risk  
patients  based  on  direct  cost  savings  alone?  
4.3  Methods  and  materials  
4.3.1  Patient  data  
The  data  were  acquired  entirely  by  Daniel  Hommes  and  Welmoed  van  Deen  at  the  
UCLA  Center  for  Inflammatory  Bowel  Diseases.    
Anthem,  California  provided  the  insurance  claims  data,  including  enrollment  data,  and  
pharmacy  and  medical  claims  from  2011  through  2013.  Medical  claims  included  a  
unique  beneficiary  ID,  provider  ID  and  specialty,  date  of  service,  location  of  service,  
Current  Procedural  Terminology  (CPT)  code,  up  to  8  International  Classification  of  
Disease  (ICD)-­9  codes,  and  a  Diagnosis-­Related  Group  (DRG)  for  hospitalizations.  
Pharmacy  claims  included  patient  and  provider  ID;;  medication  fill  date,  and  medication  
name,  dose,  and  number  of  days  filled.  Age  was  provided  for  all  beneficiaries,  though  
no  gender  details  or  other  demographic  characteristics  were  available.  
  
I  included  patients  if  they  had  at  least  two  medical  claims  with  an  ICD-­9  code  for  IBD  
(555.x  or  556.x)  or  one  medical  claim  for  IBD  and  one  pharmacy  claim  for  an  IBD-­
related  medication.  I  constructed  variables  for  IBD-­related  claims,  hospitalizations,  
Emergency  Department  (ED)  and  office  visits,  procedures,  lab  and  imaging  tests,  
medication  use,  disease  severity,  and  relapse  rate  (van  Deen  et  al.  2017).  For  each  
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medication,  I  analyzed  whether  it  had  been  used,  the  number  of  times  a  course  of  
medication  was  started,  and  the  number  of  days  of  use.  For  each  procedure  and  test,  I  
analyzed  whether  the  procedure  /  test  had  been  performed  at  all  and  the  number  of  
times  it  was  performed.  In  total,  I  extracted  110  potentially  predictive  features  (Figure  
29).  Because  multiple  variables  were  derived  for  each  medication,  test,  and  procedure,  




Figure  29  -­  pearson  correlation  matrix  of  data  features.  Pearson  correlation  matrix  of  all  110  features.  
Highly  correlated  squares  on  the  midline  correspond  to  features  describing  different  aspects  of  the  same  
medication:  whether  the  medication  had  been  used,  the  number  of  times  a  course  of  medication  was  
started,  and  the  number  of  days  of  use.  Correlation  clusters  around  (1)  systemic  steroids  and  disease  





To  design  and  validate  our  model,  I  split  the  data  into  two  mutually  exclusive  datasets.  
The  training  dataset  included  7,771  patients  who  were  enrolled  continuously  2011  
through  2012.  I  derived  a  model  in  which  the  variables  described  above  from  the  2011  
claims  data  predicted  two  outcomes  in  the  year  2012  as  (1)  the  hospitalization  for  IBD  
and  (2)  the  use  of  biologics.  To  validate  our  model,  I  then  applied  it  to  the  validation  
dataset  comprised  of  7,450  patients  enrolled  continuously  through  2012  and  2013.  A  
total  of  4,050  patients  were  enrolled  continuously  from  2011  through  2013  and  were  
present  in  both  datasets,  comprising  54%  of  the  validation  set.  I  address  the  concern  of  
overlapping  subjects  between  the  training  and  validation  set  in  Figure  36B.  
4.3.2  Classification  
To  identify  predictors  of  future  IBD-­related  hospitalizations,  I  used  L1-­regularized  logistic  
regression.  I  used  110  features  from  the  insurance  claims  data  as  independent  
variables  and  hospitalization  for  IBD  (binary)  as  the  single  dependent  variable.  Models  
were  run  on  the  entire  dataset,  as  well  as  within  each  of  the  identified  risk-­groups,  and  I  
compared  the  outcomes  of  each  approach.  To  predict  the  future  use  of  biologics,  I  ran  
one  L1-­regularized  logistic  regression  model  on  the  subset  of  patients  not  using  
biologics  currently.  Because  this  is  already  a  small  subpopulation  of  the  included  IBD  
population,  I  did  not  attempt  to  sub-­classify  this  population  further  using  topic  modeling.    
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4.3.3  Grouping    
I  used  topic  modeling  to  identify  four  patient  subgroups.  Topic  modeling  is  an  
unsupervised  learning  algorithm  (i.e.  it  makes  classifications  without  using  outcome  
data)  that  uses  data  to  identify  related  features  in  the  dataset,  based  on  which  topics  
are  created.  Specifically,  a  model  known  as  latent  Dirichlet  allocation,  or  LatDA  (Blei,  
Ng,  and  Jordan  2003),  was  utilized  for  data  dimension  reduction  and  trend  extraction.  
LatDA,  proposed  originally  as  a  model  for  word  occurrences  in  text  documents,  is  a  
probabilistic  generative  model  made  popular  due  to  the  model's  exploration  of  the  
solution  space  and  efficacy  with  large  data  sets.  More  generally,  topic  modeling  applied  
to  any  non-­negative  data  results  in  a  non-­negative  linear  decomposition  into  the  number  
  of  topics  or  components.  The  LatDA  model  in  particular  can  be  stated  as  follows:  Let  
  be  the  number  of  features  and     the  number  of  observations.  Let     be  the     by     
non-­negative  data  matrix.  LatDA  models  this  matrix  via  latent   -­by-­   and   -­by-­   
nonnegative  matrices     and     respectively  with  unit  sum  columns.  That  is,     via  
the  generative  process:  
  
     
  
Here,     are  model  parameters  that  control  the  strength  of  the  Dirichlet  
prior  assumption  on  the  distributions  in  the  columns  of     and   .  The  prior  is  responsible  
for  avoiding  degenerate  solutions  containing  zero  entries.  The  third  parameter,   ,  
specifies  the  number  of  latent  factors  used  to  model  the  data.  The  resulting  model  
resembles  another  popular  technique  known  as  non-­negative  matrix  factorization  (NMF)  
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(Lee  and  Seung  1999).  In  particular,  LatDA  is  NMF  with  the  Poisson  sampling  
assumption  and  added  smoothing  via  the  Dirichlet  assumptions.  I  use  a  simple  
maximum-­likelihood  estimation  algorithm  for  LatDA  known  as  expectation-­maximization  
(Asuncion  et  al.  2009).  
4.3.4  Significance  testing  
To  assess  the  significance  of  our  predictions,  I  used  permutation  testing  to  estimate  the  
empirical  probability  distributions  of  a  classifier  where  there  was  no  relationship  
between  potentially  predictive  features  and  outcomes.  I  broke  the  potential  relationship  
between  features  and  outcomes  by  permuting  the  2012  and  2013  outcome  information  
randomly  without  replacement  and  by  keeping  the  input  data  the  same.  I  conducted  the  
same  process  of  training  and  validation  on  these  permuted  datasets  and  repeated  this  
for  10,000  unique  permutations  to  estimate  the  probability  distribution  of  all  our  reported  
summary  statistics  empirically.  I  determined  the  empirical  p-­value  (“p-­hat”)  as  the  
fraction  of  permuted  datasets  that  achieved  a  summary  statistic  as,  or  more,  extreme  
than  the  one  observed  within  the  original  data.  
4.3.5  Intervention  
To  estimate  the  impact  of  these  predictive  models  for  insurance  companies,  I  
considered  a  hypothetical  intervention  in  which  those  patients  preventable  from  
hospitalization  would  be  instructed  to  attend  an  office  visit  (Figure  37  in  the  IBD  
hospitalization  section  below).  I  assumed  that  if,  at  the  time  of  the  office  visit,  these  
patients  were  using  steroids  only,  5-­ASA  only,  or  no  medication  at  all,  future  
hospitalizations  could  be  prevented  by  initiating  immunomodulator  treatment.    To  
account  for  the  uncertainty  about  the  efficacy  of  this  intervention  to  prevent  
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hospitalizations,  I  varied  the  probability  across  as  a  wide  range  to  determine  the  
minimum  efficacy  that  would  result  in  an  overall  cost  reduction.  I  assumed  a  consistent  
cost  of  $10,000  per  hospitalization  and  $200  per  office  visit.  
4.4  Results  
4.4.1  Statistics  
The  patients  in  the  2011  to  2012  training  set  (7,771)  and  2012  to  2013  validation  set  
(7,450)  had  an  average  age  of  42  +/-­  14  years  and  were  patients  of  this  UCLA  plan  for  
an  average  of  1.3  +/-­  0.8  years.  The  training  and  validation  sets  had  IBD-­related  
hospitalization  rates  of  8%  and  5%,  respectively.  Of  the  patients  hospitalized  in  2011,  
20%  returned  to  the  hospital  in  2012.  In  2011  and  2012,  16%  and  18%  of  the  patients  
used  biologics,  respectively.  The  majority  of  biologics  users  in  2011  remained  on  
biological  therapy  in  2012  as  88%  (Figure  30A).  
4.4.2  Feature  extraction  
An  important  exercise  in  machine  learning  is  feature  extraction  as  a  means  of  
transforming  the  initial  and  measured  data  into  an  information-­maximizing  set  of  
variables  for  subsequent  learning  (Yu  and  Liu  2004).  In  this  case,  the  original  monthly  
data  contained  temporal  trends  that  were  lost  when  looking  at  one  year  in  isolation.  To  
detect  a  latent  temporal  trend,  I  analyzed  monthly  hospitalization  rate  as  a  function  of  
time  elapsed  since  the  patient  joined  the  insurance  plan  (Supplementary  Figure  S2).  
Given  that  IBD  is  known  to  be  seasonal,  I  fit  these  data  with  a  first-­order  polynomial  and  
12-­month  cyclically  repeating  parabola.  I  discovered  that  the  monthly  IBD-­
hospitalization  rate  decreased  by  0.0046%  per  month,  which  translated  to  a  yearly  IBD-­
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hospitalization  rate  decrease  of  0.66%  per  year.  This  feature  (time  as  a  member  of  the  
insurance  plan)  was  added  to  the  data  for  classification.  
  
  
Figure  30  -­  statistics  and  topic  modeling.  A.  Frequencies  of  interest  in  training  data.  2012  |  2011  
shows  of  the  frequency  with  which  patients  who  had  an  outcome  in  2011  also  had  the  same  outcome  in  
2012.  For  example,  88%  of  patients  prescribed  biologics  in  2011  continued  using  biologics  in  2012  and  
were  thus  highly  likely  to  continue  their  use  the  following  year.  B.  Topics  revealed  by  our  topic  modeling  
analysis  and  their  associated  IBD-­hospitalization  rate.  
  
4.4.3  Topic  modeling  
Topic  modeling  revealed  4  topics  among  patient  claims  (Figure  30B).  The  model  
computed  a  score  for  each  patient’s  belongingness  in  each  topic  and  assigned  each  
patient  to  the  single  topic  for  which  they  had  the  highest  score.  
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4.4.4  IBD  hospitalization  
Univariate  analysis  
For  each  of  the  110  features,  I  fit  a  separate  L1-­regularized  logistic  regression  of  the  
feature  onto  the  (binary)  IBD  hospitalization  outcome  variable.  For  each  of  these  110  
models,  I  used  average  PPV  (the  area  under  the  AUC-­PR  curve),  as  a  metric  for  the  
usefulness  of  the  feature  in  predicting  IBD  hospitalization.  The  PR  curve  plots  positive  
predictive  value  (PPV)  versus  sensitivity;;  the  average  PPV  is  a  common  method  to  
compare  models.  The  top  20  models  ranked  in  order  of  descending  average  PPV  are  
listed  in  Figure  32.  
  
Figure  32  -­  univariate  analysis  of  IBD  hospitalization.  Outcomes  of  a  separate  univariate  regression  
on  IBD  hospitalization  by  each  of  110  claims  data  features  using  training  data.  Several  variables,  most  
notably  IBD  as  the  number  of  annual  IBD-­related  claims,  yielded  predictive  models  as  measured  by  
average  PPV.  The  LOR  is  per  1  unit  change  in  the  normalized  variable.  The  range  of  values  for  each  




Reducing  a  dataset’s  dimensionality  can  improve  classification  (Roweis  and  Saul  2000).  
One  way  to  accomplish  this  is  by  orthogonal  transformation:  reorienting  the  basis  set  
along  axes  which  explain  more  variance  and  ignoring  those  new  axes  which  do  not  
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explain  a  large  portion  of  this  variance  (Kanjilal  and  Banerjee  1995).  For  this  purpose,  I  
applied  principal  components  analysis  (PCA)  and  independent  components  analysis  
(ICA)  to  the  training  data,  varying  the  number  of  desired  components  from  1  to  110  
(Figure  32A).  Regardless  of  the  number  of  components  included,  both  PCA  and  ICA  




Figure  32  -­  optimizing  the  IBD-­hospitalization  model.  A.  The  original  data  and  its  110  features  had  an  
average  PPV  of  19%.  The  efficacy  of  PCA  saturates  never  reached  that  of  the  original  110  features.  ICA  
was  even  less  effective  on  this  data.  B.  PR  curves  for  predicting  an  IBD-­hospitalization  the  following  year  




I  classified  IBD-­hospitalization  outcomes  using  numerous  linear  classification  schemes  
(Figure  32B).  Model  performance  varied  only  slightly  across  both  regularization  and  
loss  distance  metric  (L1/L2)  and  classification  method  (logistic  regression  versus  SVM  
and  dual  vs  primal).  To  favor  sparsity  (Ryali  et  al.  2010)  and  probabilistic  interpretation  
(Liu  et  al.  2009),  I  chose  the  L1-­regularized  logistic  regression  method  for  further  
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analyses.  The  weights  from  this  model  on  the  training  data  are  shown  as  log  likelihood  
in  Figure  33  with  stars  over  significant  weights  (q  <  0.05,  corrected).    
  
Figure  33  -­  all  training  model  weights  for  predicting  IBD-­hospitalization.  Results  of  an  L1  logistic  
regression  of  the  110  features  on  IBD-­hospitalization.  Blue  bars  are  actual  fit,  and  grey  bars  are  95%  
change  confidence  intervals.  Stars  signify  p  <  0.05  after  Holm-­Bonferroni  correction.    
  
  
Likelihood  coefficients  (ORs)  for  IBD-­hospitalization  for  the  11  significant  weights  are  
shown  in  Figure  34.  These  are  the  probability  of  going  to  the  hospital  divided  by  the  
probability  of  not  going  to  the  hospital  per  1  unit  change  in  the  variable.  For  example,  an  
IBD  hospitalization  predicted  an  IBD  hospitalization  the  following  year  as  1.22  times  as  
likely  and  as  an  increase  of  22%.  Similarly,  an  office  visit  predicted  an  IBD  
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hospitalization  the  following  year  as  0.83  times  as  likely  and  as  a  decrease  of  17%.  For  
variables  that  contained  multiple  values,  it  is  important  to  consider  the  variable’s  
frequency  when  assessing  its  relative  importance.  For  example,  a  single  IBD  claim  
predicted  an  IBD  hospitalization  the  following  year  as  1.01  times  as  likely  and  as  an  
increase  of  only  1%.  However,  the  average  patients  had  5.7  claims  in  a  year  with  a  SD  
of  8.4  and  a  maximum  of  185.  Thus,  for  the  average  patient,  the  number  of  IBD  claims  
may  have  a  larger  influence  than  an  IBD-­hospitalization.  To  reflect  the  importance  of  
non-­binary  variables,  I  used  a  black  “x”  to  indicate  the  change  in  likelihood  of  an  IBD  




Figure  34  -­  likelihood  for  significant  features  of  general  model.  Significant  features  (p  <  0.05  
Bonferroni-­Holm  corrected)  and  their  relative  weights  from  an  L1-­regularized  logistic  regression  predicting  
initiation  of  biologics.  Red  bars  reflect  features  positively  predictive  of  initiation  of  biologics,  and  green  
bars  reflect  features  negatively  predictive  of  initiation  of  biologics.    
  
  
To  capture  the  differences  between  patients,  I  tried  a  completely  separate  modeling  
approach  by  creating  a  specific  model  for  each  subgroup  identified  by  the  topic  
modeling.  This  yielded  four  total  models  with  one  for  each  topic.  For  each  topic,  the  
topic-­specific  models  performed  slightly  less  well  than  the  general  model  (Figure  35A  
and  35B).  Topics  on  which  the  general  model  performed  less  well  than  others,  for  
example  Topic  #3,  were  similarly  difficult  for  the  topic-­specific  model  to  predict.    
  
I  concluded  that  topic  modeling  does  not  improve  model  accuracy  by  creating  a  
separate  model  for  each  subgroup.  Rather,  the  value  in  topic  modeling  stemmed  from  
its  ability  to  identify  at-­risk  patient  groups  that  were  otherwise  overlooked  by  the  
regression  modeling.  In  other  words,  topic  modeling  captured  important  interaction  
terms  between  features,  which  would  have  been  missed  by  the  main-­effect  nature  of  
single  and  general  multivariate  regression  otherwise.    
  
To  assess  the  overall  combined  results  of  the  topic-­specific  models,  I  combined  the  
results  of  each  topic-­specific  model  and  eliminated  suboptimal  combinations  (Figure  
35C).  Each  point  in  the  final  results  was  the  combination  of  thresholding  of  each  topic  
model  at  different  cutoff  values.  Using  this  method,  I  can  compare  (1)  the  original  
model,  (2)  the  single  model  evaluated  at  different  decision  criteria  for  each  topic,  and  (3)  
the  topic-­specific  models  each  applied  at  different  decision  criteria  (Figure  35D).  The  
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single  general  model,  thresholded  differently  for  each  topic  (labeled  as  green),  had  an  
average  PPV  of  21%;;  the  topic-­specific  models  had  an  average  PPV  of  20%.  Given  
their  comparable  performance  but  increased  number  of  parameters  (and  thus  over-­
fitting),  the  topic-­specific  models  were  not  applied  further.  
  
  
Figure  35  -­  topic  modeling  performance.  A.  Performance  in  each  of  the  4  topics.  Solid  lines  depict  the  
performance  of  the  model  created  from  the  topic  specifically,  whereas  dashed  lines  depict  the  
performance  of  the  single  and  general  model  on  the  topic.  B.  AUC-­PR  for  each  topic  using  either  the  
model  fit  for  the  topic  specifically  or  a  general  model  fit  to  all  instances  of  the  data.  The  general  model  
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outperformed  the  topic-­specific  model  in  all  topics.  C.  A  demonstration  of  how  all  the  topic-­specific  model  
results  were  combined  to  compare  performance  across  all  patients.  Since  any  threshold  could  be  chosen  
for  either  model,  there  were  m  x  n  possible  combinations,  where  m  was  the  number  of  instances  of  topic  
3  and  n  was  the  number  of  instances  of  topic  4.  Points  with  suboptimal  PPV,  sensitivity,  or  specificity  
were  eliminated.  D.  Using  the  method  in  (C),  I  assessed  the  overall  performance  of  each  methodology  on  
the  training  data.  The  single  and  general  model  thresholded  differently  for  each  topic  (green)  and  




To  reduce  the  influence  of  overfitting,  the  final  model  applied  to  the  validation  set  
utilized  only  the  11  features  that  were  significant  in  the  training  set  after  correction  for  
multiple  comparisons.  This  model  predicted  IBD  hospitalizations  in  the  validation  set  
with  an  average  PPV  of  17%,  significantly  above  the  chance  of  5%  (p  <  10-­4,  Figure  
36A,  one-­tailed  percentile  permutation  test).  After  applying  the  general  model  to  each  
topic  group  separately,  average  PPV  was  improved  to  21%.  This  model  performed  
better  on  continuing  patients  as  those  also  present  in  the  training  data  as  54%  than  on  




Figure  36  -­  IBD  hospitalization  model  validation.  A.  PR  curves  for  predicting  IBD-­hospitalization  using  
the  final  11-­feature  IBD-­hospitalization  model  on  the  validation  set  (p  <  10-­4,  one-­tailed  percentile  
permutation  test,  100  null  permutations  shown).  The  general  model,  applied  to  each  topic  with  different  
thresholds  (green),  performed  better  with  an  average  PPV  of  21%  versus  17%  for  the  single  model  
applied  to  all  data  equally  (blue).  This  difference  in  performance  was  observed  primarily  at  sensitivities  
below  25%.  B.  PR  curves  for  IBD-­hospitalization  prediction  performance  in  the  validation  set  for  both  




Next,  I  used  our  IBD-­hospitalization  model’s  predictions  to  assess  whether  an  
intervention  was  financially  feasible.  I  assumed  that  if  patients  used  steroids  only,  5-­
ASA,  or  no  medication  at  all,  a  future  hospitalization  could  be  prevented  by  initiating  
immunomodulator  or  biologic  treatment.  With  this  criteria,  I  divided  the  IBD-­
hospitalization  outcome  validation  data  into  intervention  and  nonintervention  groups;;  a  
total  of  4,918  (66%)  of  patients  in  the  validation  set  were  eligible  for  the  intervention  
group.  
  
To  estimate  the  savings  associated  with  a  proposed  intervention,  I  assumed  the  cost  
structure  as  $10,000  per  IBD-­hospitalization  (Pfuntner,  Wier,  and  Steiner  2013)  and  
$200  per  office  visit.  If  our  model  predicted  a  true  hospitalization  correctly,  it  and  its  
associated  cost  would  be  “prevented”  with  a  probability  e  (Figure  37).  To  account  for  
the  significant  uncertainty  in  the  efficacy  of  an  interventional  strategy,  I  modeled  the  
outcomes  assuming  a  range  of  efficacy  probabilities.  I  then  used  our  intervention  cost-­
savings  results  to  determine  the  minimum  efficaciousness  needed  to  make  the  
intervention  a  financial  improvement.    
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Figure  37  -­  proposed  intervention  costs.  Total  cost  of  hospitalization  and  proposed  
intervention  across  all  possible  evidence  thresholds  for  multiple  treatment  efficacies.  
Hospitalizations  can  be  prevented  with  an  efficacy  e,  which  was  between  0  and  1,  if  our  model  
correctly  predicted  a  patient’s  forthcoming  IBD-­hospitalization.  Due  to  the  uncertainty  in  e,  it  is  
left  as  free  parameter.  
  
  
Since  each  patient  had  some  risk  for  IBD  hospitalization,  the  intervention’s  threshold  for  
defining  “at-­risk”  determined  the  number  of  patients  included  and  treated  in  the  
intervention  (Figure  38A).  If  only  the  patients  our  model  identified  as  severely  at-­risk  
were  treated,  a  lower  percentage  of  the  total  IBD  hospitalizations  would  be  treated  (low  
sensitivity),  whereas  more  lax  criteria  would  yield  a  higher  sensitivity  and  potentially  
higher  cost.  For  a  given  efficacy,  X  denotes  the  minimum  cost  point,  where  the  power  of  
the  model  to  predict  IBD-­hospitalizations  was  offset  equivalently  by  the  cost  of  treating  
false  positives,  since  patients  who  were  predicted  incorrectly  by  our  model  would  have  
an  IBD  hospitalization.  Connecting  the  minimum  points  across  all  efficacies  from  0%  to  
100%  showed  savings  and  prevention  as  a  function  of  efficacy  (Figure  38B).  Greater  
efficacy  therefore  made  it  financially  optimal  to  treat  more  patients,  resulting  in  fewer  
hospitalizations.  Our  model  predicted  that  an  intervention  required  at  least  5%  efficacy  




Figure  38.  IBD-­hospitalization  intervention  results.  A.  Total  cost  of  hospitalization  and  proposed  
intervention  across  all  possible  evidence  thresholds  for  multiple  treatment  efficacies.  Colored  X’s  
represented  the  cost-­minimizing  solution  for  each  intervention  efficacy.  At  5%  efficacy,  no  intervention  
was  cost-­effective,  whereas  with  50%  efficacy  it  was  cost-­effective  to  treat  patients  for  whom  there  was  
strong  evidence  of  an  impending  hospitalization.  B.  Patient  and  monetary  impact  as  a  function  of  
treatment  efficacy.  Intervention  was  cost-­optimal  if  intervention  was  at  least  5%  efficacious  with  significant  




I  assessed  our  second  intended  outcome  measure:  predicting  a  patient’s  biologics  use  
the  following  year.  Specifically,  I  was  interested  in  predicting  a  change  in  patient  use  of  
biologics:  starting  biologics  if  not  already  in  use,  or  stopping  biologics  if  in  use  currently.  
I  focused  on  the  former  predominantly  because  many  patients  have  insurance-­related,  
non-­medical  reasons  for  stopping  biologics,  so  discontinuation  may  not  be  of  clinical  
relevance.  
Univariate  analysis  
As  before,  I  performed  a  univariate  analysis  by  regressing  each  of  the  110  features  one-­
by-­one  onto  the  outcome:  initiation  of  biologics  (Figure  39).  IBD  was  again,  by  itself,  




Figure  39  -­  univariate  analysis  of  initiation  of  biologics.  The  outcomes  of  a  separate  univariate  
regression  on  IBD  hospitalization  by  each  of  110  claims  data  features  using  the  training  data.  Several  
variables,  most  notably  IBD  as  the  number  of  annual  IBD-­related  claims,  yielded  predictive  models  as  
measured  by  average  PPV.  The  LOR  was  per  1  unit  change  in  the  variable.  The  range  of  values  for  each  
variable  is  listed  in  Supplementary  Figure  S2.  
  
Model  optimization  
I  again  performed  PCA  and  ICA  dimensionality-­reduction  techniques.  Whereas  ICA  was  
again  ineffective,  PCA  apparently  provided  a  slight  improvement  in  average  PPV  
(Figure  40).  Since  this  improvement  was  mild,  I  instead  favored  sparsity  by  using  an  
L1-­regression  to  reduce  the  final  model  to  a  subset  of  the  original  110  features.  
  
Figure  40  -­  consequences  of  feature  reduction  in  predicting  initiation  of  biologics.  A.  The  original  
data  and  its  110  features  had  an  average  PPV  of  19%.  The  effectiveness  of  PCA  saturates  never  
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reached  that  of  the  original  110  features.  ICA  was  even  less  effective  on  this  data.  B.  Variance  explained  
in  the  feature  data  as  a  function  of  the  number  of  PCs  returned.  
  
Multivariate  analysis  
I  first  constructed  a  single,  general  model  to  predict  biologics  use.  Patients  may  have  
very  different  reasons  for  initiating  biologics  versus  continuing  biologics  from  one  year  to  
the  next.  Since  a  single  model  could  not  distinguish  between  these  reasons,  I  took  a  
more  specific  approach.  I  created  one  model  to  predict  biologics  use  for  the  
subpopulation  that  was  already  using  biologics,  and  a  separate  model  to  predict  
biologics  use  for  patients  who  were  not  yet  using  them.  I  refer  to  these  two  as  the  
“specific”  models.  The  general  model  and  the  two  specific  models  performed  similarly  
(Figure  41).    
  
Figure  41  -­  general  versus  specific  modeling  on  training  set  data.  PR  curves  for  both  outcomes  of  
interest  in  both  models.  Performance  was  similar  between  models  for  predicting  which  patients  would  
begin  biologics  use.  
  




Figure  42  -­  all  training  model  weights  for  predicting  initiation  of  biologics.  Results  of  an  L1  logistic  
regression  of  the  110  features  on  initiation  of  biologics.  Blue  bars  are  actual  fit;;  grey  bars  are  95%  change  
confidence  intervals.  Stars  signify  p  <  0.05  after  Holm-­Bonferroni  correction.  Variables  30  to  43  are  
features  representing  biologics  use  and  are  non-­existent  in  this  subgroup.  
  
The  significant  weights  after  Holm-­Bonferroni  correction  are  listed  in  Figure  43A  as  
ORs.  After  applying  these  11  coefficients  to  the  validation  set,  I  saw  that  both  models  
were  significantly  predictive  of  their  respective  outcomes  (p  <  10-­3  corrected,  Figure  






Figure  43  -­  significant  weights  and  model  validation  for  predicting  initiation  of  biologics.  A.  
Significant  features  (p  <  0.05  Bonferroni-­Holm  corrected)  and  their  relative  weights  from  an  L1-­regularized  
logistic  regression  predicted  initiation  of  biologics.  Red  bars  reflect  features  positively  predictive  of  
initiation  of  biologics;;  green  bars  reflect  features  negatively  predictive  of  initiation  of  biologics.  B.  Both  




In  this  study,  we  focused  on  the  two  factors  in  IBD  treatment  with  the  most  significant  
impacts  on  the  quality-­of-­life  and  insurance  expenditure  of  patients:  hospitalizations  and  
biologics  use.  We  found  that  insurance  claims  data  could  make  substantial  and  
statistically  significant  predictions  of  both  factors.  Achieving  maximum  classification  
information  in  each  case  required  fewer  than  15  features  from  the  original  110  feature  
data.  Taking  into  account  feature  overlap  between  the  two  classifications,  both  models  
can  be  implemented  with  21  features  from  the  claims  database.  This  feature  sparsity  
broadens  our  model’s  applicability  because  it  lessens  the  risk  of  overfitting  and  may  be  
applicable  to  insurance  plans  that  support  and  track  fewer  treatments.  Since  several  
factors  in  the  univariate  analysis  are  highly  predictive  (Figure  32;;  Figure  39),  it  is  likely  
that  near-­optimal  accuracy  can  be  achieved  with  even  fewer  features.  
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I  found  that  predictors  of  hospitalization  for  IBD  include  prior  hospitalizations,  ED  visits,  
new  adalimumab  prescriptions,  and  endoscopies  of  the  small  intestines.  These  factors  
all  pointed  to  a  more  severe  disease  course,  suggesting  a  higher  risk  of  hospitalization  
in  the  future.  If  further  validated,  this  model  may  be  used  as  a  proxy  to  assess  disease  
course.  In  contrast,  office  visits  and  liver  function  tests  correlated  with  a  lower  risk  of  
hospitalization,  perhaps  indicating  the  importance  of  preventive  care.  Additionally,  older  
age  predicted  a  lower  risk  of  hospitalization,  most  likely  because  IBD  tends  to  have  a  
milder  disease  course  in  older  patients  (Burisch  and  Munkholm  2013).  I  also  found  that  
predictors  for  the  start  of  new  biologics  included  the  use  of  immunomodulators  and  IBD-­
related  healthcare.  The  number  of  days  that  immunomodulators  were  used  was  a  
negative  predictor  of  biologics  use;;  this  might  indicate  that  more  continuous  
immunomodulator  usage  is  vital  in  preventing  future  hospitalizations.  
  
Importantly,  our  hospitalization  for  IBD  model  demonstrated  sufficient  accuracy  in  the  
justification  of  an  intervention  on  the  behalf  of  the  insurer’s  financial  interests,  if  the  
efficacy  of  preventing  a  potential  hospitalization  for  IBD  exceeded  5%.  I  believe  that  this  
level  of  efficacy  is  achievable  from  available  traditional  and  non-­traditional  treatments  
ranging  from  anti-­inflammatories  to  mindfulness  (Witte,  Shivananda,  and  Lenn  2000;;  
Braddock  and  Quinn  2004;;  Laake  et  al.  2005;;  Neilson  et  al.  2016).    
  
The  hospitalization  rates  reported  in  our  data  resembled  those  found  in  other  analyses  
of  different  data  sources,  although  biologics  use  in  our  population  was  higher,  perhaps  
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due  to  the  increasing  availability  and  utilization  of  biologics  in  recent  years  (Herrinton  et  
al.  2009;;  van  Deen  et  al.  2014).  The  re-­hospitalization  rates  reflected  those  reported  in  
a  cohort  of  UC  patients  with  24%  1-­year  rehospitalization  rate  (Golovics  et  al.  2015).  
4.5.1  Topics  interpretation  
I  used  topic  modeling,  a  novel  mathematical  approach,  to  identify  patient  
subpopulations  at  higher  risk  for  hospitalization.  While  topic  modeling  did  not  improve  
model  accuracy  by  identifying  different  predictive  features  for  each  subpopulation,  its  
value  stemmed  from  its  ability  to  pinpoint  distinct  subpopulations  with  differential  risks  
for  hospitalization.    
  
Since  the  identified  clusters  improved  prediction  in  both  the  development  and  validation  
sets,  it  is  likely  that  the  cluster  modeling  identified  distinct  patient  groups  with  a  
differential  risk  of  hospitalization  for  IBD  and  different  treatment  patterns.  Given  that  it  is  
not  evident  from  a  clinical  perspective  which  types  of  patients  were  represented  by  each  
topic,  these  topics  may  represent  the  discovery  of  novel  sub-­populations  in  the  
juxtaposed  context  of  clinical  and  insurance  data.  I  hypothesized  that  multiple  distinct  





I  considered  a  narrow  subset  of  patients,  using  no  therapy  or  using  steroids/5-­ASA  only,  
as  eligible  for  intervention  with  biologics.  Because  I  excluded  the  34%  of  patients  
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already  using  immunomodulators  or  biologics,  I  were  unable  to  investigate  possible  
benefits  of  the  two  alternative  interventions.    
  
First,  IBD  may  be  managed  with  thiopurines  as  immunomodulators  rather  than  biologics  
or  steroids),  which  may  be  a  cheaper  alternative  to  biologics.  Thiopurine  therapy  may  
reduce  the  risk  of  relapse  from  66%  to  39%  in  UC  (41%  efficacy);;  for  CD,  efficacy  for  
maintaining  remission  is  estimated  at  17%  (Talley  et  al.  2011b).  Second,  more  rigorous  
therapeutic  drug  monitoring  of  thiopurines  (Haines  et  al.  2011)  or  biologics  
(Amarasingham  et  al.  2014)  may  reduce  hospitalizations  with  relatively  low  cost,  
compared  with  the  expense  of  starting  a  new  therapy  altogether.  
  
I  excluded  these  alternatives  because  their  efficacies  in  hospitalization  prevention  was  
less  clear.  I  decided  to  construct  our  model  with  patients  and  interventions  for  whom  I  
were  most  likely  to  obtain  a  treatment  effect.  In  the  future,  as  efficacies  for  these  
alternatives  are  studied  further,  our  model  may  be  adapted  to  these  interventions.  
  
Social  
It  is  worth  noting  that  this  type  of  predictive  modeling  creates  certain  concerns  with  
respect  to  volition.  First,  with  regards  to  patient  autonomy,  concerns  exist  that  
adherence  to  model  predictions  will  diminish  considerations  of  patient  preferences  for  
treatment  (Amarasingham  et  al.  2014).  Second,  their  unmanaged  application  might  
diminish  the  influence  of  the  physicians  in  managing  outcome  ambiguity  in  patient  care  
(Sniderman,  D’Agostino,  and  Pencina  2015).  A  delicate  balance  exists  between  the  
wishes  of  patients  and  physicians  in  patient  care  management.  Our  model  did  not  
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replace  the  paradigm  but  instead  introduced  a  third  component  of  algorithmic  prediction.  
Hence,  the  significant  benefit  for  patients  and  insurance  companies  may  outweigh  the  
concerns  about  both  patient  and  physician  volition.  
  
Data  
Researchers  debate  about  whether  the  use  of  events  fewer  than  10  per  explanatory  
variable  (EPV)  can  lead  to  issues,  such  as  regression  coefficients  that  are  biased  
positively  and  negatively  (van  Smeden  et  al.  2016),  overly  narrow  estimates  of  the  
sample  variance  of  the  regression  coefficients,  improper  coverage  in  90%  confidence  
limits,  and  inflated  Type  I  and  Type  II  errors,  among  other  problems  (Peduzzi  et  al.  
1996).  Our  training  dataset  on  IBD  hospitalization  had  70.6  EPV,  but  because  of  the  low  
incidence  of  hospitalization  for  IBD,  this  outcome  had  an  EPV  of  only  3.39.  This  concern  
did  not  explain  the  high  performance  in  the  validation  set  but  may  imply  instead  that  our  
model  may  be  further  improved  with  access  to  more  data.  
  
Applicability  
This  data  model  may  or  may  not  apply  to  other  insurance  plans  equally  well.  Treatment  
patterns  may  vary  depending  on  the  region  (Hilsden  et  al.  2003a)  and  setting  of  care  
delivery  (Hilsden  et  al.  2003b),  so  the  results  might  not  translate  to  other  settings  
directly.  In  light  of  the  equivalent  predictive  power  between  new  and  continuing  patients  




4.5.3  Further  directions  
Although  I  selected  only  two  outcomes  variables  (hospitalization  for  IBD  and  biologics  
use)  for  predictive  modeling,  more  predictive  power  existed  in  the  dataset.  Our  data  
reflected  medical  management  rather  than  medical  outcomes  of  testing  or  treatment.  
Ideally,  the  predictions  involved  a  generative  model  that  incorporated  underlying  causes  
and  measurements  related  to  the  biological  underpinnings  of  the  disease.  
  
Prior  work  indicates  the  underlying  epidemiology  of  IBD  as  a  complex  interaction  of  
genetics  (Chapman-­Kiddell  et  al.  2010a),  diet  (Chapman-­Kiddell  et  al.  2010b),  
pathogens  (Ananthakrishnan  2015),  season,  and  geography  (Baumgart  and  Carding  
2007).  However,  certain  intermediate  factors  may  indicate  a  poorer  prognosis  with  
higher  risks  for  hospitalization  and  surgery.  These  include  age  at  diagnosis,  presence  of  
perianal  disease,  need  for  steroids  with  first  flare-­up,  presence  of  deep  ulceration  at  
colonoscopy,  and  presence  of  multiple  antibodies  to  gastrointestinal  luminal  flora  
(Beaugerie  et  al.  2006;;  Allez  et  al.  2002;;  Dubinsky  et  al.  2006).  By  combining  this  
biologically  devoid  claims  data  with  medical  information,  I  may  be  able  to  increase  the  
predictive  power  of  the  signal  detected  in  the  data.  
  
Our  model  warrants  external  validation  to  assess  whether  it  has  generalized  insurance  
plans  and  treatment  protocols.  Future  studies  may  use  this  model  to  develop  the  
support  and  possibility  of  predictive  and  personalized  patient  care  in  IBD.  
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Chapter  V  –  General  discussion  
  
Since  neuroscience  began  in  earnest  with  Ramón  y  Cajal  and  Camillo  Golgi  studying  
the  morphology  and  behavior  of  individual  neurons  (Ramón  y  Cajal  1959;;  Golgi  1906),  
the  field  developed  technologies  to  record  the  activity  and  function  of  brain  tissue  
containing  large  populations  of  neurons.  As  non-­invasive  neuroimaging  technologies  
such  as  fMRI,  fNIRS,  and  EEG  became  increasingly  available  and  affordable,  the  
quantity  of  data  expanded  rapidly  (Gordon  et  al.  2005;;  MacKenzie-­Graham  et  al.  2008).  
To  understand  increasingly  complex  and  multi-­dimensional  data,  we  as  a  field  have  
employed  and  improved  the  tools  of  mathematics,  furthering  the  development  of  
Random  Field  Theory  (Adler  2010;;  Friston  et  al.  1994;;  Worsley  et  al.  1996),  and  
contributing  to  an  empirical  underpinning  for  hyperparameter  selection  (Xie  et  al.  2016).  
My  dissertation  is  the  product  of  this  relatively  new  but  burgeoning  intersection  of  
neuroscience  and  advanced  mathematics  which  aims  to  distinguish  different  diseases,  
mental  states,  and  actions  (Clark  et  al.  2014;;  Cohen  et  al.  2011;;  Schnyer,  Clasen,  and  
Gonzalez  2017).  Here  I  discuss  the  broad  relevance  of  my  findings  for  the  future  of  this  
field.  
5.1  Contributions  to  pure  and  applied  science  
  
My  dissertation  juxtaposes  neuroimaging  and  multivariate  classification,  often  using  the  
results  of  one  aspect  to  inform  the  other.  These  could  be  labeled  as  “pure  science”  and  
“applied  science,”  respectively,  as  outlined  in  John  Horgan’s  (in)famous  book  End  of  
Science  (Horgan  2015).  As  Horgan  defines  the  terms,  pure  science  involves  the  pursuit  
of  a  fundamental  understanding  of  the  operational  principles  of  the  universe;;  for  
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example,  the  discovery  of  nuclear  binding  energy.  In  contrast,  applied  science  uses  
knowledge  for  impact;;  for  example,  the  use  of  nuclear  binding  energy  to  make  an  
atomic  bomb.  In  this  context,  my  univariate  and  multivariate  work  contribute  to  both  pure  
and  applied  neuroscience.    
  
My  empathy  localizer  included  105  subjects  and  was  the  largest  study  of  its  kind:  
identifying  an  “empathy  network”  of  brain  regions  that  are  involved  in  someone’s  
response  to  watching  painful  stimuli.  I  replicated  previous  findings,  identified  novel  
empathy-­for-­touch  regions,  and  underscored  the  need  for  a  more  nuanced  view  of  the  
dual-­network  hypothesis  that  affective  and  cognitive  empathy  regions  overlap.  The  
localization  of  the  empathy  and  mentalizing  networks  informed  my  overarching  goal:  to  
diagnose  the  strength  of  affiliation  towards  one’s  ingroups.  After  excluding  visual  areas,  
my  a  priori  model  –  synthesized  from  the  networks  identified  in  my  univariate  model  –  
had  a  greater  accuracy  and  AUC-­ROC  than  did  one  of  the  gold  standards:  the  Harvard-­
Oxford  parcellation1.  Both  the  a  priori  and  Harvard-­Oxford  approaches  use  hypothesis-­
based  neuroscience,  relying  on  an  average  of  related  areas  to  inform  and  improve  the  
classification.  Whether  due  to  a  more  accurate  capture  of  contributing  activity  or  better  
averaging  of  correlated  noise,  my  result  supports  the  principle  of  investing  in  pure  
science  as  a  means  of  improving  feature  selection2.  The  converse  is  also  true:  
backward  modeling  can  contribute  meaningfully  to  pure  neuroscience.  
  
                                                                                                 
1  I  did  not  test  for  the  significance  of  this  improvement,  since  that  would  force  additional  multiple  
comparisons  corrections  on  other  tests  
2  My  application  of  neuroscience-­informed  feature  optimization  to  the  backward,  decoding  model  is  
analogous  to  Jack  Gallant’s  technique  in  decoding  visual  activation.  
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It  is  accepted  by  most  that  multivariate  model  weights  cannot  be  interpreted  individually  
(Haufe  et  al.  2014).  To  borrow  an  example  from  Haufe,  imagine  a  two-­feature  model:  
one  feature  contains  the  signal  of  interest  plus  heartbeat,  and  the  other  feature  contains  
the  heartbeat  only.  One  could  classify  the  signal  of  interest  perfectly  using  weights  +1  
and  -­1,  respectively,  even  though  the  second  feature  lacks  the  signal  of  interest  
completely.  Thus,  in  a  multivariate  model  an  individual  weight  could  contain  the  signal  of  
interest,  or  alternatively  may  be  relevant  because  it  contains  correlated  noise  (which  
should  be  included  to  improve  model  performance).  It  is  important  to  note  that  one  can  
conclude  from  a  model  that  the  signal  of  interest  does  indeed  exist  in  one  or  more  of  the  
features.  One  can  then  identify  the  statistically  significant  model  features  as  possible  
areas  for  future  study,  despite  the  irrelevance  of  those  features’  magnitude  and  sign,  
because  at  least  one  of  those  features  contains  the  signal  of  interest,  necessarily.3  The  
results  of  backward  models  may  be  incorporated  with  other  evidence  to  inform  future  
research.  In  this  context,  my  findings  in  Chapter  II’s  Figure  18  suggest  further  
investigation  of  the  medial  prefrontal  cortex  and  right  superior  temporal  sulcus  as  
mechanisms  for  controlling  the  response  of  the  empathy  network.  
5.2  Circumstantial  utility  
  
My  dissertation  concludes  that  the  utility  of  machine  learning  is  circumstantial,  
contributing  to  the  long-­standing  debate  about  the  cost-­benefit  tradeoff  of  machine  
learning  on  expensive  datasets  (Liu  et  al.  2001;;  Health  Quality  Ontario  2014;;  Tong  et  al.  
                                                                                                 
3  To  be  clear,  these  significant  weights  are  not  an  exhaustive  list  of  areas  for  further  research;;  it  is  entirely  
possible  for  areas  with  signal  to  receive  zero  magnitude  weights  in  sparsity-­enforcing  models.  
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2016).  Below,  I  will  discuss  in  which  circumstances  my  findings  recommend  the  
employment  of  machine-­learning.  
5.2.1  Uncooperative  patients  
Using  neuroimaging  technologies  to  diagnose  different  mental  states  is  surpassed  in  
most  cases  by  voluntary  self-­report.  As  an  example  from  my  own  data,  one  of  my  
machine  learning  models  differentiates  the  stab  versus  touch  conditions  with  96%  
accuracy,  using  five  minutes  of  fMRI  data.  It  is  no  stretch  of  the  imagination  to  believe  a  
participant  could  report  this  difference  verbally  in  a  matter  of  seconds.  Berkeley  
neuroscientist  Jack  Gallant  used  encoding  and  decoding  machine  learning  models  to  
reconstruction  visualization  from  BOLD  signals  (Kay  et  al.  2008;;  Jack  2009).  This  
groundbreaking  work  was  astounding  because  it  pushed  the  boundaries  of  just  how  
accurately  visual  perception  can  be  inferred  from  neuroimaging  data.  It  was  not,  
however,  particularly  impactful  because  it  revealed  anything  the  observer  could  not  
convey  to  us  in  less  time  and  with  far  less  expense.  
  
This  limitation  evaporates  when  the  participant  is  uncooperative.  In  Chapter  II,  I  
demonstrated  that  religious  ingroup  and  outgroup  affiliations  can  be  distinguished  
correctly  in  a  given  participant  with  70%  accuracy.  Critically,  this  classification  requires  
neither  good-­faith  nor  effort  from  the  participant.  In  fact,  the  task  –  watching  labeled  
hands  receive  needle  stabs  or  cotton-­swab  touches  –  is  removed  from  the  topic  of  
interest:  the  differences  between  one’s  mental  construct  of  ingroup  and  outgroup.  
DARPA  funded  this  project  for  the  broader  goal  of  quantifying  the  biasing  effect  of  
narrative.  In  the  future,  it  could  perhaps  be  used  to  screen  uncooperative  insurgents  or  
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personnel  handling  sensitive/dangerous  information  or  equipment.  Before  this  kind  of  
critical  deployment,  the  model  would  of  course  require  further  testing  to  determine  
whether  participants  that  are  informed  of  the  test’s  true  intention  could  modify  their  own  
neural  responses,  volitionally,  to  mentally  parry  the  model.    
  
Similarly,  in  chapter  III  I  show  that  DTI  normalized  path  length  contributes  significantly  to  
distinguishing  patients  with  AN  from  those  with  BDD.  Imaging  the  anisotropy  of  water  
movement  in  axons  in  the  brain  requires  nothing  of  the  subject,  and  as  far  as  we  know,  
is  unperturbed  by  participant  mood  or  volition.  In  cases  of  clinical  non-­compliance  and  
denial  –  which  can  be  an  issue  for  patients  with  eating  disorders  (Towell  et  al.  2001;;  
Steiner,  Mazer,  and  Litt  1990;;  Vitousek,  Daly,  and  Heiser  1991)  –  neuroimaging  may  
help  distinguish  cases  of  AN  from  BDD.    
  
The  ethical  implications  of  quantifying  a  person’s  beliefs  or  diagnosing  a  person  based  
on  neural  activation,  without  consent,  are  numerous  and  beyond  the  scope  of  this  
paper.  Nonetheless,  this  manuscript  contributes  to  the  growing  body  of  literature  
showing  that  such  calculations  are  possible.  Society  must  assess  its  legality.  
5.2.2  Unsatisfactory  forward  models  
At  its  core,  a  backward  model  such  as  machine  learning  reflects  a  gap  in  knowledge;;  it  
is  a  tool  to  overcome  ignorance.  Said  another  way,  a  fully-­understood  system  uses  a  
generative,  forward  model.  Univariate  examples  of  forward  models  include  gravity  and  
the  standard  GLM;;  Schrodinger’s  equation  is  a  multivariate  example.  When  a  system  is  
well  understood,  our  knowledge  sculpts  the  feature  parameters  and  there  is  low  or  no  
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utility  in  applying  backward  models.  In  the  data  featured  in  this  dissertation,  however,  
there  is  sufficient  ignorance  regarding  the  outcomes’  causal  mechanisms  that  
backwards  modeling  is  fruitful.  Thus,  the  collection  of  vast  quantities  of  difficult-­to-­
acquire  data  is  justified  to  improve  the  overall  accuracy  of  the  dataset,  even  if  and  when  
many  features  of  the  dataset  are  not  related  fundamentally  to  the  outcome  in  question.  
  
In  Chapter  II,  I  review  the  literature  on  the  correlation  between  ingroup/outgroup  
affiliations  and  the  empathy  and  mentalizing  networks.  I  find  that  there  is  significant  
evidence  behind  the  dual  networks  hypothesis:  the  mental  representation  of  ingroup  
and  outgroups  involves  an  interaction  between  empathy  and  mentalizing  networks.  
Although  there  is  some  evidence  to  suggest  that  the  mPFC  inhibits  the  empathy  
network  selectively  (Christov-­Moore  et  al.  2017),  the  exact  nature  of  this  interaction  
eludes  the  field  of  neuroscience  currently,  so  my  backwards  model  has  predictive  utility.  
It  is  worth  noting  that  in  the  near  future,  the  empathy-­mentalizing  circuit  may  be  better  
understood  such  that  a  forward,  generative  model  and  a  few  electrodes  over  the  frontal  
lobe  are  sufficient  for  generating  predictions  about  ingroup  and  outgroup,  supplanting  
the  need  for  massively  multivariate  data  acquisition.  
  
In  Chapter  III,  I  discover  that  the  maximum  predictive  power  in  distinguishing  patients  
with  AN  from  those  with  BDD  is  achieved  through  a  multimodal  model  of  psychometric  
and  DTI  data.  The  model  has  clinical  potential  precisely  because  the  exact  generative  
predictors  of  AN  and  BDD  are  unclear.  As  an  example,  there  is  no  concrete  evidence  to  
explain  why  an  interaction  between  BABS  and  normalized  path  length  would  distinguish  
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patients  with  AN  from  those  with  BDD  (Figure  44).  In  this  case,  a  plausible  link  may  be  
discovered  eventually,  but  until  then,  neuroimaging  and  machine  learning  can  exploit  
possibly-­causal  links,  while  assuming  correlation  only.  
  
  
Figure  44  -­  Scatter  plot  of  normalized  path  length  vs  BABS  for  both  patient  groups.  Both  
normalized  path  length  and  BABS  are  significant  features  in  the  multivariate  model.  No  strong  empirical  
results  explain  their  multivariate  contribution  in  dividing  patients  with  AN  from  those  with  BDD.  
  
  
This  concept  is  perhaps  most  explicit  in  chapter  IV,  where  I  use  insurance  claims  to  
predict  outcomes  for  patients  with  IBD  with  regards  to  hospitalization  and  treatment  with  
biologics.  I  found  that  the  number  of  IBD-­related  insurance  claims  in  a  year  was  highly  
predictive  of  hospitalization,  even  though  (presumably)  no  one  believes  that  filing  
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insurance  claims  causes  hospitalizations.  In  this  case,  multiple  correlated,  but  clearly  
not  causal,  variables  are  more  useful  than  what  we  believe  to  be  the  actual  causative  
mechanisms.  This  reality  justifies  the  considerable  work  of  getting  permission,  
aggregating,  and  cleaning  a  large  insurance  database.  
  
As  much  as  backward  models  may  be  perceived  as  a  reflection  of  ignorance,  they  may  
also  be  considered  stepping  stones:  tools  which  are  useful  because  they  deliver  results  
in  a  not-­fully-­understood  system.  These  backward  models  may  be  transient,  phased  out  
gradually  for  forward  models  as  knowledge  increases.  As  I  allude  to  above,  in  the  case  
of  using  electrodes  to  distinguish  ingroups  from  outgroups,  an  equivalent  forward  
multivariate  model  may  require  fewer  features.  Feature-­reduction  and  overfitting  are,  by  
extension,  products  of  incomplete  knowledge.  We  penalize  to  compensate  for  them  
because  we  are  on  a  somewhat-­blind  exploratory  endeavor,  trying  to  find  an  optimal  
extraction  vector  amongst  a  set  of  possibly-­superfluous  features.  
5.3  Concluding  remarks  
  
Multivariate  decoding  models  are  most  useful  in  problems  that  lack  a  well-­understood  
forward  model.  In  the  multivariate  context,  weak  univariate  signals  accumulate,  so  
models  can  use  interactions  among  features  and  correlated  noise  to  improve  prediction  
accuracy  to  a  greater  extent  that  can  be  done  in  univariate  and  generative  models.  
Multivariate  decoding  models  excel  in  fields  with  significant  distance  from  what  we  as  
scientists  might  consider  ‘truth’,  as  they  can  distill  numerous  possibly-­non-­causal  
features  on  the  basis  of  performance  alone.  Although  the  individual  features  of  the  
model  are  generally  uninterpretable,  distilled  models  may  illuminate  regions  to  target  in  
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future  study.  Their  contribution  to  neuroscience  stems  from  their  performance  in  the  
absence  of  a  forward  model,  rather  than  explainability  or  direct  contribution  to  our  
understanding  of  the  universe.  
  
As  classification  performance  improves,  this  field  will  reshape  how  we  classify  mental  
diseases  and  mental  states  in  general.  In  the  past,  we  lacked  relevant,  fine-­grained  
neuroimaging  data,  so  we  made  diagnoses  from  downstream  outputs  –  patient  behavior  
and  self-­report  –  rather  than  on  any  kind  of  neurological  basis.  For  the  sake  of  
convenience  and  as  a  result  of  human  mental  processing  limitations,  the  DSM  clusters  
these  symptomatologies  into  distinct  diseases.  With  the  introduction  of  high-­resolution  
neuroimaging  data  and  analyses,  however,  these  clusters  will  be  challenged  and  
redefined.  Imagine  that  my  Chapter  III  classification  of  patients  with  AN  versus  BDD  
reached  98%  accuracy.  We  would  need  to  differentiate  two  hypotheses  to  explain  the  
only  2%  error:  (1)  there  was  noise  and/or  important  features  were  missing  from  the  
data,  or  (2)  the  classifier  is  correct  and  the  human  diagnosis  is  not.  Said  another  way,  
what  is  the  basis  of  truth?  What  is  the  gold  standard  in  the  uncertain  space  of  mental  
diseases?  The  NIMH  recognized  the  problems  with  scalar  labels  and  implemented  the  
RDoC  initiative  (Kupfer  and  Regier  2011)  to  vectorize  disease,  but  that  is  only  part  of  
what  the  near-­perfect-­classifier  gedanken  experiment  reveals.  The  deep  point  here  is  
not  about  the  (obvious)  benefit  of  using  neural  data  to  classify  mental  disease,  nor  
about  the  efficacy  of  multi-­dimensional  disease  labels.  Instead,  the  essential  lesson  is  
that  human  notions  of  diseases  are  almost  certainly  limited  by  our  mental  processing  
power,  and  therefore  inaccurate.  
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Given  the  computational  limits  of  the  human  brain,  optimally  diagnosing  the  diseases  of  
an  organ  with  100  trillion  neural  connections  requires  help.  Just  as  the  Sumerians  
invented  writing  (Glassner  2003;;  Sampson  1985)  to  offload  the  mental  complexity  of  
record-­keeping,  one  can  think  of  machine-­learning  on  neuroimaging  data  as  offloading  
the  calculation  and  eventually,  refinement,  of  mental  diseases.  Improved  machine  
learning  models  will  work  circularly  with  our  current  understanding  of  diseases:  we  will  
use  machine  learning  to  build  models  for  identifying  the  diseases  we  have  already  
labeled,  and  then  suggest  revisions  in  our  guidelines  and  diagnoses.  Although  it  seems  
most  relevant  to  the  incomparably  complex  human  brain,  this  approach  applies  to  all  
intricate  diseases.  Just  as  we  use  an  iPhone  to  schedule,  we  will  use  machine-­learning  
to  diagnose.  We  developed  machine  learning  to  diagnose  disease,  but  this  line  of  
reasoning  applies  equally  well  to  neurotypical  states.  
    
If  one  believes  in  macroscopic  determinism  –  that  any  event  approximated  by  classical  
mechanics  has  an  antecedent  described  by  the  physical  laws  of  the  universe  –  then  
suboptimal  technology  and  poor  models  are  the  only  impediments  to  decoding  brain  
signals  into  behavior  with  very  high  accuracy.  Said  another  way,  behavior  is  the  result  of  
biological  processes  exclusively  and  can  in  theory  be  highly  predictable.  As  our  
understanding  and  technology  improve,  the  decoding  ability  of  machine  learning  will  
continue  to  approach  perfection.  This  dissertation  reflects  a  small  contribution  in  that  
trajectory.  
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Chapter  VI  -­  Appendix  
6.1  Empathy  
  
Supplementary  Figure  S1  -­  needle  and  cotton  swab  stimuli  
An  image  from  the  touch  and  the  stab  condition.  Each  image  is  a  single  frame  of  a  60-­frame  (30  frames  
per  second)  video  displayed  to  participants.  The  last  frame  lasted  an  additional  300ms,  bringing  the  total  
length  of  each  video  to  2.3  seconds.  
6.2  HBF  
Subject   MH   BABS   DTI   coherence      Subject   MH   BABS   DTI   coherence  
1002_NW   X      X         1031_NW   X   X   X   X  
1003_NW   X      X         1032_NW   X   X   X   X  
1004_NW   X               1034_NW   X   X   X   X  
1005_NW   X               1035_NW   X   X      X  
1006_NW   X      X   X      1036_NW   X   X   X   X  
1008_NW   X      X         1039_NW   X   X      X  
1012_NW   X      X         1041_NW   X   X      X  
1013_NW   X      X   X      1042_NW   X   X        
1014_NW   X      X   X      1043_NW   X   X      X  
1015_NW   X      X         2001_NW   X   X      X  
1016_NW   X               2002_NW   X   X   X   X  
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1017_NW   X   X   X   X      2003_NW   X   X        
1018_NW   X   X            2004_NW   X   X   X     
1019_NW   X   X   X   X      2005_NW   X   X        
1020_NW   X   X   X   X      2006_NW   X   X        
1021_NW   X   X   X         2007_NW   X   X   X     
1022_NW   X   X   X   X      2008_NW   X   X        
1023_NW   X   X   X   X      2009_NW   X   X   X   X  
1024_NW   X   X   X   X      2010_NW   X   X   X   X  
1025_NW   X   X   X         2011_NW   X   X   X   X  
1026_NW   X   X   X   X      2012_NW   X   X   X   X  
1027_NW   X   X   X   X      2013_NW   X   X   X     
1029_NW   X   X   X   X      2014_NW   X   X   X     
1030_NW   X   X   X   X      2015_NW   X   X   X   X  
  
Subject   MH   BABS   DTI   coherence      Subject   MH   BABS   DTI   coherence  
2016_NW   X   X            2041_NW   X   X   X   X  
2017_NW   X   X   X         2042_NW   X   X        
2018_NW   X   X      X      2043_NW            X  
2019_NW   X   X            2044_NW   X   X        
2020_NW   X   X   X         3001_NW   X      X     
2021_NW   X   X   X   X      3002_NW   X         X  
2022_NW   X   X            3003_NW   X         X  
2023_NW   X   X   X   X      3005_NW   X         X  
2024_NW   X   X   X         3006_NW   X           
2025_NW   X   X   X   X      3007_NW   X      X   X  
2026_NW   X   X   X   X      3008_NW   X           
2027_NW   X   X   X   X      3009_NW   X      X   X  
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2028_NW   X   X   X         3010_NW   X      X     
2029_NW   X   X   X         3011_NW   X      X   X  
2030_NW   X   X   X   X      3012_NW   X           
2031_NW   X   X            3013_NW   X      X     
2032_NW   X   X      X      3014_NW   X      X     
2033_NW   X   X   X   X      3015_NW   X      X     
2034_NW   X   X   X   X      3016_NW   X      X     
2035_NW   X   X   X         3017_NW   X      X   X  
2036_NW   X   X   X   X      3018_NW   X      X     
2037_NW   X   X   X   X      3019_NW   X      X   X  
2038_NW   X   X      X      3020_NW   X      X   X  
2039_NW   X   X   X   X      3021_NW   X           
2040_NW   X   X   X   X      3022_NW   X      X   X  
  
Subject   MH   BABS   DTI   coherence  
3023_NW   X      X   X  
3024_NW   X      X     
3025_NW   X      X   X  
3026_NW   X           
3027_NW   X      X   X  
3028_NW   X           
3029_NW   X      X   X  
3030_NW   X      X   X  
3031_NW   X      X   X  
3032_NW   X      X   X  
3033_NW   X           
3034_NW   X      X   X  
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3035_NW   X      X   X  
3036_NW   X      X     
3037_NW   X      X   X  
3038_NW   X      X   X  
3039_NW   X      X   X  
3040_NW   X           
3041_NW   X      X   X  
3042_NW   X      X     
3043_NW   X           
3044_NW   X      X   X  
  
Supplementary  Table  S1  -­  available  data  among  all  participants.  Rows  are  subjects.  X  indicates  data  
for  a  subject  is  present  in  a  given  modality  indicated  by  the  column.  
  
6.3  IBD  
#   Variable   Explanation   Mean   STD  
1  Any  use  of  IBD  meds  
Use  of  any  IBD  related  medications  (all  the  
medications  in  variables  #2-­#43)   0.88   0.33  
2  Days  on  rectal  5-­ASA   Number  of  days  rectal  aminosalicylates  used   15.25   52.58  
3  Any  rectal  5-­ASA  use    
Rectal  aminosalicylates  used  in  this  year:  yes  /  
no   0.14   0.35    
4  
Episodes  on  rectal  5-­
ASA    
Number  of  times  an  episode  of  rectal  
aminosalicylates  started   0.17   0.52  
5  Days  on  oral  5-­ASA   Number  of  days  oral  aminosalicylates  used   124.08   147.97  
6  Any  oral  5-­ASA  use   Oral  aminosalicylates  used  in  this  year:  yes/  no   0.53   0.50  
7  
Episodes  on  oral  5-­
ASA  
Number  of  times  an  episode  of  oral  
aminosalicylates  started   0.46   0.82  
8  Days  on  antibiotics   Number  of  days  antibiotics  used   6.29   24.88  
9  Any  antibiotics  use   Antibiotics  used  in  this  year:  yes/no   0.23   0.42  
10  
Episodes  on  
antibiotics   Number  of  times  an  episode  of  antibiotics  started     0.30   0.67  
11  Days  on  budesonide  
Number  of  days  budesonide  (local  release  
steroid)  used   7.74   38.53  
12  Any  budesonide  use  
Budesonide  (local  release  steroid)  used  in  this  




Number  of  times  an  episode  of  budesonide  (local  
release  steroid)  started   0.08   0.37  
14  Days  on  rectal   Number  of  days  rectal  steroids  used   3.75   18.24  
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steroids  
15  Any  rectal  steroid  use   Rectal  steroids  used  in  this  year:  yes/no   0.08   0.27  
16  
Episodes  on  rectal  
steroids  
Number  of  times  an  episode  of  rectal  steroids  
started     0.10   0.42  
17  
Days  on  oral/IV  
steroids   Number  of  days  systemic  steroids  used   18.63   51.06  
18  
Any  use  of  oral/IV  
steroids   Systemic  steroids  used  in  this  year:  yes/no   0.28   0.45  
19  
Episodes  on  oral/IV  
steroids    
Number  of  times  an  episode  of  systemic  steroids  
started     0.38   0.80  
20  
Episodes  of  long-­term  
steroid  use  
Number  of  times  an  episode  of  long  term  (>90  
consecutive  days)  steroids  started   0.05   0.25  
21  Days  on  thiopurines   Number  of  days  thiopurines  used   47.54   111.77  




Number  of  times  an  episode  of  thiopurines  
started   0.13   0.47  
24  Days  on  MTX     Number  of  days  methotrexate  used   6.34   41.04  
25  Any  MTX  use   Methotrexate  used  in  this  year:  yes/no   0.03   0.18  
26  Episodes  on  MTX  
Number  of  times  an  episode  of  methotrexate  
started     0.03   0.21  
27  
Days  on  cyclosporine  
or  tacrolimus   Number  of  days  on  cyclosporine  or  tacrolimus   1.09   17.70  
28  
Any  use  of  
cyclosporine  or  
tacrolimus  
Cyclosporine  or  tacrolimus  used  in  this  year:  





Number  of  times  an  episode  of  cyclosporine  or  
tacrolimus  was    started   0.00   0.08  
30  Days  on  ADA   Number  of  days  adalimumab  used   16.92   69.70  
31  Any  ADA  use   Adalimumab  used  in  this  year:  yes/no   0.07   0.26  
32  Episodes  on  ADA  
Number  of  times  an  episode  of  adalimumab  
started   0.05   0.26  
33  Days  on  IFX   Number  of  days  infliximab  used   31.03   92.95  
34  Any  IFX  use   Infliximab  used  in  this  year:  yes/no   0.12   0.32  
35  Episodes  on  IFX   Number  of  times  an  episode  of  infliximab  started     0.10   0.36  
36  Days  on  CTZ   Number  of  days  certolizumab  used   3.18   31.14  
37  Any  CTZ  use   Certolizumab  used  in  this  year:  yes/no   0.01   0.12  
38  Episodes  on  CTZ  
Number  of  times  an  episode  of  certolizumab  
started   0.01   0.12  
39  Days  on  NAT   Number  of  days  natalizumab  used   0.31   9.41  
40  Any  NAT  use   Natalizumab  used  in  this  year:  yes/no   0.00   0.03  
41  Episodes  on  NAT  
Number  of  times  an  episode  of  natalizumab  
started   0.00   0.03  
42  Episodes  on  biologics  
Number  of  times  an  episode  of  biologics  started.  
Variable  #30-­#41  are  all  biologics.  This  should  be  
the  sum  of  #32,  #35,  #38,  and  #41   0.16   0.47  
43  Any  biologic  use  
Biologics  used  in  this  year:  yes/no.  Variable  #30-­
#41  are  all  biologics.  If  any  of  those  are  >0  this   0.19   0.39  
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should  be  1.  
44  IBD  claims   Number  of  IBD  claims   5.99   8.53  
45  CD  claims   Number  of  Crohn's  disease  claims   3.35   7.96  
46  Any  CD  claims   Any  Crohn's  disease  claims  this  year:  yes/no   0.50   0.50  
47  UC  claims   Number  of  ulcerative  colitis  claims   2.75   4.77  
48  Any  UC  claims   Any  ulcerative  colitis  claims  this  year:  yes/no   0.63   0.48  
49  Office  visits   Number  of  office  visits   8.08   7.64  
50  Any  office  visits   Any  office  visits  this  year:  yes/no   0.99   0.12  
51  
IBD  related  office  
visits   Number  of  IBD  related  office  visits   2.35   2.77  
52  
Any  IBD  related  office  
visits   Any  IBD  related  office  visits  this  year:  yes/no   0.80   0.40  
53  
IBD  related  office  
visits  with  GE  
Number  of  IBD  related  office  visits  with  a  
gastroenterologist   1.21   1.78  
54  
Any  IBD  related  office  
visits  with  GE  
Any  IBD  related  office  visits  with  a  
gastroenterologist  this  year:  yes/no   0.53   0.50  
55  
IBD  related  office  
visits  with  UCLA  GE  
Number  of  IBD  related  office  visits  with  a  UCLA  
gastroenterologist   0.02   0.13  
56  
Any  IBD  related  office  
visits  with  non-­UCLA  
GE  
Any  IBD  related  office  visits  with  a  non-­UCLA  
gastroenterologist  this  year:  yes/no   0.51   0.50  
57  Colonoscopies   Number  of  colonoscopies   0.49   0.63  
58  Any  colonoscopies   Any  colonoscopies  this  year:  yes/no   0.44   0.50  
59  Upper  endoscopies   Number  of  upper  endoscopies   0.15   0.40  
60  
Any  upper  
endoscopies   Any  upper  endoscopies  this  year:  yes/no   0.13   0.34  
61  
Endoscopies  of  small  
intestines   Number  of  endoscopies  of  the  small  intestine   0.02   0.20  
62  
Any  endoscopies  of  
small  intestines  
Any  endoscopies  of  the  small  intestine  this  year:  
yes/no   0.02   0.14  
63  IBD  surgeries   Number  of  IBD  related  surgeries   0.06   0.35  
64  Any  IBD  surgeries     Any  IBD  related  surgeries  this  year:  yes/no   0.04   0.20  
65  Acute  IBD  surgeries  
Number  of  acute  IBD  related  surgeries  (this  is  a  
subset  of  IBD  related  surgeries)   0.06   0.32  
66  
Any  acute  IBD  
surgeries  
Any  acute  IBD  related  surgeries  (this  is  a  subset  
of  IBD  related  surgeries)  this  year:  yes/no   0.04   0.20  
67  CRP  tests   Number  of  C-­reactive  protein  tests   0.73   1.55  
68  Any  CRP  tests   Any  C-­reactive  protein  tests  this  year:  yes/no   0.34   0.47  
69  ESR  tests   Number  of  sedimentation  rate  tests   0.91   1.73  
70  Any  ESR  tests   Any  sedimentation  rate  tests  this  year:  yes/no   0.40   0.49  
71  Calprotectin  tests   Number  of  stool  calprotectin  tests   0.04   0.27  
72  Any  calprotectin  tests   Any  stool  calprotectin  tests  this  year:  yes/no   0.03   0.17  
73  CBC  tests   Number  of  complete  blood  counts   2.68   3.60  
74  Any  CBC  tests   Any  complete  blood  counts  this  year:  yes/no   0.83   0.37  
75  Liver  enzyme  tests   Number  of  liver  enzyme  tests   2.31   2.94  
76  Any  liver  enzyme  tests   Any  liver  enzyme  tests  this  year:  yes/no   0.80   0.40  
77  Hepatitis  B  tests   Number  of  Hepatitis  B  tests   0.12   0.41  
78  Hepatitis  B  vaccination  Hepatitis  B  vaccination  this  year:  yes/no   0.11   0.32  
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79  Abdominal  X-­rays   Number  of  X-­rays   0.23   0.86  
80  Any  abdominal  X-­rays   Any  X-­rays  this  year:  yes/no   0.13   0.33  
81  Abdominal  CT  scans   Number  of  CT  scans   0.29   0.83  
82  
Any  abdominal  CT  
scans   Any  CT  scans  this  year:  yes/no   0.19   0.40  
83  Abdominal  MR  scans   Number  of  MR  scans   0.06   0.29  
84  
Any  abdominal  MR  
scans   Any  MR  scans  this  year:  yes/no   0.05   0.23  
85  
Abdominal  
ultrasounds   Number  of  ultrasounds   0.10   0.35  
86  
Any  abdominal  
ultrasounds   Any  ultrasounds  this  year:  yes/no   0.09   0.28  
87  
Bone  loss  assessment  
done   Bone  loss  assessment  this  year:  yes/no   0.07   0.25  
88  C.  difficile  tests   Number  of  Clostridium  difficile  stool  tests   0.16   0.51  
89  Any  C.  difficile  tests    
Any  Clostridium  difficile  stool  tests  this  year:  
yes/no   0.12   0.32  
90  Tuberculosis  tests   TB  tested  this  year:  yes/no   0.09   0.28  
91  Influenza  vaccination   Influenza  vaccine  this  year:  yes/no   0.17   0.37  
92  
Pneumococcal  




Charlson  comorbidity  score  (higher  score  means  
more  comorbidities)   0.50   1.15  
94  Number  of  claims     Total  number  of  claims   73.79   89.59  
95  
Days  covered  for  
prescriptions  
Total  number  of  days  prescriptions  were  covered  
by  plan   364.15   8.02  
96  Hospitalizations   Number  of  hospitalizations   0.27   0.82  
97  Any  hospitalizations   Any  hospitalizations  this  year:  yes/no   0.17   0.38  
98  Days  in  hospital     Total  number  of  days  hospitalized     1.74   8.04  
99  
IBD  related  
hospitalizations   Number  of  IBD  related  hospitalizations   0.10   0.42  
100  
Any  IBD  related  
hospitalizations   Any  IBD  related  hospitalizations  this  year:  yes/no   0.07   0.26  
101  
Days  in  hospital  for  
IBD   Total  number  of  days  hospitalized  related  to  IBD   0.76   4.53  
102  ED  visits   Number  of  ED  visits   0.60   1.94  
103  Any  ED  visits   Any  ED  visits  this  year:  yes/no   0.27   0.44  
104  IBD  related  ED  visits   Number  of  IBD  related  ED  visits   0.26   1.17  
105  
Any  IBD  related  ED  
visits   Any  IBD  related  ED  visits  this  year:  yes/no   0.14   0.34  
106  Age   Age   42.02   13.94  
107  Moderate  disease  
Moderate  disease  this  year:  yes/no  (based  on  a  
combination  of  number  of  relapses  and  long  term  
steroid  use)   0.21   0.41  
108   Severe  disease  
Severe  disease  this  year:  yes/no  (based  on  a  
combination  of  number  of  relapses  and  long  term  
steroid  use)   0.15   0.36  
109   Relapses   Relapse  rate  (based  on  number  of  times   0.60   1.03  
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systemic  steroids  and  biologics  are  started  and  
acute  IBD  related  surgeries)  
110   Years  with  Anthem  
The  number  of  years  someone  has  been  a  
continuous  member  of  Anthem   0.04   0.21  
  
Supplemental  Table  S2  -­  insurance  claims  data.  Both  the  training  and  validation  data  contained  110  




Supplementary  Figure  S2  -­  feature  extraction.  Hospitalization  risk  is  related  to  the  time  of  year  and  
length  of  time  someone  has  been  a  continuous  member  of  the  insurance  plan.  The  length  of  membership  
time  is  conflated  with  increased  age.
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